
<html lang="en"     class="pb-page"  data-request-id="37be4480-78fe-4a84-a65a-6fee31206120"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm901812z;issue:issue:10.1021/jmcmar.2010.53.issue-18;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Oral Oxytocin Antagonists" /></meta><meta name="dc.Creator" content="Alan D.  Borthwick" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 15, 2010" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901812z" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901812z" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901812z" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901812z" /></link>
        
    
    

<title>Oral Oxytocin Antagonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901812z" /></meta><meta property="og:title" content="Oral Oxytocin Antagonists" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901812z"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901812z">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901812z&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901812z&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901812z&amp;href=/doi/10.1021/jm901812z" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 6525-6538</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm901869w" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Oral Oxytocin Antagonists</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+D.++Borthwick">Alan D. Borthwick</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">DrugMolDesign, 15 Temple Grove, London NW11 7UA, U.K.</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +44 (0)7772112742. E-mail: <a href="/cdn-cgi/l/email-protection#6c0d000d024208420e031e18041b050f072c081e190b01030008091f050b02420f0301"><span class="__cf_email__" data-cfemail="8dece1ece3a3e9a3efe2fff9e5fae4eee6cde9fff8eae0e2e1e9e8fee4eae3a3eee2e0">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901812z&amp;href=/doi/10.1021%2Fjm901812z" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 6525–6538</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 15, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 December 2009</li><li><span class="item_label"><b>Published</b> online</span>15 June 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 September 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901812z" title="DOI URL">https://doi.org/10.1021/jm901812z</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6525%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAlan%2BD.%2BBorthwick%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D18%26contentID%3Djm901812z%26title%3DOral%2BOxytocin%2BAntagonists%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6538%26publicationDate%3DSeptember%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901812z"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2444</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">25</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901812z" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Oral Oxytocin Antagonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;D. Borthwick&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;6525-6538&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901812z&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901812z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901812z" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901812z&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901812z" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901812z&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901812z" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901812z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901812z&amp;href=/doi/10.1021/jm901812z" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901812z" /></input><a href="/doi/pdf/10.1021/jm901812z" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901812z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901812z%26sid%3Dliteratum%253Aachs%26pmid%3D20550119%26genre%3Darticle%26aulast%3DBorthwick%26date%3D2010%26atitle%3DOral%2BOxytocin%2BAntagonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D18%26spage%3D6525%26epage%3D6538%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291155" title="Bioavailability">Bioavailability</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jmcmar.2010.53.issue-18/production/jmcmar.2010.53.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57181" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57181" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Oxytocin is a mammalian nonapeptide hormone produced in the hypothalamus and secreted by the posterior pituitary gland into the circulation. It is also synthesized in the peripheral tissues of the uterus, testis, and heart. Oxytocin exhibits a range of physiological roles<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> including mammary and uterine smooth muscle contraction, neurotransmission in the central nervous system, and autocrine and/or paracrine functions in the ovaries and testes. In the uterus, oxytocin is involved in the onset and progression of labor and has been long regarded as a pregnancy hormone as it stimulates labor and milk ejection. It is also recognized as having a wide spectrum of functions outside pregnancy especially in the central nervous system, where it is involved in the control of human behavior<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> including social behavior, reproductive behavior, and emotions.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Oxytocin is a clinically proven inducer of labor in pregnant women. It works as a potent stimulant of uterine contractions via the interaction with oxytocin receptors that are expressed in myometrial cells in the mammalian uterus. These receptors in the uterus vastly increase in number during pregnancy. The agonist oxytocin binds to the extracellular region and transmembrane domain of the receptor, which enables the intracellular part to couple to G-proteins and initiate a cascade of events liberating Ca<sup>2+</sup>, which causes smooth muscle contractions.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The oxytocin receptor (OTR),<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> a member of the superfamily of seven-transmembrane (7TM) G-protein coupled receptors (GPCRs<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: 7TM, seven-transmembrane; GPCRs, G-protein coupled receptors; hOTR, human oxytocin receptor; rOTR, rat oxytocin receptor; ACTH, adrenocorticotropic hormone; Rec CHO, transfected chinese hamster ovary cells; hV1aR, human vasopressin V1a receptor; hV1bR, human vasopressin V1b receptor; hV2R, human vasopressin V2 receptor; LE, ligand efficiency; LipE, lipophilic efficiency; MDCK, Madin−Darby canine kidney; DKPs, 2,5-diketopiperazines; EHOA, estimated human oral absorption; CHI log <i>D</i>, HPLC measured lipophilicity.</p></div>) has no subtypes but is structurally related to the vasopressin receptors (V1aR, V1bR, V2R).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The V1aR and V2Rs are mainly expressed peripherally and involved in the modulation of blood pressure and kidney function, respectively, while the V1bR is expressed in the brain and pituitary gland and controls ACTH and β-endorphin release.</div><div class="NLM_p">The key role played by oxytocin and its receptor in the initiation and maintenance of uterine contractions of labor during childbirth has prompted many research groups to seek an effective antagonist of these effects in the search for tocolytic agents that inhibit preterm labor and delay premature birth. The starting point for these endeavors was the cyclic part of the peptide structure <b>1</b>, found in the endogenous agonist oxytocin (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Interest in OTR antagonists began after the initial finding by du Vigneaud that modification to the 1 position of <b>1</b> by gemdimethyl (1966)<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and by cyclic spiro substituent (1975)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> gave OTR antagonism. Similar simple modifications of the cyclic peptide oxytocin such as introduction of an ornithine at position 8 and capping of the 2-tyrosine hydroxyl group as a methyl or ethyl ether, introduction of non-natural and <span class="smallcaps smallerCapital">d</span>-amino acids as well as preparing conformationally constrained bicyclic analogues, were exploited subsequently by several research groups which gave a number of potent cyclic peptidic OTR antagonists.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10">(7-10)</a> This effort led to the most prominent OTR antagonist available to date, atosiban<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (Tractocile) <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which has been shown to inhibit uterine contractions and delay preterm delivery. Intravenously administered atosiban has been established as an acute treatment of preterm labor.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However atosiban is a peptide and a mixed oxytocin/vasopressin V1a antagonist that has to be given by iv infusion and is not suitable for long-term maintenance treatment as it is not orally bioavailable.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11-14)</a> Hence there has been considerable interest during the last two decades in overcoming the shortcomings of the first generation peptide antagonists by identifying orally active nonpeptide oxytocin antagonists with a higher degree of selectivity toward V1aR, V1bR, and V2R with good levels of oral bioavailability. With the discovery that oxytocin has a wide spectrum of functions outside pregnancy,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> interest has also developed in oxytocin antagonists as a potential treatment of sexual dysfunction including premature ejaculation<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and the treatment or prevention of benign prostate hyperplasia.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0015.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of agonist oxytocin <b>1</b> and antagonist atosiban <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Oxytocin antagonists have been reviewed in 1997,<a onclick="showRef(event, 'ref7 ref17'); return false;" href="javascript:void(0);" class="ref ref7 ref17">(7, 17)</a> and recently covering the literature to the end of 2006,<a onclick="showRef(event, 'ref8 ref18'); return false;" href="javascript:void(0);" class="ref ref8 ref18">(8, 18)</a> while a general review of the condition of preterm labor and treatment options was published in 2003.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> More recently, peptide oxytocin antagonists<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and the patent literature of oxytocin receptor ligands<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> have also been reviewed. Here the focus is on advances made in the design and development of orally bioavailable oxytocin antagonists from the first orally active nonpeptide antagonist to the most recent highly selective orally bioavailable clinical candidates.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">The Structure of Oxytocin and the Oxytocin Receptor</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14300" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14300" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The structure <b>1</b> of oxytocin is very similar to vasopressin, which differs from oxytocin by two amino acids, Arg-8 and Phe-3. Because of the close structural similarity of these cyclic peptide natural ligands and their receptors, a major challenge has been to find selective peptide oxytocin antagonists and this selectivity has also been one of the chief goals in developing novel orally bioavailable nonpeptide oxytocin antagonists. The structure and the binding mode of oxytocin and the OTR have been extensively investigated to aid the design of selective oxytocin antagonists</div><div class="NLM_p">The endogenous ligand oxytocin is a cyclic nonapeptide in which a hexapeptide ring is formed as a result of disulfide bonds between Cys-1 and Cys-6 residues; it has high affinity (∼1 nM) for the receptor. The OTR<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> is a 389-amino acid polypeptide whose gene is located on the human chromosome 3p25 and is a member of the superfamily of seven-transmembrane (7TM) G-protein coupled receptors (GPCRs) that has no subtypes but is structurally related to the vasopressin receptors.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The combined evidence from studies involving site-directed mutagenesis, photoaffinity labeling, and molecular modeling indicate that in interacting with its receptor the cyclic part of oxytocin is lodged in the upper one-third of the receptor binding pocket (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) and interacts with transmembrane domains III, IV, and VI, whereas the linear C-terminal part of oxytocin remains closer to the surface and interacts with transmembrane domains II and III in addition to the first extracellular loop.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0016.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Oxytocin and the 7TM G-protein-coupled oxytocin receptor. Reprinted with permission from ref <a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">4</a>. Copyright 2003 Elsevier.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The key functionalities for agonist activity in oxytocin are the 2-Tyr and 3-Ile amino acids which occur in the cyclic part of oxytocin that binds in the upper one-third of the receptor binding pocket (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The hydrophobic 3-Ile residue is the residue that differs between oxytocin and vasopressin in the cyclic part of the molecule. Modification of the tyrosine residue at the 2-position of oxytocin produces antagonist activity. The deamino OEt-Tyr<sup>2</sup> oxytocin analogue is a potent antagonist of oxytocin-induced contractions in the rat uterus in vitro and in vivo.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Modification of the 4 and 8 positions of this deamino OEt-Tyr<sup>2</sup> oxytocin analogue gave the antagonist atosiban.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In addition, structure−activity studies of oxytocin analogues have revealed that the antagonist property depends on a specific conformation, and the appropriate modification of Tyr<sup>2</sup> plays a crucial role in this function. The incorporation of bulky apolar side chain amino acids in position 2 increased potency and made more effective oxytocin antagonists. The use of <span class="smallcaps smallerCapital">d</span>-indanylglycine (<span class="smallcaps smallerCapital">d</span>-IgL) as a rigid homophenylalanine analogue resulted in OTR affinity higher than that of <span class="smallcaps smallerCapital">d</span>-Phe<sup>2</sup> with greater selectivity for oxytocin over the vasopressin receptors.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Hence recognizing and mimicking the 2-Tyr and 3-Ile amino acids interaction of oxytocin with the OTR is one of the key targets in the design of oxytocin antagonists.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Templates for Orally Bioavailable Nonpeptide Oxytocin Antagonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28558" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28558" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Since the early days of oxytocin peptide antagonists, there has been significant interest in developing orally active agents. Researchers at Merck<a onclick="showRef(event, 'ref8 ref17'); return false;" href="javascript:void(0);" class="ref ref8 ref17">(8, 17)</a> in the early 1990s made the first major impact in the area of nonpeptide oxytocin antagonists by investigating natural products, compound collections, and vasopressin antagonist templates. They produced the first report of an orally active nonpeptide oxytocin antagonist and the first oral oxytocin antagonist in phase one clinical trials shown to block the uterine response to exogenous oxytocin in women in the immediate postpartum period. With the cloning of OTR in 1992 (Kimura et al.),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> screening strategies to identify nonpeptide leads became viable, and in the past decade Merck’s pioneering work on oral oxytocin antagonists was carried forward by Serono/Applied Systems, GSK, Sanofi-Synthelabo, and Pfizer. Numerous examples of nonpeptide OTR antagonists appeared in the literature, demonstrating that a wide range of chemical structures can satisfy the requirements for high affinity binding to the receptor. However, several factors need to be considered to obtain a viable drug from an orally bioavailable OTR antagonist. In addition to the appropriate physicochemical properties required for good aqueous solubility and permeability, there is a need to achieve high selectivity and safety in the compounds that are designed. Because V1aR is involved in modulating blood pressure, V2R in kidney function, and V1bR in ACTH and β-endorphin release, and there is close structural similarity between oxytocin and vasopressin, the high selectivity of an oral OTR antagonist over these three receptors of vasopressin is a key consideration. Also as the OTR occurs in the brain as well as peripherally, blocking blood−brain barrier penetration to achieve selective activity peripherally or targeting brain penetration for a CNS driven activity are important considerations. Good aqueous solubility and permeability to attain high orally bioavailability and good animal pharmacokinetics should be a requirement to enable sufficient exposure in humans.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Camphor Sulphonamides (Spiroindenepiperidines and <i>o</i>-Tolylpiperazines)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46517" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46517" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Screening the chemical collection at Merck identified the relatively rigid spirotetralinpiperidine derivative <b>3</b>, L-342,643, as an active oxytocin antagonist.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The spirotetralinpiperidine <b>3</b> has a low binding affinity for the human oxytocin receptor (hOTR) of 1 μM with comparable activity at the rat oxytocin receptor (rOTR) and with some selectivity with respect to the receptors of vasopressin (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). SAR studies showed that the spiroindenepiperidine ring system was more active than the related six-membered spirotetralinpiperidine analogue. Replacing the piperidine ring with an ethylamine chain led to reduced activity, and bulky lipophilic group replacements of the aromatic ring in the <i>p</i>-tolyl sulfonamide increased potency, whereas replacement with amides and ureas reduced potency. This led to the camphor sulphonamide <b>4</b>, L-366,509, containing an <i>endo</i> carboxylic acid for water solubility, which has modest activity and selectivity for the OTR (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). However, <b>4</b> given iv or id to rats caused a significant and long lasting inhibition of oxytocin induced uterine contractions. Significantly, OTR antagonist activity resulted after iv and oral dosing in a late gestation pregnant rhesus monkey, which established <b>4</b> as the first orally active nonpeptide oxytocin antagonist.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> Extensive SAR investigations to exploit this significant lead showed that both the aromatic ring of the spiroindenepiperidine and the camphor ring were important hydrophobic regions for binding to the receptor and the <i>o</i>-tolylpiperazine ring could be interchanged with the spiroindenepiperidine ring and maintain activity. Modification at the C-2 <i>endo</i> position on the camphor ring with one or more polar functionalities capable of forming hydrogen bonds led to derivatives with single figure nanomolar potency at the rOTR, of which <b>5</b>, L-368,899, was chosen for further investigation (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> This revealed that <b>5</b> possessed good potency as an antagonist of oxytocin induced uterine contractions in rats (AD<sub>50</sub> = 0.35 mg/kg iv) and late gestation pregnant rhesus monkeys (AD<sub>50</sub> = 0.027 mg/kg iv). Although it had good affinity for the hOTR, it only exhibited 14-fold and 45-fold selectivity versus the hV1aR and the hV2R, respectively, in vitro (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), however it had a 75-fold separation of oxytocin and vasopressin antagonist activities in vivo in rats. It also had oral bioavailability in several species (<i>F</i> = 35% rat, 25% dog, 21% chimpanzee), sufficient aqueous solubility (∼2.5 mg/kg at pH 5.2) for iv formulation, and an excellent overall preclinical toxicology profile.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The amine <b>5</b> had an oral bioavailability of 20% in humans and in phase one clinical trials was shown to block the uterine response to exogenous oxytocin in women in the immediate postpartum period. However, further development of <b>5</b> was discontinued because of the high oral dose, 600 mg at 6 h intervals, required to maintain the trough plasma levels associated with complete block of the uterine response to oxytocin in the study in postpartum women.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Further investigation showed that first pass metabolism involving hydroxylation at the C-5 <i>exo</i> position and the C-9 methyl group in the camphor moiety of <b>5</b> was found to be a limiting factor for obtaining good plasma levels after oral dosing in rhesus monkeys and incubations with human liver microsomes produced hydroxylated camphor derivatives as the major metabolites.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Attempts to improve the overall metabolic stability by modification of the camphor portion of the structure by substitution or isomeric replacements were unsuccessful.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Human and Rat Oxytocin/Vasopressin Receptor Binding, Oxytocin Antagonism in the Rat, and Oral Bioavailability in Rat and Humans of the Camphor Sulphonamides<a onclick="showRef(event, 'ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27">(24-27)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0017.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="/" /></col><col align="char" char="/" /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="/">oxytocin receptors</th><th class="colsep0 rowsep0" colspan="2" align="center" char="/">vasopressin receptors</th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">oxytocin antagonism in rat</th><th class="colsep0 rowsep0" colspan="2" align="center">bioavailability</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="/">hOTR/<i>rOTR</i><br /></br><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="/">hV1aR <i>/ rV1aR</i><br /></br><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="/">hV2R/<i>rV2R</i><br /></br><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">iv <br /></br>AD<sub>50</sub> (mg/kg)<a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">id <br /></br>AD<sub>50</sub> (mg/kg)<a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">rat <br /></br><i>F</i>%</th><th class="colsep0 rowsep0" align="center">human <br /></br><i>F</i>%</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="/">1000/<i>1600</i></td><td class="colsep0 rowsep0" align="char" char="/">−/<i>9800</i></td><td class="colsep0 rowsep0" align="char" char="/">−/><i>40000</i></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char="/">530/<i>370</i></td><td class="colsep0 rowsep0" align="char" char="/">1600/<i>26000</i></td><td class="colsep0 rowsep0" align="char" char="/">5600/<i>29000</i></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char="/">13/<i>3.6</i></td><td class="colsep0 rowsep0" align="char" char="/">180/<i>110</i></td><td class="colsep0 rowsep0" align="char" char="/">590/<i>200</i></td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> values refer to displacement of of [3H]-oxytocin or [3H]-vasopressin from specific binding sites in the indicated tissue. hOTR in human uterus tissue, rOTR in rat uterus tissue, hV1aR in human liver or platelet tissue, rV1aR in rat liver tissue, hV2R in human kidney tissue, rV2R in rat kidney tissue.</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">AD<sub>50</sub> values refer to the intravenous (iv) or intraduodenal (id) dose to inhibit oxytocin-induced uterine contractions by 50% in the rat.</p></div></div></div><div class="NLM_p last">Recently, it has been shown<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> that <b>5</b>, accumulates in limbic brain areas in monkeys when peripherally administered and alters female maternal and sexual behavior. It is therefore a useful pharmacological tool for the study of social motivation in nonhuman primates</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Benzoxazinylpiperidines</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72485" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72485" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Merck scientists showed<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> that the orally bioavailable V1aR antagonist <b>6</b>, OPC-21268, originally developed by researchers at Otsuka, had significant affinity for the rOTR and the hOTR (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and used it as a starting point for lead optimization to obtain more potent and selective oxytocin antagonists. Three types of modification were discovered that increased binding affinity. Replacement of the quinolinone by a benzoxazinone ring gave a 2-fold enhancement in affinity. Constraining the acetamidopropyloxy chain in the form of an <i>N</i>-acetyl-4-piperidinyloxy ring gave a further 6-fold improvement, and addition of an <i>ortho</i> methoxy substituent on the benzoyl ring gave 5-fold greater affinity. A compound with these modifications <b>7</b>, L-371,257, had single figure nanomolar affinity for the hOTR and exhibited 690-fold and >8000-fold selectivity versus the hV1aR and the hV2R, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">Compound <b>7</b> was shown to dose dependently inhibit oxytocin induced uterine contractions in anaesthetized rats by iv and intraduodenal routes, with AD<sub>50</sub> values of 0.55 mg/kg and 2.5 mg/kg, respectively, and was orally bioavailable in the rat (<i>F</i> = 39%) and rhesus monkeys (<i>F</i> = 13%). The compound optimization program was continued with the aim of further improving pharmacokinetic half-life, solubility, potency, and bioavailability. SAR studies indicated that changes to the benzoyl, benzoxazinone, and central piperidine portions of the molecule were generally deleterious to OTR affinity, whereas the piperidinyl ether terminus was more tolerant to change. Several new compounds resulted from these efforts, the most prominent being the pyridine <i>N</i>-oxide <b>8</b>, L-372,662, which retained excellent single figure nanomolar hOTR affinity and exhibited 650-fold and >5700-fold selectivity versus the hV1aR and the hV2R, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Human and Rat Oxytocin/Vasopressin Receptor Binding, Oxytocin Antagonism in the Rat, and Oral Bioavailability in the Rat, Dog, and Rhesus Monkey of the Benzoxazinylpiperidines<a onclick="showRef(event, 'ref31 ref32 ref33 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref35 ref36">(31-33, 35, 36)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0001.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="/" /></col><col align="char" char="/" /></col><col align="char" char="/" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="/">oxytocin receptors</th><th class="colsep0 rowsep0" colspan="2" align="center" char="/">vasopressin receptors</th><th class="colsep0 rowsep0" colspan="2" align="center">oxytocin antagonism in rat</th><th class="colsep0 rowsep0" colspan="3" align="center">bioavailability</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="/">hOTR/<i>rOTR</i><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><br /></br><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="/">hV1aR/<i> rV1aR</i><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><br /></br><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="/">hV2R/<i>rV2R</i><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><br /></br><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">iv <br /></br>AD<sub>50</sub> (mg/kg)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">id <br /></br>AD<sub>50</sub> (mg/kg)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">rat <br /></br><i>F</i>%</th><th class="colsep0 rowsep0" align="center">dog <br /></br><i>F</i>%</th><th class="colsep0 rowsep0" align="center">monkey<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a><br /></br><i>F</i>%</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char="/">170/<i>230</i></td><td class="colsep0 rowsep0" align="char" char="/">52000/<i>32</i></td><td class="colsep0 rowsep0" align="char" char="/">>81000/><i>30000</i></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char="/">4.6/<i>19</i></td><td class="colsep0 rowsep0" align="char" char="/">3200/<i>3.7</i></td><td class="colsep0 rowsep0" align="char" char="/">37000/><i>30000</i></td><td class="colsep0 rowsep0" align="left"><i>0.55</i></td><td class="colsep0 rowsep0" align="left"><i>2.5</i></td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char="/">4.9/<i>14</i></td><td class="colsep0 rowsep0" align="char" char="/">3200/<i>0.76</i></td><td class="colsep0 rowsep0" align="char" char="/">28000/<i>9700</i></td><td class="colsep0 rowsep0" align="left"><i>0.78</i></td><td class="colsep0 rowsep0" align="left"><i>5.2</i></td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">90</td><td class="colsep0 rowsep0" align="left">36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char="/">2/−<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="/">1260/−<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="/">>3000/−<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> values refer to displacement of of [<sup>3</sup>H]-oxytocin or [<sup>3</sup>H]-vasopressin from specific binding sites in the indicated tissue. hOTR in human uterus tissue, <i>rOTR</i> in rat uterus tissue, hV1aR in human liver or platelet tissue, <i>rV1aR</i> in rat liver tissue, hV2R in human kidney tissue, <i>rV2R</i> in rat kidney tissue.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Binding affinity inhibition constant <i>K</i><sub>i</sub> (nM) versus [<sup>3</sup>H]oxytocin or [<sup>3</sup>H]vasopressin at human receptors in CHO cells.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">AD<sub>50</sub> values refer to the intravenous (iv) or intraduodenal (id) dose to inhibit oxytocin-induced uterine contractions by 50% in the rat.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Rhesus monkey.</p></div></div></div><div class="NLM_p">It was a potent oxytocin antagonist in late-gestation pregnant rhesus monkeys (AD<sub>50</sub> = 0.036 mg/kg iv) had excellent oral bioavailability in several species (<i>F</i> = 90% dog, 80% rat, 36% rhesus monkey) with a half-life of 2 h and possessed good aqueous solubility (10 mg/mL at pH 5) to allow for iv formulation.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Molecular modeling has shown that the methoxy group present in <b>7</b> and <b>8</b> provides a direct hydrophobic contact with Ala-318 in helix 7 of the hOTR required for high affinity binding of benzoxazinone-based antagonists.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p last">Researchers at GlaxoSmithKline used <b>7</b> as a starting point for a combinatorial chemistry program based on libraries from fragments derived from cleavage of the central amide bond. Separate exploration of the SAR within the amine and the carboxylic acid fragments keeping the other half constant showed that no alternatives were found for replacement of the benzoxazinylpiperidine moiety, but several heterocyclic acids were identified as replacements for the methoxy benzoic acid core.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> This led to the potent hOTR antagonist benzofuran <b>9</b> (<i>K</i><sub>i</sub> = 2 nM), which exhibited ≥630-fold selectivity versus the hV1aR and hV2R (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The trifluoromethyl pyridine moiety of <b>9</b> conferred favorable pharmacokinetic parameters (<i>F</i> = 51% dogs and <i>F</i> = 16% rats). However, potency in the oxytocin-induced rat uterine contraction model was much lower (IC<sub>50</sub> = 3 μM) than predicted from its in vitro potency at the rOTR (IC<sub>50</sub> = 20 nM). This significant lower potency was attributed to high protein binding (96%). Also a 46-fold shift in in vitro oxytocin-binding affinity at the hOTR was observed when the compound was tested in the presence of physiologically relevant concentrations of human serum albumin, and the compound was not pursued further.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Pyrrolidine Oximes</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82887" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82887" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">High-throughput screening of the GPCR-directed compound collection in the Serono organization led to the identification of the pyrrolidine oxime ether <b>10</b>, showing good affinity to the hOTR, (IC<sub>50</sub> = 260 nM) and promising selectivity against the hV1aR (68% inhibition at 10 μM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Subsequent SAR in this series showed that the (<i>Z</i>)-double bond isomers were 3−4-fold more potent than the corresponding (<i>E</i>)-isomers and (<i>S</i>)-configuration at the α-carbon of the proline core was critical for activity in contrast to the configuration of the carbinol center, which was not critical for activity.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Also substitution on the distal ring of the biphenyl at the <i>ortho</i> position with methyl or chlorine gave a 2−4-fold increase in potency. Although cyclization of the amide carbinol chain to an oxadiazole ring (e.g., <b>24</b> Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) gave derivatives with single to double figure nanomolar binding affinity,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> the compound preferred for further progression was the (<i>Z</i>)<i>-</i>isomer of the chirally pure amide carbinol <b>11</b> containing an <i>ortho</i> methyl biphenyl (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Although it had good affinity for the hOTR (<i>K</i><sub>i</sub> = 28 nM) with 350-fold selectivity versus the hV2R, it only exhibited 6-fold selectivity versus the hV1aR. It was also somewhat less active against the rOTR (<i>K</i><sub>i</sub> = 135 nM). However, it was active at inhibiting contractions in isolated rat uterine strips (p<i>A</i><sub>2</sub> = 7.8) and it inhibited oxytocin-induced contractions in the nonpregnant rat with an ED<sub>50</sub> of 3.5 mg/kg after intravenous dosing and 89 mg/kg after oral administration. Furthermore, it showed some inhibition of spontaneous uterine contractions in the pregnant rat and favorable pharmacokinetics were observed (<i>F</i> = 49%, <i>t</i><sub>1/2</sub> = 2.8 h) in this species.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Human and Rat Oxytocin/Vasopressin Receptor Binding, Oxytocin Antagonism in the Rat, and Oral Bioavailability in Rat and Humans of the Pyrrolidine Oximes<a onclick="showRef(event, 'ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40">(37-40)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0002.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="/" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="/">oxytocin receptors</th><th class="colsep0 rowsep0" colspan="2" align="center">vasopressin receptors</th><th class="colsep0 rowsep0" colspan="2" align="center">oxytocin antagonism in rat</th><th class="colsep0 rowsep0" align="center">bioavailability</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="/">hOTR/<i>rOTR</i><br /></br><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">hV1aR/<i> rV1aR</i><br /></br><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">hV2R/<i>rV2R</i><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">iv <br /></br>ED<sub>50</sub> (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">po <br /></br>ED<sub>50</sub> (mg/kg)</th><th class="colsep0 rowsep0" align="center">rat <br /></br><i>F</i>%</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char="/"><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> 260/−</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char="/">28/<i>135</i></td><td class="colsep0 rowsep0" align="left">170/−</td><td class="colsep0 rowsep0" align="left">>10000/−</td><td class="colsep0 rowsep0" align="left"><i>3.5</i></td><td class="colsep0 rowsep0" align="char" char="."><i>89</i></td><td class="colsep0 rowsep0" align="left"><i>49</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char="/">95/<i>210</i></td><td class="colsep0 rowsep0" align="left">330/−</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">∼<i>30</i></td><td class="colsep0 rowsep0" align="left"><i>55</i></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">IC<sub>50</sub>.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Binding affinity inhibition constant <i>K</i><sub>i</sub> (nM) versus [<sup>3</sup>H]-oxytocin or [<sup>3</sup>H]-vasopressin at human and rat receptors in CHO cells.</p></div></div></div><div class="NLM_p last">Subsequent optimization iterations to identify compounds with better pharmacokinetic properties led to the hydroxymethyl derivative <b>12</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). SAR round this series showed that potent activity was observed with a number of hydroxymethyl, hydroxyethyl, and methoxymethyl derivatives, but aminomethyl substitution was poorly tolerated.<a onclick="showRef(event, 'ref8 ref40'); return false;" href="javascript:void(0);" class="ref ref8 ref40">(8, 40)</a> The compound <b>12</b> had a <i>K</i><sub>i</sub> of 95 nM against hOTR, with modest rat activity (<i>K</i><sub>i</sub> = 210 nM) against the rOTR and weak (<4-fold) selectivity versus the hV1aR (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). It had good pharmacokinetic properties in rat, being 55% orally bioavailable, and exhibited low levels of human serum protein binding (71%). Consistent with these drug-like properties, the compound was active in a number of in vivo models. At 30 mg/kg po, it inhibited oxytocin-induced contractions in nonpregnant rats by 51% and spontaneous contractions in pregnant rats were inhibited in a dose-dependent manner (around 40% inhibition observed with a 60 mg/kg oral dose). A possible issue with this series is the potential isomerization of the oxime group and its low level of selectivity verses the hV1aR.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Indolin-2-ones</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81430" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81430" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Sanofi have described a series of indolin-2-one derivatives that are potent and selective oxytocin antagonists.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The lead compound SSR126768A (<b>13</b>) has high affinity for both the hOTR and the rOTR in uterus tissue (<i>K</i><sub>i</sub> = 0.5 nM and <i>K</i><sub>i</sub> = 1.6 nM, respectively) and 280-fold lower affinity for the hV1aR and even much lower (>2000) for the hV2R in rec.CHO cells (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In rat-isolated myometrium, oxytocin-induced uterine contractions were competitively antagonized by <b>13</b> (p<i>A</i><sub>2</sub> = 8.47). In addition, the indolin-2-one <b>13</b> has oral activity. Oral administration of a 3 mg/kg dose of <b>13</b> to rats was found to be effective for up to 24 h in the competitive inhibition of uterine contractions. At higher doses, <b>13</b> (30 mg/kg po) was comparable in the delay of labor in pregnant rats to the β-adrenergic agonist tocolytic, ritodrine (10 mg/kg po).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Human and Rat Oxytocin/Vasopressin Receptor Binding, and Oxytocin Antagonism in the Rat, of the Indolin-2-one <b>13</b><a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0003.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">oxytocin receptors</th><th class="colsep0 rowsep0" colspan="3" align="center">vasopressin receptors</th><th class="colsep0 rowsep0" align="center">oxytocin antagonism in vivo</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hOTR/<i>rOTR</i><br /></br><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">hV1aR/<i>rV1aR</i><br /></br><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">hV1bR/<i>rV1bR</i><br /></br><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">hV2R/<i>rV2R</i><br /></br><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">rat po (3 mg/kg) <br /></br>ED<sub>50</sub> (nM) 1 h/5 h/24 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">0.5/<i>1.6</i><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">143<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a>/<i>99</i><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">−/<i>46</i><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">>1000<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a>/>1000<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">14/24/4.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">hOTR in human uterus tissue, <i>rOTR</i> in rat uterus tissue.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">hV1aR in Rec.CHO cells.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last"><i>rV1aR</i> in rat liver tissue.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last"><i>rV1bR</i> in Rec.CHO cells.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">hV2R in Rec.CHO cells.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last"><i>rV2R</i> in rat kidney tissue.</p></div></div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Biaryl Sulfonamides</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87527" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87527" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Screening a library of compounds biased toward G protein coupled receptors, researchers at Serono identified a series of isatin hydrazone sulfanilides that potently inhibited radioligand binding to the OTR.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The most potent compound was <b>14</b> (hOTR: <i>K</i><sub>i</sub> = 90 nM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). SAR studies showed that the isatin hydrazone ring was preferred for good activity over secondary and tertiary amide replacements. Changing the phenyl ring in the anilide part of sulfonamide <b>14</b> for a phenethyl or alkyl group abolishes activity, and substitution in this phenyl ring is more restrictive compared to the sulfonyl aryl ring. Only small <i>para</i> substituents increase activity, whereas large <i>para</i> or <i>meta</i> substituents decrease activity. Replacement of the sulfonyl aryl ring with a nonaromatic sulphonyl group was detrimental to affinity. However, a range of <i>para</i> substituents in this aryl ring conferred good potency. This led to the more potent oxytocin antagonist sulfanilide <b>15</b> (hOTR: <i>K</i><sub>i</sub> = 14 nM), which was 100-fold selective over the vasopressin receptor hV1a (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). It was also shown to be active in vivo by inhibiting the oxytocin-induced uterine contractions in nonpregnant anaesthetized rats (ED<sub>50</sub> = 10 mg/kg iv). However, a major deficiency was its poor aqueous solubility (<1 μg/mL), resulting in a very low oral bioavailability in rats (<i>F</i> = 6%). Oral bioavailability was achieved by incorporating water solubilizing groups into the sulfonyl aryl ring of the sulfonamide by modifying the preferred 4-alkyl or 4-alkoxy groups. This furnished the lead compound <b>16</b>, (hOTR: <i>K</i><sub>i</sub> = 0.65 nM) which was 65-fold, 23000-fold, and 245-fold selective for the hV1aR, the hV1bR, and the hV2R, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). It was shown to dose dependently inhibit oxytocin-induced uterine contractions in anaesthetized nonpregnant rats by the iv route (ED<sub>50</sub> = 1.4 mg/kg), while by the oral route it was also found to inhibit oxytocin-induced uterine contractions in anaesthetized nonpregnant rats by 35% at 30 mg/kg and to reduce spontaneous uterine contractions in late-term pregnant rats by 30% at 30 mg/kg.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Human and Rat Oxytocin/Vasopressin Receptor Binding, Oxytocin Antagonism in the Rat of the Isatin Hydrazone Sulfanilides <b>14</b>−<b>16</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0004.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="/">oxytocin receptors</th><th class="colsep0 rowsep0" colspan="3" align="center" char=".">vasopressin receptors</th><th class="colsep0 rowsep0" colspan="2" align="char" char=".">oxytocin antagonism in vivo rat</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="/">hOTR/<i>rOTR</i><br /></br><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="char" char=".">hV1aR <br /></br><i>K<sub>i</sub></i> (nM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="char" char=".">hV1bR <br /></br><i>K<sub>i</sub></i> (nM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="char" char=".">hV2R <br /></br><i>K<sub>i</sub></i> (nM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="char" char=".">iv <br /></br>ED<sub>50</sub> (mg/kg)</th><th class="colsep0 rowsep0" align="left">po <br /></br>ED<sub>50</sub> (mg/kg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char="/">90/−</td><td class="colsep0 rowsep0" align="char" char="."><50% @ 10 μM</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char="/">14/<i>25</i></td><td class="colsep0 rowsep0" align="char" char=".">1410</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">2500</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char="/">0.65/<i>0.67</i></td><td class="colsep0 rowsep0" align="char" char=".">42</td><td class="colsep0 rowsep0" align="char" char=".">3539</td><td class="colsep0 rowsep0" align="char" char=".">377</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="left"><i>35%</i> (30 mg/kg)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Binding affinity inhibition constant <i>K</i><sub>i</sub> (nM) at hOTR and rOTR in HEK293-EBNA cells, and at hV1aR, hV1bR, and hV2R in CHO cells.</p></div></div></div><div class="NLM_p">High-throughput screening of the GSK compound collection for oxytocin antagonists also identified a similar tertiary sulfonamide <b>17</b>, which contained a tricyclic quinolinone ring.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> It was shown to be moderately potent as an OTR antagonist with good selectivity (>50 fold) against the related hV1aR (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). However, it had poor aqueous solubility (<1 μg/mL) and oral bioavailability (<i>F</i> = 4%) in rats.</div><div class="NLM_p">SAR studies to improve potency, solubility, and oral bioavailability while not significantly increasing molecular weight (<500) involved biaryl replacements of the tricyclic quinolinone ring. The initial biaryl compounds <b>18</b> were moderately potent (OTR p<i>K</i><sub>i</sub> = 7.2−7.4). In an attempt to improve the potency of <b>18</b>, these compounds were mapped to the consensus pharmacophore based on known active OTR antagonists <b>20</b> and <b>37</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). This suggested a hydrogen bond acceptor (pyridine) in the proximal ring and a nonplanar distal ring which was achieved by a 2′ substituent. This gave a range of potent compounds <b>19</b>, for example, the <i>ortho</i> chloro derivative <b>21</b>, where the increase in functional potency was encouraging (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). However, its selectivity against the hV1aR was poor.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Design of Biaryl Tertiary Sulfonamides Based on Consensus Pharmacophore Derived from Compounds <b>20</b> (grey) and <b>37</b> (gold) (Reprinted with permission from ref <a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">44</a>. Copyright 2003 Elsevier.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Human and Rat Oxytocin/Vasopressin Receptor Binding, and Rat Oral Bioavailability of the Biaryl Tertiary Sulfonamides<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0006.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">oxytocin receptor</th><th class="colsep0 rowsep0" colspan="6" align="center" char=".">vasopressin receptors</th><th class="colsep0 rowsep0" align="center" char=".">PK</th><th class="colsep0 rowsep0" align="center" char=".">sol</th><th class="colsep0 rowsep0" colspan="6" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">hOTR</th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">hV1aR</th><th class="colsep0 rowsep0" colspan="2" align="center">hV1bR</th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">hV2R</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">aq</th><th class="colsep0 rowsep0" colspan="6" align="center" char=".">Cyp450 (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">fp<i>K</i><sub>i</sub><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">p<i>K</i><sub>i</sub><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">fp<i>K</i><sub>i</sub><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">p<i>K</i><sub>i</sub><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="left">fp<i>K</i><sub>i</sub><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="left" char=".">p<i>K</i><sub>i</sub><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="left" char=".">fp<i>K</i><sub>i</sub><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="left" char=".">p<i>K</i><sub>i</sub><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> %</th><th class="colsep0 rowsep0" align="center" char=".">μM</th><th class="colsep0 rowsep0" align="center" char=".">1A2</th><th class="colsep0 rowsep0" align="center" char=".">2C9</th><th class="colsep0 rowsep0" align="center" char=".">2C19</th><th class="colsep0 rowsep0" align="center" char=".">2D6</th><th class="colsep0 rowsep0" align="center" char=".">3A4 <br /></br>DEF</th><th class="colsep0 rowsep0" align="center" char=".">3A4 <br /></br>7BQ</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."><5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="."><1</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">8.5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">7.6</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">inact</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">>33</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td><td class="colsep0 rowsep0" align="char" char=".">0.45</td><td class="colsep0 rowsep0" align="char" char=".">>33</td><td class="colsep0 rowsep0" align="char" char=".">0.75</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="char" char=".">9.1</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="left">inact</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">259</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Functional receptor antagonism (fp<i>K</i><sub>i</sub>) was determined in FLIPR assays using recombinant hOTRs or hV1aRs/hV1bRs stably transfected in CHO cells, and recombinant hV2Rs stably transfected in yeast cells.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Filtration binding was determined by displacement of [<sup>3</sup>H]-oxytocin from recombinant hOTRs stably transfected in CHO cells.</p></div></div></div><div class="NLM_p">Also it had relatively poor Cyp450 (cytochrome P450 enzyme) profiles and poor solubility, resulting in low oral exposure. The serious PK shortcomings were tackled by in silico profiling of derivatives suggested by pharmacophore analysis, which showed that although the sulfonamide oxygen atoms are required as hydrogen bond acceptors, the aryl sulfonyl ring can be replaced to optimize the PK properties and retain potency.</div><div class="NLM_p last">A number of highly potent oxytocin receptor antagonists were prepared with both electron rich and electron deficient aryl sulfonamides, which led to the imidazole sulfonamide <b>22</b> which was predicted to have good solubility and a improved Cyp450 profile. This proved to be the case, and the oral bioavailability of <b>22</b> in the rat (<i>F</i> = 40%) was found to be superior to that of <b>21</b>. Selectivity profiles for <b>22</b> were determined in functional assays and in lower throughput filtration binding assays. A significant improvement in selectivity was achieved with <b>22</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>) which had good binding affinity at the hOTR (<i>K</i><sub>i</sub> = 0.8 nM) and was 80-fold, 40-fold, and 15856-fold selective for the hV1aR, the hV1bR, and the hV2R, respectively.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Triazoles</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The known hV1aR antagonist <b>23</b><a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> was also identified as an OTR antagonist by researchers at Pfizer by high throughput screening (HTS) of their compound collection.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Although 10-fold more selective for the hV1aR (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>), the triazole <b>23</b> was used as a starting point for the development of selective orally bioavailable oxytocin antagonists. Pharmacophoric overlap of <b>23</b> with the oxime template <b>24</b> (similar to that present in the oxytocin antagonists <b>11</b> and <b>12</b>) suggested (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) replacement of the alkoxy aryl ring in <b>21</b> with the methoxy pyridyl ring and incorporation of an <i>ortho</i> substituent in the biaryl substituent to give the pyridyl triazole <b>25</b>. This improved the oxytocin potency and selectivity with respect to hV1aR antagonism, reduced lipophilicity (clogP = 3.2), and improved the heavy atom ligand efficiency (LE)<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and the lipophilic efficiency (LipE)<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). They used the latter two parameters to track the success of this new lead series during an optimization program to improve the metabolic stability, selectivity, and aqueous solubility properties.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Pharmacophore Design of Biaryl Triazole Template</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Heavy atom ligand efficiency is the normalization of MW and potency and is used to rank lead series. It shows the efficiency of each heavy atom.<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/jm-2009-01812z_m001.gif" alt="" /></img></span></div><div class="NLM_p">For example, a desirable value would be LE 0.36; <i>K</i><sub>i</sub> = 10 nM, MW 405.<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/jm-2009-01812z_m002.gif" alt="" /></img></span></div><div class="NLM_p">Introduction of the concept LipE was used to avoid medicinal chemists being seduced by potency driven by lipophilicity and enabled the focus to be on the efficiency of each lipophilic fragment. Their goal was to identify a series where compounds routinely have LE > 0.35 and LipE >5.</div><div class="NLM_p">Replacement of the central aryl of the C-3 biaryl triazole substituent with a pyrazine gave a significant reduction in hV2R antagonism. Further SAR optimization involving substitution in the distal aryl ring of the biaryl substituent suggested that disubstitution with small groups at the 2,4-positions gave the best oxytocin activity and selectivity vs the vasopressin receptors. Also exploration of SAR around the C-5 (methyl) triazole substituent identified methoxymethyl as a substituent which typically gave ca. 3-fold improvement in oxytocin potency (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Triazole SAR<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This led to the potent triazole OTR antagonist <b>26</b> (<i>K</i><sub>i</sub> = 6 nM), which had good levels of selectivity over the hV1bR and the hV2R (>1600-fold) and moderate selectivity over the hV1aR (65-fold) (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Encouragingly, <b>26</b> had a reasonable rat PK profile with moderate oral bioavailability (<i>F</i> = 24%) and a clearance of 50 mL/min/kg but had low aqueous solubility (6 μg/mL).</div><div class="NLM_p">Further developments to address the low aqueous solubility of <b>26</b> led to replacement of the biaryl substituent with an ethoxy aryl ring in <b>27</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>), which had increased aqueous solubility (344 μg/mL) but lower OTR antagonist potency (<i>K</i><sub>i</sub> = 28 nM) and lost selectivity over the hV1aR (20-fold).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> However, replacement of the biaryl substituent with N-linked ethers<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> led to the potent triazole OTR antagonist <b>28</b> (PF-3274167) with good levels of activity (<i>K</i><sub>i</sub> = 9.5 nM), selectivity over the hV1aR (118-fold), and the hV2R (>1000-fold) and aqueous solubility (59 μg/mL)<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Human Oxytocin/Vasopressin Receptor Binding, and Animal Pharmacokinetics of Triazoles <b>26</b>−<b>28</b><a onclick="showRef(event, 'ref47 ref48 ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49 ref50 ref51">(47-51)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0009.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="/" /></col><col align="char" char="/" /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">oxytocin receptor</th><th class="colsep0 rowsep0" colspan="3" align="center" char=".">vasopressin receptors</th><th class="colsep0 rowsep0" colspan="3" align="center" char="/">PK <br /></br>rat/<i>dog</i></th><th class="colsep0 rowsep0" colspan="3" align="center" char=".">physical properties</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">hOTR <br /></br><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">hV1aR <br /></br><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">hV1bR <br /></br><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">hV2R <br /></br><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="/"><i>F</i>%</th><th class="colsep0 rowsep0" align="center" char="/">Cl</th><th class="colsep0 rowsep0" align="center" char="/"><i>t</i><sub>1/2</sub></th><th class="colsep0 rowsep0" align="center" char=".">sol<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a> @ pH 7.4</th><th class="colsep0 rowsep0" align="center" char=".">LE</th><th class="colsep0 rowsep0" align="center" char=".">LipE</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">304</td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="char" char=".">525</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">500</td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">388</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char="/">24/−</td><td class="colsep0 rowsep0" align="char" char="/">50/−</td><td class="colsep0 rowsep0" align="char" char="/">1 h/−</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">0.41</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">549</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="char" char="/"> </td><td class="colsep0 rowsep0" align="char" char=".">344</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">9.5</td><td class="colsep0 rowsep0" align="char" char=".">1120</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char=".">>10000</td><td class="colsep0 rowsep0" align="char" char="/">62/<i>81</i></td><td class="colsep0 rowsep0" align="char" char="/">36/<i>8</i></td><td class="colsep0 rowsep0" align="char" char="/">0.9 h/<i>1.9</i> h</td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Binding affinity inhibition constant <i>K</i><sub>i</sub> (nM) at hOTR and rOTR in HEK293-EBNA cells and at hV1aR, hV1bR, and hV2R in CHO cells.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Solubility in μg/mL on crystalline material.</p></div></div></div><div class="NLM_p last">Modeling the minimized X-ray structure of <b>26</b> and <b>28</b> showed good overlay of the terminal aryl rings required for good levels of potency. The azetidine aryl ether <b>28</b> had good oral bioavailability in the rat (62%) and dog (81%)<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> showed no significant Cyp450 inhibition, good CNS penetration (in vitro MDCK 34/37), and was clean in both the Ames and micronucleus test and was selected for progression as a potential clinical candidate.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> In first time in human exposure it was well tolerated across the dose range 0.3−2400 mg (single dose) and the estimated human PK data from this was (<i>F</i> ∼ 80%, <i>t</i><sub>1/2</sub> ∼ 12 h, 1.5 > Cl > 8 mL/min/kg).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> However, no in vivo oxytocin antagonist activity was reported and the preferred therapeutic target: preterm labor, benign prostatic hyperplasia, or sexual dysfunction was not indicated</div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">2,5-Diketopiperazines</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Screening the GSK compound collection and various libraries produced several templates with moderate levels of antagonist activity at the OTR. A key consideration was to choose a template with good levels of selectivity over the three vasopressin receptors rather than to try and build this in during the lead optimization stage. It was hoped this would avoid the problem in the past of having to repeatedly increase the size of the template in an attempt to increase receptor selectivity. Furthermore, as blocking OTRs in the uterus was the objective in developing an oral treatment for preterm labor, all templates were also assessed by in silico profiling and suitable templates were evaluated in vitro for predicted CNS penetration. This was to decrease the risk that templates would be chosen that would cross the blood−brain barrier and thus block the central effects of oxytocin both in the fetus and in the mother. The screening program identified 2,5-diketopiperazines (DKPs) exemplified by <b>29</b> as novel templates for antagonists of the hOTR. The lead, <b>29</b>, showed potency of p<i>K</i><sub>i</sub> = 6.5 (<i>K</i><sub>i</sub> = 300 nM) as a mixture of isomers in the amide side-chain. Initial SAR studies led to the semirigid and chirally pure DKP <b>30</b>, p<i>K</i><sub>i</sub> = 8.4, (<i>K</i><sub>i</sub> = 4 nM), with <i>cis</i> disposed substituents at C-3 and C-6 and the <i>R</i> side-chain configuration (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0010.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Indanyl 2,5-Diketopiperazine Template</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Optimal activity was shown to lie in the <i>RRR</i> series, e.g., <b>31</b>−<b>33</b>: the <i>RRS</i> isomers, where the stereochemistry in the amide side-chain at C-7 is inverted, were 10-fold less potent. At C-6, an indanyl group was preferred; its replacement by phenethyl and benzyl groups led to a progressive weakening of activity. At C-3, a 4-carbon branched alkyl was shown to be optimal; smaller alkyl groups result in reduced antagonist activity (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The <i>RRR</i> series showed very good levels of selectivity relative to the vasopressin receptors, e.g., <b>31</b> (hOTR <i>K</i><sub>i</sub> = 4 nM), >1500-fold selective over the hVIaR and the hVIbR, and >300-fold selective over the hV2R, and <b>32</b> (hOTR <i>K</i><sub>i</sub> = 3nM) >13000-fold selective over the hVIaR, the hVIbR, and the hV2R, Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>, and low predicted CNS penetration from in silico<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and in vitro studies.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Substituted Aryl (3<i>R</i>,6<i>R</i>,7<i>R</i>)-2,5-Diketopiperazines Oxytocin Antagonists: Inhibition of Oxytocin Binding at the hOTR and Vasopressin Binding at the hV1aR, hV1bR, and hV2R, and Oral Bioavailability in the Rat and Dog<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0011.gif" alt="" id="fx8" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">oxytocin receptor</th><th class="colsep0 rowsep0" colspan="3" align="center" char=".">vasopressin receptors</th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">bioavailability</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">hOTR <br /></br>p<i>K</i><sub>i</sub><a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="left" char=".">hVIaR <br /></br>p<i>K</i><sub>i</sub><a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="left" char=".">hVIbR <br /></br>p<i>K</i><sub>i</sub><a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="left" char=".">hV2R <br /></br>p<i>K</i><sub>i</sub><a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="left" char=".">rat <br /></br><i>F</i> %</th><th class="colsep0 rowsep0" align="left" char=".">dog <br /></br><i>F</i> %</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char=".">8.4</td><td class="colsep0 rowsep0" align="char" char="."><5.2</td><td class="colsep0 rowsep0" align="char" char="."><5.2</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">4-NMe<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">8.5</td><td class="colsep0 rowsep0" align="char" char="."><4.4</td><td class="colsep0 rowsep0" align="char" char="."><4.3</td><td class="colsep0 rowsep0" align="char" char="."><4.1</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">2,4-diF</td><td class="colsep0 rowsep0" align="char" char=".">8.9</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char="."><5.2</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Displacement of [<sup>3</sup>H]-oxytocin from hOTR or [<sup>3</sup>H]-vasopressin from hV1aR, hV1bR and hV2R by the test compound.</p></div></div></div><div class="NLM_p">Further SAR studies on this chiral system revealed that alkylation of the ring <i>N</i>-atom or removal of the C-2 carbonyl group decreased potency. Potency was retained when the aryl group on the <i>N</i>4-glycinamide was replaced by 5-membered heteroaryl or 5,6-fused heteroaryl systems; cycloalkyl or alkyl groups were not well tolerated. <i>Para</i> substitution was preferred on the arylglycinamide moiety and a broad range of groups at this position (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) conferred good antagonist activity; <i>meta</i> substitution was less well tolerated.<a onclick="showRef(event, 'ref52 ref55'); return false;" href="javascript:void(0);" class="ref ref52 ref55">(52, 55)</a> Potency was maintained by a wide range of <i>N</i>-substituted and <i>N</i>,<i>N</i>-disubstituted glycinamides.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0012.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. 2,5-Diketopiperazine SAR<a onclick="showRef(event, 'ref52 ref55 ref56 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref52 ref55 ref56 ref57 ref58 ref59">(52, 55-59)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In these 2,5-diketopiperazine oxytocin antagonists, the <i>RRR</i> stereochemistry of the three chiral centers at the 3, 6, and 7 positions, together with 6-indanyl and 3-isobutyl substituents linked via the key functionality of the carbonyl at the 2-position and the NH at the 1-position, are essential for high antagonist potency and hence must be crucial elements in binding to the OTR. This can be explained by the similar pharamacophores (those in bold Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) exhibited by the X-ray crystal structure of the 2,5-diketopiperazine <b>33</b> and deamino oxytocin <b>34</b>.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> This shows that there is a similar stereochemical relationship of the required aryl ring, peptide backbone, and isoleucine in <b>34</b> (2-Tyr 3-Ile) and the required aryl ring, diketopiperazine fragment, and leucine in the 2,5-diketopiperazines.</div><div class="NLM_p">Although all the <i>RRR</i> isomers of the monosubstituted aryl DKPs with wide range of different functionality (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) had similar high levels of potency, they all had low bioavailability in the rat (eg see Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). Optimization of the pharmacokinetic profile of this template was achieved by a combination of analogy and property-based design. The 2,4-difluoro derivative <b>35</b> (R = 2,4-diF) was prepared by analogy with the benzoxazine series <b>9</b> (GW 575695X), where aromatic fluoro substitution next to a ring junction produced a >3-fold improvement in rat bioavailability. A similar improvement (<i>F</i>: 13−46%) was seen in the bioavailability of <b>35</b> (R = 2,4-diF) in this species (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). To achieve good bioavailability in both rat and dog, optimization was taken further by using property-based design to estimate the human oral absorption (EHOA) derived from HPLC measured lipophilicity (CHI log <i>D</i>) and calculated size (cMR) see eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a><a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> for a whole range of disubstituted 7-aryl and 7-heteroaryl 2,5-diketopiperazines.<figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0013.jpeg" id="_i24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray Crystal Structures of 2,5-Diketopiperazine <b>33</b> and Deamino-oxytocin <b>34</b><a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/jm-2009-01812z_m003.gif" alt="" /></img><span class="labelSpan">(1)</span></span></div><div class="NLM_p">The highest EHOA was obtained with small DKPs, where large aryl/heteroaryl rings at the 7- exocyclic position and large amides were avoided. This led to the tertiary amide 2′,4′-difluorophenyl-dimethylamide <b>36</b> with high levels of potency (p<i>K</i><sub>i</sub> = 9.2) and good oral bioavailability in the rat (53%) and dog (51%) with low clearance (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>). It was >60-fold more potent than atosiban in vitro at the hOTR and had comparable potency to atosiban in the rat (IC<sub>50</sub> = 227 nM). In addition, <b>36</b> showed a high degree of selectivity toward the vasopressin receptors (>10000 for hV1aR/hV1bR and ∼500 for hV2R) and had a satisfactory safety profile in the 4-day oral toxicity test in rats.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Comparison of the Oxytocin Antagonist Potency, Selectivity vs the Human Vasopressin Receptors, Pharmacokinetic Profile in Rat and Activity in Vivo of <b>36</b> and <b>37</b><a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0014.gif" alt="" id="fx9" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center" char=".">oxytocin receptors</th><th class="colsep0 rowsep0" colspan="3" align="center" char=".">vasopressin receptors</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" colspan="3" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" valign="top"> </th><th class="colsep0 rowsep0" colspan="2" align="center" valign="top" char=".">hOTR</th><th class="colsep0 rowsep0" align="center" valign="top" char=".">rOTR</th><th class="colsep0 rowsep0" align="center" valign="top" char=".">hV1aR</th><th class="colsep0 rowsep0" align="center" valign="top" char=".">hV1bR</th><th class="colsep0 rowsep0" align="center" valign="top" char=".">hV2R</th><th class="colsep0 rowsep0" align="center" valign="top" char=".">oxytocin antagonism</th><th class="colsep0 rowsep0" colspan="3" align="center" valign="top" char=".">rat PK<a class="ref internalNav" href="#t9fn5" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center" valign="top" char=".">sol aq<a class="ref internalNav" href="#t9fn6" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center" valign="top" char="."> </th><th class="colsep0 rowsep0" align="center" valign="top" char=".">hum serum Al<a class="ref internalNav" href="#t9fn8" aria-label="i">i</a></th><th class="colsep0 rowsep0" align="center" valign="top" char=".">Cyp 450<a class="ref internalNav" href="#t9fn9" aria-label="j">j</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" valign="top">compd</th><th class="colsep0 rowsep0" align="center" valign="top" char=".">fp<i>K</i><sub>i</sub><a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" valign="top" char=".">p<i>K</i><sub>i</sub><a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" valign="top" char=".">p<i>K</i><sub>i</sub><a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" valign="top" char=".">p<i>K</i><sub>i</sub><a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" valign="top" char=".">p<i>K</i><sub>i</sub><a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" valign="top" char=".">p<i>K</i><sub>i</sub><a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" valign="top" char=".">in vivo rat <br /></br>IC<sub>50</sub><a class="ref internalNav" href="#t9fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" valign="top" char=".">Auc po</th><th class="colsep0 rowsep0" align="center" valign="top" char=".">Cl</th><th class="colsep0 rowsep0" align="center" valign="top" char="."><i>F</i>%</th><th class="colsep0 rowsep0" align="center" valign="top" char=".">mg/mL</th><th class="colsep0 rowsep0" align="center" valign="top" char=".">CHI Log <i>D</i><a class="ref internalNav" href="#t9fn7" aria-label="h">h</a></th><th class="colsep0 rowsep0" align="center" valign="top" char=".">%</th><th class="colsep0 rowsep0" align="center" valign="top" char=".">3A4 <br /></br>IC<sub>50</sub> μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char=".">8.8</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char="."><5.2</td><td class="colsep0 rowsep0" align="char" char="."><5.2</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">227</td><td class="colsep0 rowsep0" align="char" char=".">2971</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">0.083</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">94</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">8.2</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">8.4</td><td class="colsep0 rowsep0" align="char" char="."><4.9</td><td class="colsep0 rowsep0" align="char" char="."><5.0</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">180</td><td class="colsep0 rowsep0" align="char" char=".">5465</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">∼100</td><td class="colsep0 rowsep0" align="char" char=".">>0.22</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char="."><80</td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">atosiban</td><td class="colsep0 rowsep0" align="char" char=".">-</td><td class="colsep0 rowsep0" align="char" char=".">7.9</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">∼186</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Functional receptor antagonism (fp<i>K</i><sub>i</sub>) was determined in FLIPR assays using recombinant human oxytocin receptors stably transfected in CHO cells</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last">Displacement of [<sup>3</sup>H] oxytocin from hOTR or vasopressin from hV1aR, hV1bR, and hV2R by the test compound,</p></div><div class="footnote" id="t9fn3"><sup>c</sup><p class="last">Displacement of [<sup>3</sup>H] oxytocin from rOTR by the test compound.</p></div><div class="footnote" id="t9fn4"><sup>d</sup><p class="last">Plasma IC<sub>50</sub> nM in the rat.</p></div><div class="footnote" id="t9fn5"><sup>f</sup><p class="last">Rat PK (<i>n</i> = 4): AUC (h ng mL<sup>−1</sup>) at 5 mg/kg, 5%DMSO/95%PEG400 formulation, Cl in mL min <sup>−1</sup> kg <sup>−1</sup>.</p></div><div class="footnote" id="t9fn6"><sup>g</sup><p class="last">Solubility (mg/mL) a precipitation/HPLC based measurement.</p></div><div class="footnote" id="t9fn7"><sup>h</sup><p class="last">An HPLC method based measurement of lipophilicity</p></div><div class="footnote" id="t9fn8"><sup>i</sup><p class="last">% Human serum albumin binding.</p></div><div class="footnote" id="t9fn9"><sup>j</sup><p class="last">Cypex Cyp450.</p></div></div></div><div class="NLM_p last">However, <b>36</b> had a suboptimal solubility and Cyp450 profile. Increased solubility was achieved by increasing the polarity of substituents on the 7-aryl ring or the amide function, but this resulted in a worse PK profile. Focusing away from this peripheral functionality by increasing the polarity of the aromatic ring itself by replacing it with an heterocyclic ring increased solubility without losing the excellent PK profile achieved with this template. This led to a range of 2′-substituted 7-(1′,3′-oxazol-4′-yl)-(3<i>R</i>,6<i>R</i>,7<i>R</i>)-2,5-diketopiperazine amides with increased solubility and an improved Cyp450 profile. Branching at the α-carbon of the 3-butyl group led to a superior rat pharmacokinetic profile that resulted in the discovery of the 2′-methyl-1′,3′-oxazol-4′-yl morpholine amide derivative <b>37</b> GSK221149A (Retosiban), which had the best oral exposure and bioavailability in the rat.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Retosiban has nanomolar affinity (<i>K</i><sub>i</sub> = 0.65 nM) for the hOTR with >15000- and >1400-fold selectivity over the closely related hV1aR/hV1bR and the hV2R, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>). It has good solubility, low protein binding, and has a good Cyp450 profile with no significant inhibition IC<sub>50</sub> > 100 μM and low predicted CNS penetration.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Retosiban is >15-fold more potent at the hOTR than atosiban (a marketed iv peptide oxytocin antagonist), and it has been shown to be an effective tocolytic by iv and by oral administration in rats<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> and was selected for progression as a potential clinical candidate for preterm labor.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Follow up compounds in this series can be seen in the most recent patent applications where heterocyclic variants of the arylglycinamide moiety, including the 1-methyl-1<i>H</i>-indazol-5-yl<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60, 61)</a> and the 2,6- dimethyl-3-pyridinyl<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> ring systems, are described.</div></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34221" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34221" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The suboptimal pharmacokinetics and oral bioavailability of the initial oxytocin antagonist <b>5</b> which caused its clinical trials to be suspended has been superseded with the more recent oxytocin antagonists <b>28</b> (Pfizer) and <b>37</b> (GSK) Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>. It can be seen from Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a> that the templates investigated in the previous decade contravene the Lipinski “rule of five”, which accounts for their poor oral bioavailability, but this is not the case with the more recent compounds <b>28</b> and <b>37</b> that have lower MWt and logP. While the earlier compounds investigated, e.g., <b>7</b> and <b>8</b> did have single figure nanomolar potency at hOTR with 10<sup>2</sup> and 10<sup>3</sup> selectivity over hV1aR and hV2R, respectively, they all had inferior ligand efficiency of ≤0.31, in contrast to the superior ligand efficiency of ≥0.36 exhibited by the later compounds <b>22</b>, <b>28</b>, and <b>37</b>. An advantage of the DKP template is that in contrast to the typical planarity/mobility of the benzamides (benzoxazinylpiperidine, <b>6</b>−<b>9</b>, <b>13</b>, and pyrrolidino oximes <b>10</b>−<b>12</b>), tertiary arylsulphonamides (<b>14</b>−<b>17</b>, <b>21</b>) or triazole <b>28</b> templates, it has 3 chiral centers and a semirigid ring that presents a similar pharmacophore for the key functionality required for activity to that found in the natural ligand oxytocin. Retosiban has superior subnanomolar potency at the hOTR and 10<sup>4</sup> and 10<sup>3</sup> selectivity over hV1aR and hV2R ,respectively, compared to the oral nonpeptide oxytocin antagonists reported by Merck, Serono, Sanofi, and Pfizer and has a better rat bioavailability. Furthermore, unlike <b>5</b>, which accumulates in the brain, and <b>28</b>, which has good brain penetration, Retosiban, which was developed as an oral treatment for preterm labor, has low predicted CNS penetration and this reduces the risk that this drug might cross the blood−brain barrier and thus block the central effects of oxytocin both in the fetus and in the mother.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Comparison of Potency Selectivity and Bioavailability of Oral Oxytocin Antagonists</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center">hOTR</th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">selectivity</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="right">date<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="right"><i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">p<i>K</i><sub>i</sub></th><th class="colsep0 rowsep0" align="center" char=".">hOTR/hV1aR</th><th class="colsep0 rowsep0" align="center" char=".">hOTR/hV2R</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i>%</th><th class="colsep0 rowsep0" align="center" char=".">LE<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center" char="."><i>M</i><sub>w</sub><a class="ref internalNav" href="#t10fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">Log P<a class="ref internalNav" href="#t10fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">rule 5<a class="ref internalNav" href="#t10fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">1992</td><td class="colsep0 rowsep0" align="center"><b>530</b><a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char="."><b>3</b></td><td class="colsep0 rowsep0" align="char" char="."><b>11</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">1994</td><td class="colsep0 rowsep0" align="center"><b>13</b><a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">7.9</td><td class="colsep0 rowsep0" align="char" char="."><b>14</b></td><td class="colsep0 rowsep0" align="char" char="."><b>45</b></td><td class="colsep0 rowsep0" align="char" char="."><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">0.30</td><td class="colsep0 rowsep0" align="char" char=".">554.8</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">1995</td><td class="colsep0 rowsep0" align="center"><b>4.6</b><a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="char" char="."><b>690</b></td><td class="colsep0 rowsep0" align="char" char="."><b>8043</b></td><td class="colsep0 rowsep0" align="char" char="."><b>39</b></td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="char" char=".">507.6</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">1998</td><td class="colsep0 rowsep0" align="center"><b>4.9</b><a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="char" char="."><b>650</b></td><td class="colsep0 rowsep0" align="char" char="."><b>5714</b></td><td class="colsep0 rowsep0" align="char" char="."><b>80</b></td><td class="colsep0 rowsep0" align="char" char=".">0.27</td><td class="colsep0 rowsep0" align="char" char=".">586.7</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">2002</td><td class="colsep0 rowsep0" align="center"><b>2</b><a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">8.7</td><td class="colsep0 rowsep0" align="char" char="."><b>630</b></td><td class="colsep0 rowsep0" align="char" char="."><b>>1500</b></td><td class="colsep0 rowsep0" align="char" char="."><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="char" char=".">608.6</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">2003</td><td class="colsep0 rowsep0" align="center"><b>28</b><a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">7.5</td><td class="colsep0 rowsep0" align="char" char="."><b>6</b></td><td class="colsep0 rowsep0" align="char" char="."><b>>357</b></td><td class="colsep0 rowsep0" align="char" char="."><b>49</b></td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="char" char=".">455.6</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">2004</td><td class="colsep0 rowsep0" align="center"><b>0.5</b><a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">9.3</td><td class="colsep0 rowsep0" align="char" char="."><b>280</b></td><td class="colsep0 rowsep0" align="char" char="."><b>>2000</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="char" char=".">604.5</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">2005</td><td class="colsep0 rowsep0" align="center"><b>0.65</b><a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char="."><b>60</b></td><td class="colsep0 rowsep0" align="char" char="."><b>580</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.30</td><td class="colsep0 rowsep0" align="char" char=".">625.2</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">2009</td><td class="colsep0 rowsep0" align="center"><b>0.8</b><a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">9.1</td><td class="colsep0 rowsep0" align="char" char="."><b>80</b></td><td class="colsep0 rowsep0" align="char" char="."><b>15738</b></td><td class="colsep0 rowsep0" align="char" char="."><b>40</b></td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="char" char=".">463.6</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">2009</td><td class="colsep0 rowsep0" align="center"><b>9.5</b><a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char="."><b>118</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1053</b></td><td class="colsep0 rowsep0" align="char" char="."><b>62</b></td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="char" char=".">419.8</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">2008</td><td class="colsep0 rowsep0" align="center"><b>0.63</b><a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char="."><b>>18,000</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1587</b></td><td class="colsep0 rowsep0" align="char" char="."><b>100</b></td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">494.6</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> values refer to displacement of [<sup>3</sup>H]-oxytocin from hOTR binding sites in human uterus tissue.</p></div><div class="footnote" id="t10fn2"><sup>b</sup><p class="last">Binding affinity inhibition constant <i>K</i><sub>i</sub> (nM) versus [<sup>3</sup>H]-oxytocin at hOTRs in CHO or HEK293-EBNA cells.</p></div><div class="footnote" id="t10fn3"><sup>c</sup><p class="last">ChemSpider.</p></div><div class="footnote" id="t10fn4"><sup>d</sup><p class="last">PubChem XLogP3-AA.</p></div><div class="footnote" id="t10fn5"><sup>e</sup><p class="last">Date publication in literature.</p></div><div class="footnote" id="t10fn6"><sup>f</sup><p class="last">Ref <a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">47</a>.</p></div></div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03480" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03480" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan D. Borthwick</span> - <span class="hlFld-Affiliation affiliation">DrugMolDesign, 15 Temple Grove, London NW11 7UA, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8beae7eae5a5efa5e9e4f9ffe3fce2e8e0cbeff9feece6e4e7efeef8e2ece5a5e8e4e6"><span class="__cf_email__" data-cfemail="16777a7778387238747964627e617f757d56726463717b797a7273657f71783875797b">[email protected]</span></a></span></div></li></ul></li><li><ul></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm901812z" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="bio"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Biography</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43625" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43625" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Alan D. Borthwick</b> is a Drug Design/Medicinal Chemistry Consultant with over 35 years of experience in the pharmaceutical industry. He received his Ph.D. in Organic Chemistry from the University of London, UK (1971). After joining Glaxo, he designed the once a day antihypertensive Lacidipine and was coinventor of the α2-antagonist Fluparoxan. He then moved to GlaxoWellcome, Stevenage, UK, and as Project Leader for the HSV and HCMV Protease Projects 1995−1999, designed a novel class of α-methyl-translactams as antiviral HCMV protease inhibitors. At GlaxoSmithKline 2000−2006, he was a senior scientific manager for two research groups involved in factor Xa inhibitors for thrombosis related diseases and oxytocin antagonists for preterm labor which lead to Retosiban. His interests are structure- and property-based drug design.</p></figure></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04218" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04218" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">I express my thanks to Dr. Alec Oxford for proofreading the manuscript.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72020" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72020" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 64 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Gimpl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrenholz, F.</span><span> </span><span class="NLM_article-title">The oxytocin receptor system: structure, function, and regulation</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1152%2Fphysrev.2001.81.2.629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=11274341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD3MXislCrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=629-683&author=G.+Gimplauthor=F.+Fahrenholz&title=The+oxytocin+receptor+system%3A+structure%2C+function%2C+and+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The oxytocin receptor system: structure, function, and regulation</span></div><div class="casAuthors">Gimpl, Gerald; Fahrenholz, Falk</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">629-683</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review with 624 refs.  The neurohypophysial peptide oxytocin (OT) and OT-like hormones facilitate reprodn. in all vertebrates at several levels.  The major site of OT gene expression is the magnocellular neurons of the hypothalamic paraventricular and supraoptic nuclei.  In response to a variety of stimuli such as suckling, parturition, or certain kinds of stress, the processed OT peptide is released from the posterior pituitary into the systemic circulation.  Such stimuli also lead to an intranuclear release of OT.  Moreover, oxytocinergic neurons display widespread projections throughout the central nervous system.  However, OT is also synthesized in peripheral tissues, e.g., uterus, placenta, amnion, corpus luteum, testis, and heart.  The OT receptor is a typical class I G protein-coupled receptor that is primarily coupled via Gq proteins to phospholipase C-β.  The high-affinity receptor state requires both Mg2+ and cholesterol, which probably function as allosteric modulators.  The agonist-binding region of the receptor has been characterized by mutagenesis and mol. modeling and is different from the antagonist binding site.  The function and physiol. regulation of the OT system is strongly steroid dependent.  However, this is, unexpectedly, only partially reflected by the promoter sequences in the OT receptor gene.  The classical actions of OT are stimulation of uterine smooth muscle contraction during labor and milk ejection during lactation.  While the essential role of OT for the milk let-down reflex has been confirmed in OT-deficient mice, OT's role in parturition is obviously more complex.  Before the onset of labor, uterine sensitivity to OT markedly increases concomitant with a strong upregulation of OT receptors in the myometrium and, to a lesser extent, in the decidua where OT stimulates the release of PGF2α.  Expts. with transgenic mice suggest that OT acts as a luteotropic hormone opposing the luteolytic action of PGF2α.  Thus, to initiate labor, it might be essential to generate sufficient PGF2α to overcome the luteotropic action of OT in late gestation.  OT also plays an important role in many other reprodn.-related functions, such as control of the estrus cycle length, follicle luteinization in the ovary, and ovarian steroidogenesis.  In the male, OT is a potent stimulator of spontaneous erections in rats and is involved in ejaculation.  OT receptors have also been identified in other tissues, including the kidney, heart, thymus, pancreas, and adipocytes.  For example, in the rat, OT is a cardiovascular hormone acting in concert with atrial natriuretic peptide to induce natriuresis and kaliuresis.  The central actions of OT range from the modulation of the neuroendocrine reflexes to the establishment of complex social and bonding behaviors related to the reprodn. and care of the offspring.  OT exerts potent anti-stress effects that may facilitate pair bonds.  Overall, the regulation by gonadal and adrenal steroids is one of the most remarkable features of the OT system and is, unfortunately, the least understood.  One has to conclude that the physiol. regulation of the OT system will remain puzzling as long as the mol. mechanisms of genomic and nongenomic actions of steroids have not been clarified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp46jO2zW6dQ7Vg90H21EOLACvtfcHk0lhuuVmKgM_WRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXislCrsLk%253D&md5=2ee2bbe969b9d4c81729ad2380d3d293</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.2.629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.2.629%26sid%3Dliteratum%253Aachs%26aulast%3DGimpl%26aufirst%3DG.%26aulast%3DFahrenholz%26aufirst%3DF.%26atitle%3DThe%2520oxytocin%2520receptor%2520system%253A%2520structure%252C%2520function%252C%2520and%2520regulation%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D629%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macbeth, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagani, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, W. S.,  III.</span><span> </span><span class="NLM_article-title">Oxytocin: the great facilitator of life</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=19482229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFyksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2009&pages=127-151&author=H.+J.+Leeauthor=A.+H.+Macbethauthor=J.+H.+Paganiauthor=W.+S.+Young&title=Oxytocin%3A+the+great+facilitator+of+life"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin: The great facilitator of life</span></div><div class="casAuthors">Lee, Heon-Jin; Macbeth, Abbe H.; Pagani, Jerome H.; Young, W. Scott III</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-151</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxytocin (Oxt) is a nonapeptide hormone best known for its role in lactation and parturition.  Since 1906 when its uterine-contracting properties were described until 50 years later when its sequence was elucidated, research has focused on its peripheral roles in reprodn.  Only over the past several decades have researchers focused on what functions Oxt might have in the brain, the subject of this review.  Immunohistochem. studies revealed that magnocellular neurons of the hypothalamic paraventricular and supraoptic nuclei are the neurons of origin for the Oxt released from the posterior pituitary.  Smaller cells in various parts of the brain, as well as release from magnocellular dendrites, provide the Oxt responsible for modulating various behaviors at its only identified receptor.  Although Oxt is implicated in a variety of "non-social" behaviors, such as learning, anxiety, feeding and pain perception, it is Oxt's roles in various social behaviors that have come to the fore recently.  Oxt is important for social memory and attachment, sexual and maternal behavior, and aggression.  Recent work implicates Oxt in human bonding and trust as well.  Human disorders characterized by aberrant social interactions, such as autism and schizophrenia, may also involve Oxt expression.  Many, if not most, of Oxt's functions, from social interactions (affiliation, aggression) and sexual behavior to eventual parturition, lactation and maternal behavior, may be viewed as specifically facilitating species propagation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9FUABILrYYbVg90H21EOLACvtfcHk0lhuuVmKgM_WRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFyksrw%253D&md5=c3550f5708ef2ff6ceccc6a9055e3732</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DMacbeth%26aufirst%3DA.%2BH.%26aulast%3DPagani%26aufirst%3DJ.%2BH.%26aulast%3DYoung%26aufirst%3DW.%2BS.%26atitle%3DOxytocin%253A%2520the%2520great%2520facilitator%2520of%2520life%26jtitle%3DProg.%2520Neurobiol.%26date%3D2009%26volume%3D88%26spage%3D127%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Uvnas-Moberg, K.</span> <span class="citation_source-book">The Oxytocin Factor</span>; <span class="NLM_publisher-name">Da Capo Press</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=K.+Uvnas-Moberg&title=The+Oxytocin+Factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DUvnas-Moberg%26aufirst%3DK.%26btitle%3DThe%2520Oxytocin%2520Factor%26pub%3DDa%2520Capo%2520Press%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Zingg, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laporte, S. A.</span><span> </span><span class="NLM_article-title">The oxytocin receptor</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1016%2FS1043-2760%2803%2900080-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=12826328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVCmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=222-227&author=H.+H.+Zinggauthor=S.+A.+Laporte&title=The+oxytocin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The oxytocin receptor</span></div><div class="casAuthors">Zingg, Hans H.; Laporte, Stephane A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">222-227</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Novel sites of oxytocin receptor expression have recently been detected, including breast cancer cells, bone cells, myoblasts, cardiomyocytes, and endothelial cells.  These discoveries have greatly expanded the possible spectrum of oxytocin action beyond its classic role as an inducer of uterine contractions and milk ejection.  Addnl. advances in the understanding of oxytocin receptor structure-function relationships, receptor trafficking, and novel receptor-linked signaling cascades have made this receptor an attractive model for the study of G-protein-linked receptor function.  Finally, the tocolytic efficiency of the oxytocin receptor antagonist atosiban, recently approved for clin. use in Europe, has opened new avenues for the prevention and treatment of preterm labor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqax1K5BVg-z7Vg90H21EOLACvtfcHk0ljlZa8qh-i5rA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVCmu70%253D&md5=5c150703702c627e6823d08839e5c51e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1043-2760%2803%2900080-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-2760%252803%252900080-8%26sid%3Dliteratum%253Aachs%26aulast%3DZingg%26aufirst%3DH.%2BH.%26aulast%3DLaporte%26aufirst%3DS.%2BA.%26atitle%3DThe%2520oxytocin%2520receptor%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2003%26volume%3D14%26spage%3D222%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Schulz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">du Vigneaud, V.</span><span> </span><span class="NLM_article-title">Synthesis of 1-L-penicillamine-oxytocin, 1-<span class="smallcaps smallerCapital">d</span>-penicillamine-oxytocin, and 1-deaminopenicillamine-oxytocin, potent inhibitors of the oxytocic response of oxytocin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00323a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1966&pages=647-650&author=H.+Schulzauthor=V.+du+Vigneaud&title=Synthesis+of+1-L-penicillamine-oxytocin%2C+1-d-penicillamine-oxytocin%2C+and+1-deaminopenicillamine-oxytocin%2C+potent+inhibitors+of+the+oxytocic+response+of+oxytocin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm00323a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00323a001%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DH.%26aulast%3Ddu%2BVigneaud%26aufirst%3DV.%26atitle%3DSynthesis%2520of%25201-L-penicillamine-oxytocin%252C%25201-d-penicillamine-oxytocin%252C%2520and%25201-deaminopenicillamine-oxytocin%252C%2520potent%2520inhibitors%2520of%2520the%2520oxytocic%2520response%2520of%2520oxytocin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1966%26volume%3D9%26spage%3D647%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Nestor, J. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferger, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">du Vigneaud, V.</span><span> </span><span class="NLM_article-title">[1-Beta-mercapto-beta,beta-pentamethylenepropionic acid]oxytocin, a potent inhibitor of oxytocin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00237a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1975&pages=284-287&author=J.+J.+Nestorauthor=M.+F.+Fergerauthor=V.+du+Vigneaud&title=%5B1-Beta-mercapto-beta%2Cbeta-pentamethylenepropionic+acid%5Doxytocin%2C+a+potent+inhibitor+of+oxytocin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm00237a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00237a015%26sid%3Dliteratum%253Aachs%26aulast%3DNestor%26aufirst%3DJ.%2BJ.%26aulast%3DFerger%26aufirst%3DM.%2BF.%26aulast%3Ddu%2BVigneaud%26aufirst%3DV.%26atitle%3D%255B1-Beta-mercapto-beta%252Cbeta-pentamethylenepropionic%2520acid%255Doxytocin%252C%2520a%2520potent%2520inhibitor%2520of%2520oxytocin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1975%26volume%3D18%26spage%3D284%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span> </span><span class="NLM_article-title">Recent advances in the development of oxytocin receptor antagonists</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaK28XjtVKntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=41-58&author=P.+D.+Williamsauthor=D.+J.+Pettibone&title=Recent+advances+in+the+development+of+oxytocin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of oxytocin receptor antagonists</span></div><div class="casAuthors">Williams, P. D.; Pettibone, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-58</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review, with 228 refs.  During the last decade there has been significant progress in the design and discovery of new structural classes of oxytocin antagonists.  Continued study of oxytocin analogs has led to the design of antagonists with novel linear and bicyclic structures, and receptor-based screening has identified smaller cyclic hexapeptide oxytocin antagonists as well as several structural classes of non-peptide oxytocin antagonists.  The similar topog. of important functionalities in peptide and non-peptide oxytocin antagonists suggest the possibility of a common pharmacophore.  New modifications to the classical antagonist analogs of oxytocin have provided analogs with significant improvements in potency, duration of action, oxytocin receptor selectivity, and bioavailability by non-parenteral routes of administration.  In addn., optimization within two structural classes of non-peptides has provided potent and selective analogs which offer the potential for obtaining a clin. useful, orally bioavailable oxytocin antagonist.  Human clin. studies with the peptide oxytocin antagonist, atosiban, have implicated oxytocin as a potential contributor to the pathophysiol. of preterm labor and suggests that oxytocin receptor blockade may offer a useful new method for preventing premature birth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIraVPkCf2ObVg90H21EOLACvtfcHk0lhJ1SrnbEjReA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVKntLc%253D&md5=5075a28ed13180968cd13ed3b2e82880</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520oxytocin%2520receptor%2520antagonists%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D1996%26volume%3D2%26spage%3D41%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D. G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordaunt, J. E.</span><span> </span><span class="NLM_article-title">Oxytocin antagonists as potential therapeutic agents for the treatment of preterm labour</span> <span class="citation_source-journal">Proc. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1016%2FS0079-6468%2805%2944407-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=16697900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVShtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2006&pages=331-373&author=M.+J.+Allenauthor=D.+G.+H.+Livermoreauthor=J.+E.+Mordaunt&title=Oxytocin+antagonists+as+potential+therapeutic+agents+for+the+treatment+of+preterm+labour"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin antagonists as potential therapeutic agents for the treatment of preterm labour</span></div><div class="casAuthors">Allen, Michael J.; Livermore, David G. H.; Mordaunt, Jacqueline E.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">331-373</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on the developments and discovery of new potent and selective, orally bioavailable non-peptidic antagonists.  Topics discussed include epidemiol. and the impact of preterm labor, the anatomy of the uterus, the treatment of preterm labor, the methods used to measure oxytocin, the antagonist activity, the peptide and non-peptide antagonists, the oxytocin agonists and the structural studies of oxytocin receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUyRFw_Wo9ArVg90H21EOLACvtfcHk0lhJ1SrnbEjReA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVShtbg%253D&md5=8bcac9661bc4e1ab51055b706b95e481</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2805%2944407-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252805%252944407-0%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%2BH.%26aulast%3DMordaunt%26aufirst%3DJ.%2BE.%26atitle%3DOxytocin%2520antagonists%2520as%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520preterm%2520labour%26jtitle%3DProc.%2520Med.%2520Chem.%26date%3D2006%26volume%3D44%26spage%3D331%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1016%2FS0079-6123%2808%2900437-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=18655903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2008&pages=473-512&author=M.+Manningauthor=S.+Stoevauthor=B.+Chiniauthor=T.+Durrouxauthor=B.+Mouillacauthor=G.+Guillon&title=Peptide+and+non-peptide+agonists+and+antagonists+for+the+vasopressin+and+oxytocin+V1a%2C+V1b%2C+V2+and+OT+receptors%3A+research+tools+and+potential+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents</span></div><div class="casAuthors">Manning, Maurice; Stoev, Stoytcho; Chini, Bice; Durroux, Thierry; Mouillac, Bernard; Guillon, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">Advances in Vasopressin and Oxytocin</span>),
    <span class="NLM_cas:pages">473-512</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxytocin (OT) and vasopressin (AVP) mediate their biol. actions by acting on four known receptors: The OT (uterine) and the AVP V1a (vasopressor), V1b (pituitary), V2 (renal) receptors and a fifth putative AVP V1c (vasodilating) receptor.  This presentation will summarize some highlights of the recent progress, in the design and synthesis of selective peptide agonists, antagonists, radioiodinated ligands, fluorescent ligands and bivalent ligands for these receptors.  Here we present published and unpublished pharmacol. data on the most widely used agonists, antagonists and labeled ligands.  The pharmacol. properties of promising new selective OT antagonists and V1b agonists are also presented.  This review should serve as a useful guide for the selection of the most appropriate ligand for a given study.  The current status of non-peptide OT and AVP antagonists and agonists is also summarized.  The relative merits of peptide and non-peptide AVP and OT agonists and antagonists as: (1) research tools and (2) therapeutic agents will be evaluated.  Many of the receptor selective peptide agonists and antagonists from this and other labs. are far more widely used as pharmacol. tools for studies on the peripheral and central effects of OT and AVP than their non-peptide counterparts.  In addn. to OT and to a lesser extent AVP (pitressin), a no. of OT and AVP analogs; such as carbetocin (OT agonist) dDAVP (desmopressin, V2 agonist), terlipressin (V1a agonist), felypressin (V1a agonist) and atosiban (Tractocile OT antagonist) are also in clin. use.  Despite much early promise, no non-peptide V1a or OT antagonists are currently in clin. trials.  While a no. of orally active non-peptide V2 antagonists (Vaptans); notably, Tolvaptan, Lixivaptan and Satavaptan, are currently in Phase III clin. trials; to date, only the mixed V2/V1a, antagonist Conivaptan (Vaprisol), has been approved by the US FDA for clin. use (by i.v. administration), for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.  Promising new non-peptide V1b and OT antagonists, as well as non-peptide V2 and OT agonists are now in pre-clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3jiQ5LZT5gLVg90H21EOLACvtfcHk0lhJ1SrnbEjReA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfJ&md5=c21ad467eaee4a2651232a16c7dc61c5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2808%2900437-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252808%252900437-8%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DChini%26aufirst%3DB.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DPeptide%2520and%2520non-peptide%2520agonists%2520and%2520antagonists%2520for%2520the%2520vasopressin%2520and%2520oxytocin%2520V1a%252C%2520V1b%252C%2520V2%2520and%2520OT%2520receptors%253A%2520research%2520tools%2520and%2520potential%2520therapeutic%2520agents%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2008%26volume%3D170%26spage%3D473%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Gimpl, G.</span><span> </span><span class="NLM_article-title">Oxytocin receptor ligands: a survey of the patent literature</span> <span class="citation_source-journal">Expert Opin.Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1239</span><span class="NLM_x">–</span> <span class="NLM_lpage">1251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1517%2F13543776.18.11.1239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlShu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1239-1251&author=G.+Gimpl&title=Oxytocin+receptor+ligands%3A+a+survey+of+the+patent+literature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin receptor ligands: a survey of the patent literature</span></div><div class="casAuthors">Gimpl, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1239-1251</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Background: Oxytocin is produced primarily in hypothalamic neurons and is secreted from the posterior pituitary gland into the circulation in response to stimuli such as suckling, parturition, or stress.  Oxytocin functions as an essential component in milk ejection and is among the most potent uterotonic substances known.  The oxytocin receptor system supports physiol. processes assocd. with reprodn. at several levels.  Objective: To characterize and evaluate oxytocin receptor ligands for therapeutic applications.  Methods: Anal. of oxytocin analogs and nonpeptide oxytocin receptor ligands, and major applications of these substances.  Results/conclusion: Oxytocin receptor ligands, peptides, and nonpeptide mols., with high specificity over the related vasopressin receptors, are currently available.  These ligands are expected to show therapeutic utility for a vast range of applications, e.g., increasing lactation, improving in vitro inseminations, and inducing cardiomyogenesis; and also acting against preterm labor, breast cancer, an over-reactive immune system, osteoporosis, and autism-related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXEAZdk8Cy8bVg90H21EOLACvtfcHk0li-YUzqgGuiZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlShu7jK&md5=02503dd059ccf4cdee3e6ca8f2b37bf5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.11.1239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.11.1239%26sid%3Dliteratum%253Aachs%26aulast%3DGimpl%26aufirst%3DG.%26atitle%3DOxytocin%2520receptor%2520ligands%253A%2520a%2520survey%2520of%2520the%2520patent%2520literature%26jtitle%3DExpert%2520Opin.Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D1239%26epage%3D1251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Tsatsaris, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbonne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabrol, D.</span><span> </span><span class="NLM_article-title">Atosiban for Preterm Labour</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=375-382&author=V.+Tsatsarisauthor=B.+Carbonneauthor=D.+Cabrol&title=Atosiban+for+Preterm+Labour"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsatsaris%26aufirst%3DV.%26aulast%3DCarbonne%26aufirst%3DB.%26aulast%3DCabrol%26aufirst%3DD.%26atitle%3DAtosiban%2520for%2520Preterm%2520Labour%26jtitle%3DDrugs%26date%3D2004%26volume%3D64%26spage%3D375%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lamont, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kam, K. Y. R.</span><span> </span><span class="NLM_article-title">Atosiban as a tocolytic for the treatment of spontaneous preterm labor</span> <span class="citation_source-journal">Expert Rev. Obstet. Gynecol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1586%2F17474108.3.2.163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislKnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=163-174&author=R.+F.+Lamontauthor=K.+Y.+R.+Kam&title=Atosiban+as+a+tocolytic+for+the+treatment+of+spontaneous+preterm+labor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Atosiban as a tocolytic for the treatment of spontaneous preterm labor</span></div><div class="casAuthors">Lamont, Ronald F.; Kam, Ky ronald</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Obstetrics & Gynecology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-174</span>CODEN:
                <span class="NLM_cas:coden">EROGBG</span>;
        ISSN:<span class="NLM_cas:issn">1747-4108</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Preterm birth is the major cause of perinatal mortality and morbidity in the developed world, imposing a huge burden on healthcare costs.  Tocolytic drugs inhibit contractions and delay delivery in the hope of improving survival and preventing handicap.  Historically, most tocolytics were not initially developed to treat preterm labor, and so are not uterospecific and have multiorgan side effects.  Atosiban (Tractocile) is a vasopressin-oxytocin receptor antagonist, which is much more uterospecific than previous tocolytics, and, consequently has placebo-level side effects.  Atosiban has a strong evidence base and is a significant addn. to the treatment options for preterm labor and should be used for first-line therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqieFYnJ9OnKrVg90H21EOLACvtfcHk0li-YUzqgGuiZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislKnsLo%253D&md5=153cc3f20e24b73761d24adaecedafbe</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1586%2F17474108.3.2.163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F17474108.3.2.163%26sid%3Dliteratum%253Aachs%26aulast%3DLamont%26aufirst%3DR.%2BF.%26aulast%3DKam%26aufirst%3DK.%2BY.%2BR.%26atitle%3DAtosiban%2520as%2520a%2520tocolytic%2520for%2520the%2520treatment%2520of%2520spontaneous%2520preterm%2520labor%26jtitle%3DExpert%2520Rev.%2520Obstet.%2520Gynecol.%26date%3D2008%26volume%3D3%26spage%3D163%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Coomarasamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, K. S.</span><span> </span><span class="NLM_article-title">Oxytocin antagonists for tocolysis in preterm labour−a systematic review</span> <span class="citation_source-journal">Med. Sci. Monit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">RA268</span><span class="NLM_x">–</span> <span class="NLM_lpage">RA273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=RA268-RA273&author=A.+Coomarasamyauthor=E.+M.+Knoxauthor=H.+Geeauthor=K.+S.+Khan&title=Oxytocin+antagonists+for+tocolysis+in+preterm+labour%E2%88%92a+systematic+review"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoomarasamy%26aufirst%3DA.%26aulast%3DKnox%26aufirst%3DE.%2BM.%26aulast%3DGee%26aufirst%3DH.%26aulast%3DKhan%26aufirst%3DK.%2BS.%26atitle%3DOxytocin%2520antagonists%2520for%2520tocolysis%2520in%2520preterm%2520labour%25E2%2588%2592a%2520systematic%2520review%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2002%26volume%3D8%26spage%3DRA268%26epage%3DRA273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Bossmar, T.</span><span> </span><span class="NLM_article-title">Treatment of preterm labor with the oxytocin and vasopressin antagonist atosiban</span> <span class="citation_source-journal">J. Perinat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1515%2Fjpme.1998.26.6.458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=10224602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaK1MXhtV2ltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1998&pages=458-465&author=T.+Bossmar&title=Treatment+of+preterm+labor+with+the+oxytocin+and+vasopressin+antagonist+atosiban"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of preterm labor with the oxytocin and vasopressin antagonist atosiban</span></div><div class="casAuthors">Bossmar, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Perinatal Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">458-465</span>CODEN:
                <span class="NLM_cas:coden">JPEMAO</span>;
        ISSN:<span class="NLM_cas:issn">0300-5577</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter & Co.</span>)
        </div><div class="casAbstract">A review with 67 refs., describing the role of oxytocin and vasopressin in the initiation of labor preterm and at term, etiol. and current available treatment of preterm labor, and clin. development and potential risks of atosiban.  Atosiban is a specific inhibitor of oxytocin induced uterine contractions, it offers a much more specific treatment in comparison to current therapies, and has fewer side-effects compared to β-mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC8SaCBPPgfbVg90H21EOLACvtfcHk0ljdwczsqKCSGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtV2ltr8%253D&md5=4e81624f95710b905c6b86bea72ca032</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1515%2Fjpme.1998.26.6.458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fjpme.1998.26.6.458%26sid%3Dliteratum%253Aachs%26aulast%3DBossmar%26aufirst%3DT.%26atitle%3DTreatment%2520of%2520preterm%2520labor%2520with%2520the%2520oxytocin%2520and%2520vasopressin%2520antagonist%2520atosiban%26jtitle%3DJ.%2520Perinat.%2520Med.%26date%3D1998%26volume%3D26%26spage%3D458%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Brown, A. D.; Ellis, D.; Smith, C. R.</span><span> </span><span class="NLM_article-title">Substituted triazole derivatives as oxytocin antagonist</span>. Patent WO2005028452,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">, </span>and references therein .</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=A.+D.+Brown&author=D.+Ellis&author=C.+R.+Smith&title=Substituted+triazole+derivatives+as+oxytocin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DSubstituted%2520triazole%2520derivatives%2520as%2520oxytocin%2520antagonist%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Tiwari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chugh, A.</span><span> </span><span class="NLM_article-title">Benign prostatic hyperplasia: an insight into current investigational medical therapies</span> <span class="citation_source-journal">Expert. Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1372</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=1359-1372&author=A.+Tiwariauthor=N.+S.+Krishnaauthor=K.+Nandaauthor=A.+Chugh&title=Benign+prostatic+hyperplasia%3A+an+insight+into+current+investigational+medical+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTiwari%26aufirst%3DA.%26aulast%3DKrishna%26aufirst%3DN.%2BS.%26aulast%3DNanda%26aufirst%3DK.%26aulast%3DChugh%26aufirst%3DA.%26atitle%3DBenign%2520prostatic%2520hyperplasia%253A%2520an%2520insight%2520into%2520current%2520investigational%2520medical%2520therapies%26jtitle%3DExpert.%2520Opin.%2520Investig.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D1359%26epage%3D1372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span> </span><span class="NLM_article-title">Small molecule ligands for oxytocin and vasopressin receptors</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C1%3A%3AAID-MED1%3E3.0.CO%3B2-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=8979247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaK2sXkslSnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=1-16&author=R.+M.+Freidingerauthor=D.+J.+Pettibone&title=Small+molecule+ligands+for+oxytocin+and+vasopressin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule ligands for oxytocin and vasopressin receptors</span></div><div class="casAuthors">Freidinger, Roger M.; Pettibone, Douglas J.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">A review, with 68 refs.  Topics discussed include: endogenous hormones and receptors, peptide structure-activity studies, and small mol. vasopressin and oxytocin receptor-selective antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF6NnlfieO3bVg90H21EOLACvtfcHk0ljdwczsqKCSGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslSnug%253D%253D&md5=8f085a42967e880d4d78716972a1a4a1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C1%3A%3AAID-MED1%3E3.0.CO%3B2-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199701%252917%253A1%253C1%253A%253AAID-MED1%253E3.0.CO%253B2-5%26sid%3Dliteratum%253Aachs%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26atitle%3DSmall%2520molecule%2520ligands%2520for%2520oxytocin%2520and%2520vasopressin%2520receptors%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1997%26volume%3D17%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Borthwick, A. D.</span><span> </span><span class="NLM_article-title">Oxytocin antagonists and agonists</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=413-422&author=A.+D.+Borthwick&title=Oxytocin+antagonists+and+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26atitle%3DOxytocin%2520antagonists%2520and%2520agonists%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2006%26volume%3D41%26spage%3D413%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, P.</span><span> </span><span class="NLM_article-title">Preterm labour: an overview of current and emerging therapeutics</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1441</span><span class="NLM_x">–</span> <span class="NLM_lpage">1468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.2174%2F0929867033457331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=12871140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1Wrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=1441-1468&author=M.+K.+Schwarzauthor=P.+Page&title=Preterm+labour%3A+an+overview+of+current+and+emerging+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Preterm labor: An overview of current and emerging therapeutics</span></div><div class="casAuthors">Schwarz, Matthias K.; Page, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1441-1468</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Preterm labour is a major cause of perinatal mortality and morbidity.  However, during the past 40 yr of clin. studies and despite the use of multiple therapeutic agents, the rate of preterm birth has not drastically declined.  In 1991, it was estd. that in the US approx. 116,000 women admitted with acute episodes of preterm labour were treated each year with ritodrine, which is the first drug approved by the US FDA and still remains the std. therapy for treating preterm labour.  Ritodrine (Yutopar) stimulates the β2-adrenergic receptor throughout the body, causing an inhibitory action in different tissues that, among other side effects, also leads to an attenuation of uterine contractility.  More recently, a new therapeutic agent, atosiban (Tractocile), a peptidic oxytocin receptor antagonist, has been introduced to the market.  However, the use of the various pharmacol. agents to treat preterm labour remains restricted, due to lack of uterine selectivity, low efficacy and potentially serious side effects for the mother or the fetus.  Therefore, there is an urgent need to develop drugs with myometrial selectivity that would allow long-lasting inhibition of labour and prolong pregnancy up to a stage when good fetal maturation raises the chances of survival.  One of the major obstacles hampering the development of new therapeutic agents is the marked inter-species difference in terms of preterm labour physiol., which complicates the preclin. evaluation of new candidate mols. in animal models of disease.  In this review, the authors will provide a comprehensive update of past, current and new approaches for the management of preterm labour, including β2-adrenergic agonists, calcium channel blockers, oxytocin antagonists, prostaglandin antagonists and other potential therapeutics.  For each of the therapies used today, the review will cover the mechanism of action, benefit and adverse effects, and discuss the promise and potential benefits of new emerging therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVKIjKbPIIQbVg90H21EOLACvtfcHk0lhOnZOk4BhTtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1Wrur4%253D&md5=b4f99b81170d59cf3dda33a0843d73fc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F0929867033457331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033457331%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DPage%26aufirst%3DP.%26atitle%3DPreterm%2520labour%253A%2520an%2520overview%2520of%2520current%2520and%2520emerging%2520therapeutics%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D1441%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Havass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulop, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zupko, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falkay, G.</span><span> </span><span class="NLM_article-title">Noncompetitive nature of oxytocin antagonists with general structure Mpa1Xxx2Sar7Arg8</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1419</span><span class="NLM_x">–</span> <span class="NLM_lpage">1425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=1419-1425&author=J.+Havassauthor=K.+Bakosauthor=A.+Markiauthor=R.+Gasparauthor=L.+Geraauthor=J.+M.+Stewartauthor=F.+Fulopauthor=G.+K.+Tothauthor=I.+Zupkoauthor=G.+Falkay&title=Noncompetitive+nature+of+oxytocin+antagonists+with+general+structure+Mpa1Xxx2Sar7Arg8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHavass%26aufirst%3DJ.%26aulast%3DBakos%26aufirst%3DK.%26aulast%3DMarki%26aufirst%3DA.%26aulast%3DGaspar%26aufirst%3DR.%26aulast%3DGera%26aufirst%3DL.%26aulast%3DStewart%26aufirst%3DJ.%2BM.%26aulast%3DFulop%26aufirst%3DF.%26aulast%3DToth%26aufirst%3DG.%2BK.%26aulast%3DZupko%26aufirst%3DI.%26aulast%3DFalkay%26aufirst%3DG.%26atitle%3DNoncompetitive%2520nature%2520of%2520oxytocin%2520antagonists%2520with%2520general%2520structure%2520Mpa1Xxx2Sar7Arg8%26jtitle%3DPeptides%26date%3D2002%26volume%3D23%26spage%3D1419%26epage%3D1425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Melin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojnar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilhardt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerlund, M.</span><span> </span><span class="NLM_article-title">Synthetic antagonists of the myometrial response to vasopressin and oxytocin</span> <span class="citation_source-journal">J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1677%2Fjoe.0.1110125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=3783079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaL28XmtF2js7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=1986&pages=125-131&author=P.+Melinauthor=J.+Trojnarauthor=B.+Johanssonauthor=H.+Vilhardtauthor=M.+Akerlund&title=Synthetic+antagonists+of+the+myometrial+response+to+vasopressin+and+oxytocin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic antagonists of the myometrial response to vasopressin and oxytocin</span></div><div class="casAuthors">Melin, P.; Trojnar, J.; Johansson, B.; Vilhardt, H.; Aakerlund, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-31</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    </div><div class="casAbstract">In an attempt to develop inhibitors of vasopressin- and oxytocin-induced uterine activity, 17 analogs of 1-deamino-oxytocin were synthesized by the solid-phase method.  Modifications were made at position 2, O-methyltyrosine (Tyr(OMe)), O-ethyltyrosine (Tyr(OEt)),D-Tyr, D-Tyr(OEt), or D-Trptophan (D-Trp), at position 4, Valine (Val) or Threonine (Thr), and(or) at position 8, Ornithine (Orn), Citrulline (Cit), Arginine (Arg), or D-Arg.  The analogs were tested for antiuterotonic activity in vitro and in vivo in the rat and in vitro on myometrial strips from nonpregnant women and pregnant women at term.  Their selectivity was also investigated in the blood pressure and antidiuretic bioassay in rats.  Results were compared with those of the antiuterotonic analog 1-deamino-Tyr(OEt)2-oxytocin (d(OEt)-oxytocin)  [77648-79-4].  All analogs possessed higher antiuterotonic activity than d(OEt)-oxytocin in the rat in vitro and in vivo.  The neg. logarithm of the molar concn. of the antagonist which reduced the effect of a dose of agonist to that of half the dose (pA2) was 7.6-8.9 for all the new inhibitors, compared with 7.2 for d(OEt)-oxytocin.  The highest pA2 value was found for [1-deamino-Tyr(OMe)2,Orn8]-oxytocin  [105317-61-1] (8.9) and [1-deamino-Tyr(OEt)2-Thr4,Orn8]-oxytocin  [90779-66-1] (8.9).  In myometrium from nonpregnant women, the most potent peptide was [1-deamino-D-Tyr(OEt)2,Thr4,Orn8]-oxytocin  [90779-69-4] (17.2-fold more potent that d(OEt)-oxytocin).  In myometrium from pregnant women, the inhibitory effects of the majority of the analogs were less pronounced.  In the rat in vivo, the most potent analog, [1-deamino-D-Trp2,Val4,Orn8]-oxytocin  [92407-79-9], was 19.9-fold more active than d(OEt)-oxytocin.  Exchanging L-Tyr for the D-form generally increased inhibitory activity as well as the specificity of the analogs.  Alkylation of the D-Tyr residue did not appear to be necessary for inhibition.  Substitution with D-tryptophan at position 2 gave analogs with high inhibitory potency in the rat in vitro and in vivo, but which exhibited weak effects in women in vitro.  There was no correlation between the inhibitory effects on myometrium from nonpregnant and pregnant women or between rat and human data.  The high antiuterotonic activity of [1-deamino-D-Tyr(OEt)2-Val4-Orn8]-oxytocin  [90779-68-3] and [1-deamino-D-Tyr(OEt)2-Thr4-Orn8]-oxytocin combined with low blood pressure and antidiuretic effects make these 2 analogs interesting for clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpclwW2oDDmYLVg90H21EOLACvtfcHk0liTgjMICV_bIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XmtF2js7k%253D&md5=02585b2a019acd05fc685d7b80b4c516</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1677%2Fjoe.0.1110125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Fjoe.0.1110125%26sid%3Dliteratum%253Aachs%26aulast%3DMelin%26aufirst%3DP.%26aulast%3DTrojnar%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DB.%26aulast%3DVilhardt%26aufirst%3DH.%26aulast%3DAkerlund%26aufirst%3DM.%26atitle%3DSynthetic%2520antagonists%2520of%2520the%2520myometrial%2520response%2520to%2520vasopressin%2520and%2520oxytocin%26jtitle%3DJ.%2520Endocrinol.%26date%3D1986%26volume%3D111%26spage%3D125%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Melin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilhardt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerlund, M.</span><span> </span><span class="NLM_article-title">Inhibitory effect of O-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity</span> <span class="citation_source-journal">J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1677%2Fjoe.0.0880173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=7193709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaL3MXitVaqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1981&pages=173-180&author=P.+Melinauthor=H.+Vilhardtauthor=G.+Lindebergauthor=L.+E.+Larssonauthor=M.+Akerlund&title=Inhibitory+effect+of+O-alkylated+analogues+of+oxytocin+and+vasopressin+on+human+and+rat+myometrial+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of O-alkylated analogs of oxytocin and vasopressin on human and rat myometrial activity</span></div><div class="casAuthors">Melin, P.; Vilhardt, H.; Lindeberg, G.; Larsson, L. E.; Aakerlund, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-80</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    </div><div class="casAbstract">Analogs of oxytocin and vasopressin modified by O-alkylation (Me, Et, and Bu) at position 2 of the peptide chain showed no appreciable oxytocic activity on rat uterus in vivo and isolated rat and human myometrial prepns.  When tested together with oxytocin or vasopressin the analogs inhibited the uterine response to the hormones in a dose-dependent and reversible manner.  Et analogs were more powerful antagonists than Me analogs, but further prolongation of the alkyl chain (Bu) diminished the antagonistic properties of the compds.  The effect on antagonistic potency of deamination at position 1 of the analogs varied among the analogs and depended on the test system used.  The possible clin. value of the antagonists is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe7bRRgMErLrVg90H21EOLACvtfcHk0liTgjMICV_bIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXitVaqurs%253D&md5=d0cdccc51721f9b82b9c6f3c230b92d9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1677%2Fjoe.0.0880173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Fjoe.0.0880173%26sid%3Dliteratum%253Aachs%26aulast%3DMelin%26aufirst%3DP.%26aulast%3DVilhardt%26aufirst%3DH.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DLarsson%26aufirst%3DL.%2BE.%26aulast%3DAkerlund%26aufirst%3DM.%26atitle%3DInhibitory%2520effect%2520of%2520O-alkylated%2520analogues%2520of%2520oxytocin%2520and%2520vasopressin%2520on%2520human%2520and%2520rat%2520myometrial%2520activity%26jtitle%3DJ.%2520Endocrinol.%26date%3D1981%26volume%3D88%26spage%3D173%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanizawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownstein, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okayama, H.</span><span> </span><span class="NLM_article-title">Structure and expression of a human oxytocin receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=1992&pages=526-529&author=T.+Kimuraauthor=O.+Tanizawaauthor=K.+Moriauthor=M.+J.+Brownsteinauthor=H.+Okayama&title=Structure+and+expression+of+a+human+oxytocin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DTanizawa%26aufirst%3DO.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DBrownstein%26aufirst%3DM.%2BJ.%26aulast%3DOkayama%26aufirst%3DH.%26atitle%3DStructure%2520and%2520expression%2520of%2520a%2520human%2520oxytocin%2520receptor%26jtitle%3DNature%26date%3D1992%26volume%3D356%26spage%3D526%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clineschmidt, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishel, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lis, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woyden, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haluska, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novy, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowensohn, R. I.</span><span> </span><span class="NLM_article-title">Identification of an orally active, nonpeptidyl oxytocin antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=8423533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaK3sXhtFKksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1993&pages=308-314&author=D.+J.+Pettiboneauthor=B.+V.+Clineschmidtauthor=M.+T.+Kishelauthor=E.+V.+Lisauthor=D.+R.+Reissauthor=C.+J.+Woydenauthor=B.+E.+Evansauthor=R.+M.+Freidingerauthor=D.+F.+Veberauthor=M.+J.+Cookauthor=G.+J.+Haluskaauthor=M.+J.+Novyauthor=R.+I.+Lowensohn&title=Identification+of+an+orally+active%2C+nonpeptidyl+oxytocin+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an orally active, nonpeptidyl oxytocin antagonist</span></div><div class="casAuthors">Pettibone, D. J.; Clineschmidt, B. V.; Kishel, M. T.; Lis, E. V.; Reiss, D. R.; Woyden, C. J.; Evans, B. E.; Freidinger, R. M.; Veber, D. F.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">308-14</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">L-366,509 (I), a member of a novel class of nonpeptidyl compds., has been characterized as an orally active oxytocin (OT) antagonist.  L-366,509 exhibits a moderate binding affinity (Ki values, 370-780 nM) for the rat, rhesus and human uterine OT receptor.  L-366,509 also binds to vasopressin receptor subtypes (arginine vasopressin-V1 and V2) with measurable affinity in rat (Ki values, 25-30 μM) and primate (Ki values, 2-6 μM) tissues.  In rat uterine slices, L-366,509 inhibits (IC50 = 1.6 μM) the stimulation of phosphatidylinositol turnover induced by OT but not bradykinin.  In the rat isolated uterus, L-366,509 is a competitive and reversible OT antagonist (pA2 = 7.32).  In vitro, L-366,509 given i.v. (10 mg/kg) or intraduodenally (10-50 mg/kg) to rats causes a marked and long-lasting inhibition of OT-stimulated uterine activity.  OT antagonist activity in a pregnant rhesus macaque (∼day 135 gestation) is also obsd. with L-366,509 after i.v. or p.o. dosing.  L-366,509 represents a prototype for a new chem. class of OT antagonists with significant p.o. bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8VfFkVEYgCLVg90H21EOLACvtfcHk0lj5rLu8jW-cag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtFKksr4%253D&md5=c1b187aaed0a7cf3818b5d8bd55cba75</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DKishel%26aufirst%3DM.%2BT.%26aulast%3DLis%26aufirst%3DE.%2BV.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DWoyden%26aufirst%3DC.%2BJ.%26aulast%3DEvans%26aufirst%3DB.%2BE.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DCook%26aufirst%3DM.%2BJ.%26aulast%3DHaluska%26aufirst%3DG.%2BJ.%26aulast%3DNovy%26aufirst%3DM.%2BJ.%26aulast%3DLowensohn%26aufirst%3DR.%2BI.%26atitle%3DIdentification%2520of%2520an%2520orally%2520active%252C%2520nonpeptidyl%2520oxytocin%2520antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1993%26volume%3D264%26spage%3D308%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Evans, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leighton, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPardo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber., D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clineschmidt, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span> </span><span class="NLM_article-title">Orally active, nonpeptide oxytocin antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">3919</span><span class="NLM_x">–</span> <span class="NLM_lpage">3927</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00099a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaK38XlvFWltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=3919-3927&author=B.+E.+Evansauthor=J.+L.+Leightonauthor=K.+E.+Rittleauthor=K.+F.+Gilbertauthor=G.+F.+Lundellauthor=N.+P.+Gouldauthor=D.+W.+Hobbsauthor=R.+M.+DiPardoauthor=D.+F.+Veber.author=D.+J.+Pettiboneauthor=B.+V.+Clineschmidtauthor=P.+S.+Andersonauthor=R.+M.+Freidinger&title=Orally+active%2C+nonpeptide+oxytocin+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Orally active, nonpeptide oxytocin antagonists</span></div><div class="casAuthors">Evans, Ben E.; Leighton, James L.; Rittle, Kenneth E.; Gilbert, Kevin F.; Lundell, George F.; Gould, Norman P.; Hobbs, Doug W.; DiPardo, Robert M.; Veber, Daniel F.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3919-27</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Spiroindenepiperidines, including I, were prepd. as orally bioavailable oxytocin antagonists; I showed good in vivo duration.  The potential use of these agents for treatment of preterm labor and their significance as new nonpeptide ligands for peptide receptors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFxnwaKxipsrVg90H21EOLACvtfcHk0lj5rLu8jW-cag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvFWltrY%253D&md5=b6b67125432c382fe7d8861f04666a38</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00099a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00099a020%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DB.%2BE.%26aulast%3DLeighton%26aufirst%3DJ.%2BL.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DLundell%26aufirst%3DG.%2BF.%26aulast%3DGould%26aufirst%3DN.%2BP.%26aulast%3DHobbs%26aufirst%3DD.%2BW.%26aulast%3DDiPardo%26aufirst%3DR.%2BM.%26aulast%3DVeber.%26aufirst%3DD.%2BF.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26atitle%3DOrally%2520active%252C%2520nonpeptide%2520oxytocin%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D3919%26epage%3D3927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, S.-H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clineschmidt, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawluczyk, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlow, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitzenberger, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span> </span><span class="NLM_article-title">1-((7,7-Dimethyl-2(<i>S</i>)-(2(<i>S</i>)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(<i>S</i>)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00031a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=565-571&author=P.+D.+Williamsauthor=P.+S.+Andersonauthor=R.+G.+Ballauthor=M.+G.+Bockauthor=L.+A.+Carrollauthor=S.-H.+L.+Chiuauthor=B.+V.+Clineschmidtauthor=J.+C.+Culbersonauthor=J.+M.+Erbauthor=B.+E.+Evansauthor=S.+L.+Fitzpatrickauthor=R.+M.+Freidingerauthor=M.+J.+Kaufmanauthor=G.+F.+Lundellauthor=J.+S.+Murphyauthor=J.+M.+Pawluczykauthor=D.+S.+Perlowauthor=D.+J.+Pettiboneauthor=S.+M.+Pitzenbergerauthor=K.+L.+Thompsonauthor=D.+F.+Veber&title=1-%28%287%2C7-Dimethyl-2%28S%29-%282%28S%29-amino-4-%28methylsulfonyl%29butyramido%29bicyclo+%5B2.2.1%5D-heptan-1%28S%29-yl%29methyl%29sulfonyl%29-4-%282-methylphenyl%29piperazine+%28L-368%2C899%29%3A+an+orally+bioavailable%2C+non-peptide+oxytocin+antagonist+with+potential+utility+for+managing+preterm+labor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm00031a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00031a004%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26aulast%3DBall%26aufirst%3DR.%2BG.%26aulast%3DBock%26aufirst%3DM.%2BG.%26aulast%3DCarroll%26aufirst%3DL.%2BA.%26aulast%3DChiu%26aufirst%3DS.-H.%2BL.%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DCulberson%26aufirst%3DJ.%2BC.%26aulast%3DErb%26aufirst%3DJ.%2BM.%26aulast%3DEvans%26aufirst%3DB.%2BE.%26aulast%3DFitzpatrick%26aufirst%3DS.%2BL.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DKaufman%26aufirst%3DM.%2BJ.%26aulast%3DLundell%26aufirst%3DG.%2BF.%26aulast%3DMurphy%26aufirst%3DJ.%2BS.%26aulast%3DPawluczyk%26aufirst%3DJ.%2BM.%26aulast%3DPerlow%26aufirst%3DD.%2BS.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DPitzenberger%26aufirst%3DS.%2BM.%26aulast%3DThompson%26aufirst%3DK.%2BL.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26atitle%3D1-%2528%25287%252C7-Dimethyl-2%2528S%2529-%25282%2528S%2529-amino-4-%2528methylsulfonyl%2529butyramido%2529bicyclo%2520%255B2.2.1%255D-heptan-1%2528S%2529-yl%2529methyl%2529sulfonyl%2529-4-%25282-methylphenyl%2529piperazine%2520%2528L-368%252C899%2529%253A%2520an%2520orally%2520bioavailable%252C%2520non-peptide%2520oxytocin%2520antagonist%2520with%2520potential%2520utility%2520for%2520managing%2520preterm%2520labor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D565%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clineschmidt, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidotti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lis, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woyden, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, S.-H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schorn, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegl, P. K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cukierski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haluska, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novy, M. J.</span><span> </span><span class="NLM_article-title">L-368,899, a potent orally active oxytocin antagonist for potential use in preterm labor</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1993&pages=129-142&author=D.+J.+Pettiboneauthor=B.+V.+Clineschmidtauthor=M.+T.+Guidottiauthor=E.+V.+Lisauthor=D.+R.+Reissauthor=C.+J.+Woydenauthor=M.+G.+Bockauthor=B.+E.+Evansauthor=R.+M.+Freidingerauthor=D.+W.+Hobbsauthor=D.+F.+Veberauthor=P.+D.+Williamsauthor=S.-H.+L.+Chiuauthor=K.+L.+Thompsonauthor=T.+W.+Schornauthor=P.+K.+S.+Sieglauthor=M.+J.+Kaufmanauthor=M.+A.+Cukierskiauthor=S.+J.+Haluskaauthor=M.+J.+Cookauthor=M.+J.+Novy&title=L-368%2C899%2C+a+potent+orally+active+oxytocin+antagonist+for+potential+use+in+preterm+labor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DGuidotti%26aufirst%3DM.%2BT.%26aulast%3DLis%26aufirst%3DE.%2BV.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DWoyden%26aufirst%3DC.%2BJ.%26aulast%3DBock%26aufirst%3DM.%2BG.%26aulast%3DEvans%26aufirst%3DB.%2BE.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DHobbs%26aufirst%3DD.%2BW.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DChiu%26aufirst%3DS.-H.%2BL.%26aulast%3DThompson%26aufirst%3DK.%2BL.%26aulast%3DSchorn%26aufirst%3DT.%2BW.%26aulast%3DSiegl%26aufirst%3DP.%2BK.%2BS.%26aulast%3DKaufman%26aufirst%3DM.%2BJ.%26aulast%3DCukierski%26aufirst%3DM.%2BA.%26aulast%3DHaluska%26aufirst%3DS.%2BJ.%26aulast%3DCook%26aufirst%3DM.%2BJ.%26aulast%3DNovy%26aufirst%3DM.%2BJ.%26atitle%3DL-368%252C899%252C%2520a%2520potent%2520orally%2520active%2520oxytocin%2520antagonist%2520for%2520potential%2520use%2520in%2520preterm%2520labor%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1993%26volume%3D30%26spage%3D129%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Egerman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capra, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staub, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winchell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constanzer, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catroneo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caritis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibai, B.</span><span> </span><span class="NLM_article-title">The oxytocin receptor antagonist L-368,899 inhibits stimulated uterine contractions in women during the post partum period (Abstract)</span> <span class="citation_source-journal">Am. J. Obstet. Gynecol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=1995&pages=414&author=R.+Egermanauthor=M.+G.+Murphyauthor=E.+Doughertyauthor=N.+Capraauthor=T.+Staubauthor=G.+Winchellauthor=M.+L.+Constanzerauthor=C.+Chavezauthor=N.+Meyerauthor=M.+Catroneoauthor=S.+Caritisauthor=B.+Sibai&title=The+oxytocin+receptor+antagonist+L-368%2C899+inhibits+stimulated+uterine+contractions+in+women+during+the+post+partum+period+%28Abstract%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgerman%26aufirst%3DR.%26aulast%3DMurphy%26aufirst%3DM.%2BG.%26aulast%3DDougherty%26aufirst%3DE.%26aulast%3DCapra%26aufirst%3DN.%26aulast%3DStaub%26aufirst%3DT.%26aulast%3DWinchell%26aufirst%3DG.%26aulast%3DConstanzer%26aufirst%3DM.%2BL.%26aulast%3DChavez%26aufirst%3DC.%26aulast%3DMeyer%26aufirst%3DN.%26aulast%3DCatroneo%26aufirst%3DM.%26aulast%3DCaritis%26aufirst%3DS.%26aulast%3DSibai%26aufirst%3DB.%26atitle%3DThe%2520oxytocin%2520receptor%2520antagonist%2520L-368%252C899%2520inhibits%2520stimulated%2520uterine%2520contractions%2520in%2520women%2520during%2520the%2520post%2520partum%2520period%2520%2528Abstract%2529%26jtitle%3DAm.%2520J.%2520Obstet.%2520Gynecol.%26date%3D1995%26volume%3D172%26spage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Chiu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvaro, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huskey, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span> </span><span class="NLM_article-title">The role of drug metabolism in drug discovery: a case study in the selection of an oxytocin receptor antagonist for development</span> <span class="citation_source-journal">Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1177%2F019262339502300204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=7569665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaK2MXlslCqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1995&pages=124-130&author=S.+H.+Chiuauthor=K.+A.+Thompsonauthor=S.+H.+Vincentauthor=R.+F.+Alvaroauthor=S.+W.+Huskeyauthor=R.+A.+Stearnsauthor=D.+J.+Pettibone&title=The+role+of+drug+metabolism+in+drug+discovery%3A+a+case+study+in+the+selection+of+an+oxytocin+receptor+antagonist+for+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The role of drug metabolism in drug discovery: a case study in the selection of an oxytocin receptor antagonist for development</span></div><div class="casAuthors">Chiu, Shuet-Hing L.; Thompson, Katherine A.; Vincent, Stella H.; Alvaro, Raul F.; Huskey, Su-Er W.; Stearns, Ralph A.; Pettibone, Douglas J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-30</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    </div><div class="casAbstract">Drug discovery is a process involving multiple disciplines and interests.  During the research phase of drug discovery, usually a large no. of compds. are evaluated for biol. activity and toxicol. potential in animal species.  Various types of problems with respect to pharmacodynamics, pharmacokinetics, and toxicity are commonly encountered at this stage.  Drug metab., as a discipline participating in a drug discovery team, can play an important role in identifying factors underlying the problems, facilitate the optimal selection of compds. for further development, provide information on metabolites for possible improvement in drug design, and contribute to the identification of the appropriate animal species for subsequent toxicity testing.  During the process of evaluating oxytocin receptor antagonists for further development for treatment of preterm labor, in vivo and in vitro drug metab. studies conducted in rats, dogs, and monkeys contributed to the selection of L-368,899 as the development candidate on the basis of pharmacokinetic and metab. observations.  The presence of active N-demethylated metabolites of two other equipotent compds. in rats and dogs was found to be the major factor responsible for the discrepancy between oral bioavailability and efficacies obsd. for these 2 compds.  For L-368,899, a compd. that demonstrated 20-40% oral bioavailability in rats, dogs, and chimpanzees, extensive first-pass metab. rather than absorption was detd. as the major factor responsible for the poor bioavailability (<1%) in rhesus monkeys.  In vitro metab. studies with hepatic microsomes from rats, dogs, monkeys, and humans substantiated the conclusion that the rate of hepatic metab. of L-368,899 in monkeys is faster than in the other species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9bHtGrwarc7Vg90H21EOLACvtfcHk0ljrkwoBi1Ri6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlslCqtb4%253D&md5=5f1931284e8c5bb88b4838a79bfe113b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1177%2F019262339502300204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F019262339502300204%26sid%3Dliteratum%253Aachs%26aulast%3DChiu%26aufirst%3DS.%2BH.%26aulast%3DThompson%26aufirst%3DK.%2BA.%26aulast%3DVincent%26aufirst%3DS.%2BH.%26aulast%3DAlvaro%26aufirst%3DR.%2BF.%26aulast%3DHuskey%26aufirst%3DS.%2BW.%26aulast%3DStearns%26aufirst%3DR.%2BA.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520role%2520of%2520drug%2520metabolism%2520in%2520drug%2520discovery%253A%2520a%2520case%2520study%2520in%2520the%2520selection%2520of%2520an%2520oxytocin%2520receptor%2520antagonist%2520for%2520development%26jtitle%3DToxicol.%2520Pathol.%26date%3D1995%26volume%3D23%26spage%3D124%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Boccia, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goursaud, A. P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachevalier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, C. A.</span><span> </span><span class="NLM_article-title">Peripherally administered non-peptide oxytocin antagonist, L368,899, accumulates in limbic brain areas: a new pharmacological tool for the study of social motivation in non-human primates</span> <span class="citation_source-journal">Horm. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1016%2Fj.yhbeh.2007.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=17583705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFKis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=344-351&author=M.+L.+Bocciaauthor=A.+P.+S.+Goursaudauthor=J.+Bachevalierauthor=K.+D.+Andersonauthor=C.+A.+Pedersen&title=Peripherally+administered+non-peptide+oxytocin+antagonist%2C+L368%2C899%2C+accumulates+in+limbic+brain+areas%3A+a+new+pharmacological+tool+for+the+study+of+social+motivation+in+non-human+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Peripherally administered non-peptide oxytocin antagonist, L368,899, accumulates in limbic brain areas: A new pharmacological tool for the study of social motivation in non-human primates</span></div><div class="casAuthors">Boccia, Maria L.; Goursaud, Anne-Pierre S.; Bachevalier, Jocelyne; Anderson, Kenneth D.; Pedersen, Cort A.</div><div class="citationInfo"><span class="NLM_cas:title">Hormones and Behavior</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-351</span>CODEN:
                <span class="NLM_cas:coden">HOBEAO</span>;
        ISSN:<span class="NLM_cas:issn">0018-506X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Central administration of oxytocin (OT) antagonists inhibits maternal and sexual behavior in non-primates, providing the strongest exptl. evidence that endogenous OT facilitates these behaviors.  While there have been a few reports that ICV administration of OT increases social behaviors in monkeys, no studies to date have assessed the effects of OT antagonists.  Therefore, we studied in rhesus monkeys whether L368,899 a non-peptide antagonist produced by Merck that selectively blocks the human uterine OT receptor, penetrates the CNS after peripheral administration and alters female maternal and sexual behavior.  In two studies in four male monkeys, L368,899 was injected iv (1 mg/kg) after which (1) CSF samples were collected at intervals over 4 h and (2) brains were collected at 60 min.  Assay of samples confirmed that iv-administered L368,899 entered CSF and accumulated in the hypothalamus, septum, orbitofrontal cortex, amygdala and hippocampus, but not other areas.  An adult female monkey was tested for interest in either an infant or sexual behavior, receiving a different iv treatment prior to each test (1 or 3 mg/kg of L368,899 or saline).  OT antagonist treatment reduced or eliminated interest in the infant and sexual behavior.  These results, although preliminary, are the first to directly implicate endogenous OT in activation of primate maternal interest and sexual behavior.  While it remains to be empirically demonstrated that peripherally administered L368,899 blocks central OT receptors, our behavioral findings suggest that this non-peptide antagonist may facilitate testing OT involvement in a variety of social and other behaviors in primates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXBQycmcApGrVg90H21EOLACvtfcHk0ljrkwoBi1Ri6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFKis7Y%253D&md5=90dcde56dec03719e61ca64b21774b00</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.yhbeh.2007.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yhbeh.2007.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DBoccia%26aufirst%3DM.%2BL.%26aulast%3DGoursaud%26aufirst%3DA.%2BP.%2BS.%26aulast%3DBachevalier%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DK.%2BD.%26aulast%3DPedersen%26aufirst%3DC.%2BA.%26atitle%3DPeripherally%2520administered%2520non-peptide%2520oxytocin%2520antagonist%252C%2520L368%252C899%252C%2520accumulates%2520in%2520limbic%2520brain%2520areas%253A%2520a%2520new%2520pharmacological%2520tool%2520for%2520the%2520study%2520of%2520social%2520motivation%2520in%2520non-human%2520primates%26jtitle%3DHorm.%2520Behav.%26date%3D2007%26volume%3D52%26spage%3D344%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clineschmidt, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidotti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lis, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawluczyk, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woyden, C. J.</span><span> </span><span class="NLM_article-title">1-(1-[4-[(<i>N</i>-Acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4-yl)-4<i>H</i>-3,1-benzoxazin-2(1<i>H</i>)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4634</span><span class="NLM_x">–</span> <span class="NLM_lpage">4636</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00023a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=4634-4636&author=P.+D.+Williamsauthor=B.+V.+Clineschmidtauthor=J.+M.+Erbauthor=R.+M.+Freidingerauthor=M.+T.+Guidottiauthor=E.+V.+Lisauthor=J.+M.+Pawluczykauthor=D.+J.+Pettiboneauthor=D.+R.+Reissauthor=D.+F.+Veberauthor=C.+J.+Woyden&title=1-%281-%5B4-%5B%28N-Acetyl-4-piperidinyl%29oxy%5D-2-methoxybenzoyl%5Dpiperidin-4-yl%29-4H-3%2C1-benzoxazin-2%281H%29-one+%28L-371%2C257%29%3A+a+new%2C+orally+bioavailable%2C+non-peptide+oxytocin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00023a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00023a002%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DErb%26aufirst%3DJ.%2BM.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DGuidotti%26aufirst%3DM.%2BT.%26aulast%3DLis%26aufirst%3DE.%2BV.%26aulast%3DPawluczyk%26aufirst%3DJ.%2BM.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DWoyden%26aufirst%3DC.%2BJ.%26atitle%3D1-%25281-%255B4-%255B%2528N-Acetyl-4-piperidinyl%2529oxy%255D-2-methoxybenzoyl%255Dpiperidin-4-yl%2529-4H-3%252C1-benzoxazin-2%25281H%2529-one%2520%2528L-371%252C257%2529%253A%2520a%2520new%252C%2520orally%2520bioavailable%252C%2520non-peptide%2520oxytocin%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D4634%26epage%3D4636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidotti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halpin, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homnick, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lis, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathre, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawluczyk, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woyden, C. J.</span><span> </span><span class="NLM_article-title">Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2146</span><span class="NLM_x">–</span> <span class="NLM_lpage">2163</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9800797" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2146-2163&author=I.+M.+Bellauthor=J.+M.+Erbauthor=R.+M.+Freidingerauthor=S.+N.+Gallicchioauthor=J.+P.+Guareauthor=M.+T.+Guidottiauthor=R.+A.+Halpinauthor=D.+W.+Hobbsauthor=C.+F.+Homnickauthor=M.+S.+Kuoauthor=E.+V.+Lisauthor=D.+J.+Mathreauthor=S.+R.+Michelsonauthor=J.+M.+Pawluczykauthor=D.+J.+Pettiboneauthor=D.+R.+Reissauthor=S.+Vickersauthor=P.+D.+Williamsauthor=C.+J.+Woyden&title=Development+of+orally+active+oxytocin+antagonists%3A+studies+on+1-%281-%5B4-%5B1-%282-methyl-1-oxidopyridin-3-ylmethyl%29piperidin-4-yloxy%5D-2-+methoxybenzoyl%5Dpiperidin-4-yl%29-1%2C4-dihydrobenz%5Bd%5D%5B1%2C3%5Doxazin-2-one+%28L-372%2C662%29+and+related+pyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm9800797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9800797%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DErb%26aufirst%3DJ.%2BM.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DGallicchio%26aufirst%3DS.%2BN.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DGuidotti%26aufirst%3DM.%2BT.%26aulast%3DHalpin%26aufirst%3DR.%2BA.%26aulast%3DHobbs%26aufirst%3DD.%2BW.%26aulast%3DHomnick%26aufirst%3DC.%2BF.%26aulast%3DKuo%26aufirst%3DM.%2BS.%26aulast%3DLis%26aufirst%3DE.%2BV.%26aulast%3DMathre%26aufirst%3DD.%2BJ.%26aulast%3DMichelson%26aufirst%3DS.%2BR.%26aulast%3DPawluczyk%26aufirst%3DJ.%2BM.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DVickers%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DWoyden%26aufirst%3DC.%2BJ.%26atitle%3DDevelopment%2520of%2520orally%2520active%2520oxytocin%2520antagonists%253A%2520studies%2520on%25201-%25281-%255B4-%255B1-%25282-methyl-1-oxidopyridin-3-ylmethyl%2529piperidin-4-yloxy%255D-2-%2520methoxybenzoyl%255Dpiperidin-4-yl%2529-1%252C4-dihydrobenz%255Bd%255D%255B1%252C3%255Doxazin-2-one%2520%2528L-372%252C662%2529%2520and%2520related%2520pyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2146%26epage%3D2163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span> </span><span class="NLM_article-title">Progress in the development of oxytocin antagonists for use in preterm labor</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">449</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=1998&pages=473-479&author=P.+D.+Williamsauthor=M.+G.+Bockauthor=B.+E.+Evansauthor=R.+M.+Freidingerauthor=D.+J.+Pettibone&title=Progress+in+the+development+of+oxytocin+antagonists+for+use+in+preterm+labor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DBock%26aufirst%3DM.%2BG.%26aulast%3DEvans%26aufirst%3DB.%2BE.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520oxytocin%2520antagonists%2520for%2520use%2520in%2520preterm%2520labor%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1998%26volume%3D449%26spage%3D473%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Hawtin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, M.</span><span> </span><span class="NLM_article-title">A Gly/Ala switch contributes to high affinity binding of benzoxazinone-based non-peptide oxytocin receptor antagonists</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">579</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2005&pages=349-356&author=S.+R.+Hawtinauthor=S.+N.+Haauthor=D.+J.+Pettiboneauthor=M.+Wheatley&title=A+Gly%2FAla+switch+contributes+to+high+affinity+binding+of+benzoxazinone-based+non-peptide+oxytocin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHawtin%26aufirst%3DS.%2BR.%26aulast%3DHa%26aufirst%3DS.%2BN.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DWheatley%26aufirst%3DM.%26atitle%3DA%2520Gly%252FAla%2520switch%2520contributes%2520to%2520high%2520affinity%2520binding%2520of%2520benzoxazinone-based%2520non-peptide%2520oxytocin%2520receptor%2520antagonists%26jtitle%3DFEBS%2520Lett.%26date%3D2005%26volume%3D579%26spage%3D349%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilcott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordaunt, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woollard, P. M.</span><span> </span><span class="NLM_article-title">Identification of potent and selective oxytocin antagonists. Part 1: indole and benzofuran derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1399-1404&author=P.+G.+Wyattauthor=M.+J.+Allenauthor=J.+Chilcottauthor=A.+Fosterauthor=D.+G.+Livermoreauthor=J.+E.+Mordauntauthor=J.+Scicinskiauthor=P.+M.+Woollard&title=Identification+of+potent+and+selective+oxytocin+antagonists.+Part+1%3A+indole+and+benzofuran+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DChilcott%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DA.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DMordaunt%26aufirst%3DJ.%2BE.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DWoollard%26aufirst%3DP.%2BM.%26atitle%3DIdentification%2520of%2520potent%2520and%2520selective%2520oxytocin%2520antagonists.%2520Part%25201%253A%2520indole%2520and%2520benzofuran%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1399%26epage%3D1404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilcott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordaunt, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nerozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perren, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weingarten, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woollard, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span> </span><span class="NLM_article-title">Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1405</span><span class="NLM_x">–</span> <span class="NLM_lpage">1411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1405-1411&author=P.+G.+Wyattauthor=M.+J.+Allenauthor=J.+Chilcottauthor=C.+Gardnerauthor=A.+Fosterauthor=D.+G.+Livermoreauthor=J.+E.+Mordauntauthor=F.+Nerozziauthor=M.+Patelauthor=M.+J.+Perrenauthor=G.+G.+Weingartenauthor=S.+Shabirauthor=P.+M.+Woollardauthor=P.+Zhou&title=Identification+of+potent+and+selective+oxytocin+antagonists.+Part+2%3A+further+investigation+of+benzofuran+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DChilcott%26aufirst%3DJ.%26aulast%3DGardner%26aufirst%3DC.%26aulast%3DFoster%26aufirst%3DA.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DMordaunt%26aufirst%3DJ.%2BE.%26aulast%3DNerozzi%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DPerren%26aufirst%3DM.%2BJ.%26aulast%3DWeingarten%26aufirst%3DG.%2BG.%26aulast%3DShabir%26aufirst%3DS.%26aulast%3DWoollard%26aufirst%3DP.%2BM.%26aulast%3DZhou%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520potent%2520and%2520selective%2520oxytocin%2520antagonists.%2520Part%25202%253A%2520further%2520investigation%2520of%2520benzofuran%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1405%26epage%3D1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ashton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, M.</span><span> </span><span class="NLM_article-title">The selection and design of GPCR ligands: from concept to the clinic</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.2174%2F1386207043328607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=15320711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFegsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=441-452&author=M.+Ashtonauthor=M.+H.+Charltonauthor=M.+K.+Schwarzauthor=R.+J.+Thomasauthor=M.+Whittaker&title=The+selection+and+design+of+GPCR+ligands%3A+from+concept+to+the+clinic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The selection and design of GPCR ligands: From concept to the clinic</span></div><div class="casAuthors">Ashton, Mark; Charlton, Michael H.; Schwarz, Matthias K.; Thomas, Russell J.; Whittaker, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry and High Throughput Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">441-452</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Virtual screening methods using structure-based, pharmacophore-based and descriptor based protocols may be used to identify ligands for the G-protein coupled receptor target family.  A complementary approach is the synthesis and screening of compd. libraries designed using privileged motifs and/or based on validated hit mols.  A virtual screening approach based on mol. docking performed with GOLD using a templated homol. model and a consensus scoring procedure can identify vasopressin 1a receptor antagonists.  In a sep. project a library design and synthesis approach based around validated hit GPCR ligands led to the identification of potent oxytocin antagonists.  Subsequent optimization of the initial library compds. has provided compds. that are now being evaluated in the clinic for the treatment of preterm labor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZgujPxZO_XLVg90H21EOLACvtfcHk0ljq8yXwRtXexA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFegsrg%253D&md5=603d8db3e597f1fafc727f52448add13</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F1386207043328607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1386207043328607%26sid%3Dliteratum%253Aachs%26aulast%3DAshton%26aufirst%3DM.%26aulast%3DCharlton%26aufirst%3DM.%2BH.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DThomas%26aufirst%3DR.%2BJ.%26aulast%3DWhittaker%26aufirst%3DM.%26atitle%3DThe%2520selection%2520and%2520design%2520of%2520GPCR%2520ligands%253A%2520from%2520concept%2520to%2520the%2520clinic%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2004%26volume%3D7%26spage%3D441%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Schwarz, M.; Page, P.; Pomel, V.; Quattropani, A.; Thomas, R. J.</span><span> </span><span class="NLM_article-title">Pyrrolidine oxidazaole and thiadiazole derivatives</span>. Patent WO 02102799,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=M.+Schwarz&author=P.+Page&author=V.+Pomel&author=A.+Quattropani&author=R.+J.+Thomas&title=Pyrrolidine+oxidazaole+and+thiadiazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarz%26aufirst%3DM.%26atitle%3DPyrrolidine%2520oxidazaole%2520and%2520thiadiazole%2520derivatives%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Cirillo., R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillio.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quattropani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missotten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorbais, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giachetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golzio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevillard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portet, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, A.</span><span> </span><span class="NLM_article-title">Pharmacology of (2<i>S</i>,4<i>Z</i>)-<i>N</i>-[(2<i>S</i>)-2-hydroxy-2-phenylethyl]-4-(methoxyimino)-1-[(2′-methyl[1,1′-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1124%2Fjpet.103.049395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=12660315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvF2lu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=253-61&author=R.+Cirillo.author=+Gillio.author=E.+Tosauthor=M.+K.+Schwarzauthor=A.+Quattropaniauthor=A.+Scheerauthor=M.+Missottenauthor=J.+Dorbaisauthor=A.+Nicholsauthor=F.+Borrelliauthor=C.+Giachettiauthor=L.+Golzioauthor=P.+Marinelliauthor=R.+J.+Thomasauthor=C.+Chevillardauthor=F.+Laurentauthor=K.+Portetauthor=C.+Barberisauthor=A.+Chollet&title=Pharmacology+of+%282S%2C4Z%29-N-%5B%282S%29-2-hydroxy-2-phenylethyl%5D-4-%28methoxyimino%29-1-%5B%282%E2%80%B2-methyl%5B1%2C1%E2%80%B2-biphenyl%5D-4-yl%29carbonyl%5D-2-pyrrolidinecarboxamide%2C+a+new+potent+and+selective+nonpeptide+antagonist+of+the+oxytocin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino)-1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor</span></div><div class="casAuthors">Cirillo, Rocco; Tos, Enrico Gillio; Schwarz, Matthias K.; Quattropani, Anna; Scheer, Alexander; Missotten, Marc; Dorbais, Jerome; Nichols, Anthony; Borrelli, Francesco; Giachetti, Claudio; Golzio, Lucia; Marinelli, Paolo; Thomas, Russell J.; Chevillard, Claude; Laurent, Florence; Portet, Karine; Barberis, Claude; Chollet, Andre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">253-261</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have discovered a new, potent, selective, and orally active oxytocin receptor antagonist, (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino)-1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide (I).  We report the biochem., pharmacol., and pharmacokinetic characterization in vitro and in vivo of this compd.  I competitively inhibits binding of [3H]oxytocin and the peptide antagonist 125I-ornithine vasotocin analog to human and rat oxytocin receptor expressed in human embryonic kidney 293-EBNA or Chinese hamster ovary cells with nanomolar potency.  Selectivity against vasopressin receptor subtypes is >6-fold for V1a and >350-fold for V2 and V1b.  I inhibits oxytocin-evoked intracellular Ca2+ mobilization (IC50 = 8 nM).  I has no intrinsic agonist activity at the oxytocin receptor.  Oxytocin-induced contraction of isolated rat uterine strips is blocked by I (pA2 = 7.82).  In anesthetized nonpregnant rats, single administration of I by i.v. or oral routes causes dose-dependent inhibition of contractions elicited by repeated injections of oxytocin with ED50 = 3.5 mg/kg i.v. and 89 mg/kg p.o., resp.  I significantly inhibits spontaneous uterine contractions in pregnant rats near term when administered i.v. or orally.  We conclude that I is a potent, selective, and orally active nonpeptide oxytocin receptor antagonist, which is a suitable candidate for evaluation as a potential tocolytic agent for the management of preterm labor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruo04G8lDiGrVg90H21EOLACvtfcHk0lh0SQVXXKBwPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvF2lu7k%253D&md5=d00ce1eedf70a781fa47116af4749c87</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.049395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.049395%26sid%3Dliteratum%253Aachs%26aulast%3DCirillo.%26aufirst%3DR.%26aulast%3DGillio.%26aulast%3DTos%26aufirst%3DE.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DQuattropani%26aufirst%3DA.%26aulast%3DScheer%26aufirst%3DA.%26aulast%3DMissotten%26aufirst%3DM.%26aulast%3DDorbais%26aufirst%3DJ.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DBorrelli%26aufirst%3DF.%26aulast%3DGiachetti%26aufirst%3DC.%26aulast%3DGolzio%26aufirst%3DL.%26aulast%3DMarinelli%26aufirst%3DP.%26aulast%3DThomas%26aufirst%3DR.%2BJ.%26aulast%3DChevillard%26aufirst%3DC.%26aulast%3DLaurent%26aufirst%3DF.%26aulast%3DPortet%26aufirst%3DK.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DChollet%26aufirst%3DA.%26atitle%3DPharmacology%2520of%2520%25282S%252C4Z%2529-N-%255B%25282S%2529-2-hydroxy-2-phenylethyl%255D-4-%2528methoxyimino%2529-1-%255B%25282%25E2%2580%25B2-methyl%255B1%252C1%25E2%2580%25B2-biphenyl%255D-4-yl%2529carbonyl%255D-2-pyrrolidinecarboxamide%252C%2520a%2520new%2520potent%2520and%2520selective%2520nonpeptide%2520antagonist%2520of%2520the%2520oxytocin%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D253%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Jorand-Lebrun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valognes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorbais, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quattropani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, A.</span><span> </span><span class="NLM_article-title">Pyrrolidine ether derivatives of new oxytocin receptors antagonists</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. A</span><span class="NLM_x">) </span> <span class="NLM_fpage">P222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=P222&issue=Suppl.+A&author=C.+Jorand-Lebrunauthor=D.+Valognesauthor=M.+Schwarzauthor=J.+Dorbaisauthor=A.+Quattropaniauthor=A.+Chollet&title=Pyrrolidine+ether+derivatives+of+new+oxytocin+receptors+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJorand-Lebrun%26aufirst%3DC.%26aulast%3DValognes%26aufirst%3DD.%26aulast%3DSchwarz%26aufirst%3DM.%26aulast%3DDorbais%26aufirst%3DJ.%26aulast%3DQuattropani%26aufirst%3DA.%26aulast%3DChollet%26aufirst%3DA.%26atitle%3DPyrrolidine%2520ether%2520derivatives%2520of%2520new%2520oxytocin%2520receptors%2520antagonists%26jtitle%3DDrugs%2520Future%26date%3D2004%26volume%3D29%26issue%3DSuppl.%2520A%26spage%3DP222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Foulon, L.; Garcia, G.; Serradeil-Le Gal, C.; Valette, G.</span><span> </span><span class="NLM_article-title">Indolin-2-one derivatives, preparation and their use as oxytocin receptor ligands</span> Patent WO2001074775(A1),<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=L.+Foulon&author=G.+Garcia&author=C.+Serradeil-Le+Gal&author=G.+Valette&title=Indolin-2-one+derivatives%2C+preparation+and+their+use+as+oxytocin+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFoulon%26aufirst%3DL.%26atitle%3DIndolin-2-one%2520derivatives%252C%2520preparation%2520and%2520their%2520use%2520as%2520oxytocin%2520receptor%2520ligands%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Serradeil-Le Gal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valette, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foulon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Advenier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naline, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinolle, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouzet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raufaste, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double-Cazanave, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scatton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffrand, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Fur, G.</span><span> </span><span class="NLM_article-title">SSR126768A (4-chloro-3-[3<i>R</i>)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1<i>H</i>-indol-3-yl]-<i>N</i>-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1124%2Fjpet.103.061200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=14722330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A280%3ADC%252BD2c7lsVyitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=414-424&author=C.+Serradeil-Le+Galauthor=G.+Valetteauthor=L.+Foulonauthor=G.+Germainauthor=C.+Advenierauthor=E.+Nalineauthor=M.+Bardouauthor=J.+P.+Martinolleauthor=B.+Pouzetauthor=D.+Raufasteauthor=C.+Garciaauthor=E.+Double-Cazanaveauthor=M.+Paulyauthor=M.+Pascalauthor=A.+Barbierauthor=B.+Scattonauthor=J.+P.+Maffrandauthor=G.+Le+Fur&title=SSR126768A+%284-chloro-3-%5B3R%29-%28%2B%29-5-chloro-1-%282%2C4-dimethoxybenzyl%29-3-methyl-2-oxo-2%2C3-dihydro-1H-indol-3-yl%5D-N-%283-pyridylmethyl%29-benzamide%2C+hydrochloride%29%3A+a+new+selective+and+orally+active+oxytocin+receptor+antagonist+for+the+prevention+of+preterm+labor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor</span></div><div class="casAuthors">Serradeil-Le Gal Claudine; Valette Gerard; Foulon Loic; Germain Guy; Advenier Charles; Naline Emmanuel; Bardou Marc; Martinolle Jean-Pierre; Pouzet Brigitte; Raufaste Danielle; Garcia Corinne; Double-Cazanave Eleonore; Pauly Maxime; Pascal Marc; Barbier Alain; Scatton Bernard; Maffrand Jean-Pierre; Le Fur Gerard</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">414-24</span>
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)benzamide, hydrochloride (SSR126768A), a new potent and selective, orally active oxytocin (OT) receptor antagonist was characterized in several biochemical and pharmacological models.  In binding studies, SSR126768A showed nanomolar affinity for rat and human recombinant and native OT receptors (K(i) = 0.44 nM) and exhibited much lower affinity for V(1a), V(1b), and V(2) receptors.  In addition, it did not interact with a large number of other receptors, enzymes, and ion channels (1 microM).  In autoradiographic experiments performed on at-term human pregnant uterus sections, SSR126768A dose dependently displaced [I(125)]d(CH(2))(5)[Tyr(Me)(2), Thr(4), Orn(8) (125)I-Tyr-NH(2)(9)]VT in situ labeling to OT receptors highly expressed in these tissues.  In functional studies, SSR126768A behaved as a full antagonist and potently antagonized OT-induced intracellular Ca(2+) increase (K(i) = 0.50 nM) and prostaglandin release (K(i) = 0.45 nM) in human uterine smooth muscle cells.  In rat isolated myometrium, OT-induced uterine contractions were competitively antagonized by SSR126768A (pA(2) = 8.47).  Similarly, in human pregnant myometrial strips, SSR126768A inhibited the contractile uterine response to OT.  In conscious telemetrated rats, oral administration of SSR126768A (1-10 mg/kg) produced a competitive inhibition of the dose response to OT on uterine contractions up to 24 h at 3 mg/kg p.o.; no tachyphylaxis was observed after 4-day repeated treatment.  Finally, SSR126768A (30 mg/kg p.o.) significantly delayed parturition in pregnant rats in labor similar to ritodrine (10 mg/kg p.o.).  Thus, SSR126768A is a potent, highly selective, orally active OT receptor antagonist with a long duration of action.  This molecule could find therapeutic application as a tocolytic agent for acute and chronic oral management of preterm labor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6iUVbkwozC5dYoSR9eyvsfW6udTcc2eYCZvTx6BvOH7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7lsVyitQ%253D%253D&md5=136e693c816a368597799687f167dc0a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.061200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.061200%26sid%3Dliteratum%253Aachs%26aulast%3DSerradeil-Le%2BGal%26aufirst%3DC.%26aulast%3DValette%26aufirst%3DG.%26aulast%3DFoulon%26aufirst%3DL.%26aulast%3DGermain%26aufirst%3DG.%26aulast%3DAdvenier%26aufirst%3DC.%26aulast%3DNaline%26aufirst%3DE.%26aulast%3DBardou%26aufirst%3DM.%26aulast%3DMartinolle%26aufirst%3DJ.%2BP.%26aulast%3DPouzet%26aufirst%3DB.%26aulast%3DRaufaste%26aufirst%3DD.%26aulast%3DGarcia%26aufirst%3DC.%26aulast%3DDouble-Cazanave%26aufirst%3DE.%26aulast%3DPauly%26aufirst%3DM.%26aulast%3DPascal%26aufirst%3DM.%26aulast%3DBarbier%26aufirst%3DA.%26aulast%3DScatton%26aufirst%3DB.%26aulast%3DMaffrand%26aufirst%3DJ.%2BP.%26aulast%3DLe%2BFur%26aufirst%3DG.%26atitle%3DSSR126768A%2520%25284-chloro-3-%255B3R%2529-%2528%252B%2529-5-chloro-1-%25282%252C4-dimethoxybenzyl%2529-3-methyl-2-oxo-2%252C3-dihydro-1H-indol-3-yl%255D-N-%25283-pyridylmethyl%2529-benzamide%252C%2520hydrochloride%2529%253A%2520a%2520new%2520selective%2520and%2520orally%2520active%2520oxytocin%2520receptor%2520antagonist%2520for%2520the%2520prevention%2520of%2520preterm%2520labor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D414%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Quattropani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorbais, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittet, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colovray, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxhead, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halazy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missotten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradshaw, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Raemy-Schenk, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tos, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giachetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golzio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Church, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span> </span><span class="NLM_article-title">Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7882</span><span class="NLM_x">–</span> <span class="NLM_lpage">7905</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050645f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7882-7905&author=A.+Quattropaniauthor=J.+Dorbaisauthor=D.+Coviniauthor=P.-A.+Pittetauthor=V.+Colovrayauthor=R.+J.+Thomasauthor=R.+Coxheadauthor=S.+Halazyauthor=A.+Scheerauthor=M.+Missottenauthor=G.+Ayalaauthor=C.+Bradshawauthor=A.-M.+De+Raemy-Schenkauthor=A.+Nicholsauthor=R.+Cirilloauthor=E.+G.+Tosauthor=C.+Giachettiauthor=L.+Golzioauthor=P.+Marinelliauthor=D.+J.+Churchauthor=C.+Barberisauthor=A.+Cholletauthor=M.+K.+Schwarz&title=Discovery+and+development+of+a+new+class+of+potent%2C+selective%2C+orally+active+oxytocin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm050645f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050645f%26sid%3Dliteratum%253Aachs%26aulast%3DQuattropani%26aufirst%3DA.%26aulast%3DDorbais%26aufirst%3DJ.%26aulast%3DCovini%26aufirst%3DD.%26aulast%3DPittet%26aufirst%3DP.-A.%26aulast%3DColovray%26aufirst%3DV.%26aulast%3DThomas%26aufirst%3DR.%2BJ.%26aulast%3DCoxhead%26aufirst%3DR.%26aulast%3DHalazy%26aufirst%3DS.%26aulast%3DScheer%26aufirst%3DA.%26aulast%3DMissotten%26aufirst%3DM.%26aulast%3DAyala%26aufirst%3DG.%26aulast%3DBradshaw%26aufirst%3DC.%26aulast%3DDe%2BRaemy-Schenk%26aufirst%3DA.-M.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DCirillo%26aufirst%3DR.%26aulast%3DTos%26aufirst%3DE.%2BG.%26aulast%3DGiachetti%26aufirst%3DC.%26aulast%3DGolzio%26aufirst%3DL.%26aulast%3DMarinelli%26aufirst%3DP.%26aulast%3DChurch%26aufirst%3DD.%2BJ.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DChollet%26aufirst%3DA.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26atitle%3DDiscovery%2520and%2520development%2520of%2520a%2520new%2520class%2520of%2520potent%252C%2520selective%252C%2520orally%2520active%2520oxytocin%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7882%26epage%3D7905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Barton, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellenie, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvagno, C. M.</span><span> </span><span class="NLM_article-title">Discovery and optimization of a potent and selective tertiary sulfonamide oxytocin antagonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=528-532&author=N.+P.+Bartonauthor=B.+R.+Bellenieauthor=A.+T.+Doranauthor=A.+J.+Emmonsauthor=J.+P.+Heerauthor=C.+M.+Salvagno&title=Discovery+and+optimization+of+a+potent+and+selective+tertiary+sulfonamide+oxytocin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DN.%2BP.%26aulast%3DBellenie%26aufirst%3DB.%2BR.%26aulast%3DDoran%26aufirst%3DA.%2BT.%26aulast%3DEmmons%26aufirst%3DA.%2BJ.%26aulast%3DHeer%26aufirst%3DJ.%2BP.%26aulast%3DSalvagno%26aufirst%3DC.%2BM.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520potent%2520and%2520selective%2520tertiary%2520sulfonamide%2520oxytocin%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D528%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Kakefuda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.</span><span> </span><span class="NLM_article-title">Discovery of 4,5-diphenyl-1,2,4-triazole derivatives as a novel class of selective antagonists for the human V(1A) receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1905</span><span class="NLM_x">–</span> <span class="NLM_lpage">1912</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=1905-1912&author=A.+Kakefudaauthor=T.+Suzukiauthor=T.+Tobeauthor=A.+Taharaauthor=S.+Sakamotoauthor=S.+Tsukamoto&title=Discovery+of+4%2C5-diphenyl-1%2C2%2C4-triazole+derivatives+as+a+novel+class+of+selective+antagonists+for+the+human+V%281A%29+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKakefuda%26aufirst%3DA.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DTobe%26aufirst%3DT.%26aulast%3DTahara%26aufirst%3DA.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DTsukamoto%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25204%252C5-diphenyl-1%252C2%252C4-triazole%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520selective%2520antagonists%2520for%2520the%2520human%2520V%25281A%2529%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D1905%26epage%3D1912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Brown, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puhalo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, L.</span><span> </span><span class="NLM_article-title">Design and optimization of potent, selective antagonists of oxytocin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4278</span><span class="NLM_x">–</span> <span class="NLM_lpage">4281</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4278-4281&author=A.+Brownauthor=L.+Brownauthor=D.+Ellisauthor=N.+Puhaloauthor=C.+R.+Smithauthor=O.+Wallaceauthor=L.+Watson&title=Design+and+optimization+of+potent%2C+selective+antagonists+of+oxytocin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DPuhalo%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DC.%2BR.%26aulast%3DWallace%26aufirst%3DO.%26aulast%3DWatson%26aufirst%3DL.%26atitle%3DDesign%2520and%2520optimization%2520of%2520potent%252C%2520selective%2520antagonists%2520of%2520oxytocin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4278%26epage%3D4281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZP-Q0AQY1dfrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: a lipophilic efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB%282%29+agonists+using+parallel+synthesis+protocols%3A+a+lipophilic+efficiency+%28LipE%29+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0licRlBWCq9tkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB%25282%2529%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520a%2520lipophilic%2520efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Brown, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puhalo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, L.5.</span><span> </span><span class="NLM_article-title">Triazole oxytocin antagonists: identification of aryl ether replacements for a biaryl substituent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5242</span><span class="NLM_x">–</span> <span class="NLM_lpage">5244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1016%2Fj.bmcl.2008.08.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=18778939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFert7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5242-5244&author=A.+Brownauthor=L.+Brownauthor=T.+B.+Brownauthor=A.+Calabreseauthor=D.+Ellisauthor=N.+Puhaloauthor=C.+R.+Smithauthor=O.+Wallaceauthor=L.5.+Watson&title=Triazole+oxytocin+antagonists%3A+identification+of+aryl+ether+replacements+for+a+biaryl+substituent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Triazole oxytocin antagonists: Identification of aryl ether replacements for a biaryl substituent</span></div><div class="casAuthors">Brown, Alan; Brown, Lindsay; Brown, T. Bruce; Calabrese, Andrew; Ellis, Dave; Puhalo, Nicholas; Smith, Chris R.; Wallace, Olga; Watson, Lesa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5242-5244</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Several potent aryl ether/triazole oxytocin antagonists are described.  The lead compd. in this series had significantly improved aq. soly. over related systems contg. a biaryl substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8262GdEWJdbVg90H21EOLACvtfcHk0licRlBWCq9tkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFert7%252FE&md5=c7c71c5defecf0626e40639296846116</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.08.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.08.066%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DT.%2BB.%26aulast%3DCalabrese%26aufirst%3DA.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DPuhalo%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DC.%2BR.%26aulast%3DWallace%26aufirst%3DO.%26aulast%3DWatson%26aufirst%3DL.5.%26atitle%3DTriazole%2520oxytocin%2520antagonists%253A%2520identification%2520of%2520aryl%2520ether%2520replacements%2520for%2520a%2520biaryl%2520substituent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5242%26epage%3D5244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Brown, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puhalo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, L.</span><span> </span><span class="NLM_article-title">Triazole oxytocin antagonists: identification of an aryloxyazetidine replacement for a biaryl substituent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=516-520&author=A.+Brownauthor=T.+B.+Brownauthor=A.+Calabreseauthor=D.+Ellisauthor=N.+Puhaloauthor=M.+Ralphauthor=L.+Watson&title=Triazole+oxytocin+antagonists%3A+identification+of+an+aryloxyazetidine+replacement+for+a+biaryl+substituent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DT.%2BB.%26aulast%3DCalabrese%26aufirst%3DA.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DPuhalo%26aufirst%3DN.%26aulast%3DRalph%26aufirst%3DM.%26aulast%3DWatson%26aufirst%3DL.%26atitle%3DTriazole%2520oxytocin%2520antagonists%253A%2520identification%2520of%2520an%2520aryloxyazetidine%2520replacement%2520for%2520a%2520biaryl%2520substituent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D516%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Brown, A.</span><span> </span><span class="NLM_article-title">Identification and optimization of triazole oxytocin antagonists, leading to a clinical candidate</span>. Presented at the <span class="NLM_conf-name">15th RSC-SCI Medicinal Chemistry Symposium</span>, <span class="NLM_conf-loc">Cambridge, UK</span>, <span class="NLM_conf-date">6−9 September, 2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Brown%2C+A.+Identification+and+optimization+of+triazole+oxytocin+antagonists%2C+leading+to+a+clinical+candidate.+Presented+at+the+15th+RSC-SCI+Medicinal+Chemistry+Symposium%2C+Cambridge%2C+UK%2C+6%E2%88%929+September%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520triazole%2520oxytocin%2520antagonists%252C%2520leading%2520to%2520a%2520clinical%2520candidate" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borthwick, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exall, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatley, R. J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irving, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nerozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span> </span><span class="NLM_article-title">2,5-Diketopiperazines as potent and selective oxytocin antagonists. 1: Identification, stereochemistry and initial SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2579</span><span class="NLM_x">–</span> <span class="NLM_lpage">2582</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2579-2582&author=P.+G.+Wyattauthor=M.+J.+Allenauthor=A.+D.+Borthwickauthor=D.+E.+Daviesauthor=A.+M.+Exallauthor=R.+J.+D.+Hatleyauthor=W.+R.+Irvingauthor=D.+G.+Livermoreauthor=N.+D.+Millerauthor=F.+Nerozziauthor=S.+L.+Sollisauthor=A.+K.+Szardenings&title=2%2C5-Diketopiperazines+as+potent+and+selective+oxytocin+antagonists.+1%3A+Identification%2C+stereochemistry+and+initial+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DExall%26aufirst%3DA.%2BM.%26aulast%3DHatley%26aufirst%3DR.%2BJ.%2BD.%26aulast%3DIrving%26aufirst%3DW.%2BR.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DMiller%26aufirst%3DN.%2BD.%26aulast%3DNerozzi%26aufirst%3DF.%26aulast%3DSollis%26aufirst%3DS.%2BL.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26atitle%3D2%252C5-Diketopiperazines%2520as%2520potent%2520and%2520selective%2520oxytocin%2520antagonists.%25201%253A%2520Identification%252C%2520stereochemistry%2520and%2520initial%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2579%26epage%3D2582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="note"><p class="first last">The in silico predictions (with high levels of confidence) for CNS-penetration of this class of compounds (and in particular Retosiban) have always been low and therefore it was not been considered a significant risk.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="note"><p class="first last">High B/A efflux ratios of 16:1 and 19:1 were obtained for the initial leads 4-F-phenyl derivative <b>31</b> and the 4-NMe<sub>2</sub>-phenyl derivative <b>32</b> in the in vitro MDR1-MDCK cell line model for CNS-penetration, unpublished observations.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Borthwick, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exall, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nerozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabbir, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woollard, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span> </span><span class="NLM_article-title">2,5-Diketopiperazines as potent, selective and orally bioavailable oxytocin antagonists. 2: Synthesis, chirality and pharmacokinetics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6956</span><span class="NLM_x">–</span> <span class="NLM_lpage">6969</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050557v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6956-6969&author=A.+D.+Borthwickauthor=D.+E.+Daviesauthor=A.+M.+Exallauthor=D.+G.+Livermoreauthor=S.+L.+Sollisauthor=F.+Nerozziauthor=M.+J.+Allenauthor=M.+Perrenauthor=S.+S.+Shabbirauthor=P.+M.+Woollardauthor=P.+G.+Wyatt&title=2%2C5-Diketopiperazines+as+potent%2C+selective+and+orally+bioavailable+oxytocin+antagonists.+2%3A+Synthesis%2C+chirality+and+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm050557v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050557v%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DExall%26aufirst%3DA.%2BM.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DSollis%26aufirst%3DS.%2BL.%26aulast%3DNerozzi%26aufirst%3DF.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DPerren%26aufirst%3DM.%26aulast%3DShabbir%26aufirst%3DS.%2BS.%26aulast%3DWoollard%26aufirst%3DP.%2BM.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26atitle%3D2%252C5-Diketopiperazines%2520as%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520oxytocin%2520antagonists.%25202%253A%2520Synthesis%252C%2520chirality%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6956%26epage%3D6969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Borthwick, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exall, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatley, R. J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irving, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nerozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valko, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabbir, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woollard, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, M. A.</span><span> </span><span class="NLM_article-title">2,5-Diketopiperazines as Potent, Selective and Orally Bioavailable Oxytocin Antagonists 3: Synthesis, Pharmacokinetics and in vivo potency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4159</span><span class="NLM_x">–</span> <span class="NLM_lpage">4970</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060073e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4159-4970&author=A.+D.+Borthwickauthor=D.+E.+Daviesauthor=A.+M.+Exallauthor=R.+J.+D.+Hatleyauthor=J.+A.+Hughesauthor=W.+R.+Irvingauthor=D.+G.+Livermoreauthor=S.+L.+Sollisauthor=F.+Nerozziauthor=K.+L.+Valkoauthor=M.+J.+Allenauthor=M.+Perrenauthor=S.+S.+Shabbirauthor=P.+M.+Woollardauthor=M.+A.+Price&title=2%2C5-Diketopiperazines+as+Potent%2C+Selective+and+Orally+Bioavailable+Oxytocin+Antagonists+3%3A+Synthesis%2C+Pharmacokinetics+and+in+vivo+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm060073e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060073e%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DExall%26aufirst%3DA.%2BM.%26aulast%3DHatley%26aufirst%3DR.%2BJ.%2BD.%26aulast%3DHughes%26aufirst%3DJ.%2BA.%26aulast%3DIrving%26aufirst%3DW.%2BR.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DSollis%26aufirst%3DS.%2BL.%26aulast%3DNerozzi%26aufirst%3DF.%26aulast%3DValko%26aufirst%3DK.%2BL.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DPerren%26aufirst%3DM.%26aulast%3DShabbir%26aufirst%3DS.%2BS.%26aulast%3DWoollard%26aufirst%3DP.%2BM.%26aulast%3DPrice%26aufirst%3DM.%2BA.%26atitle%3D2%252C5-Diketopiperazines%2520as%2520Potent%252C%2520Selective%2520and%2520Orally%2520Bioavailable%2520Oxytocin%2520Antagonists%25203%253A%2520Synthesis%252C%2520Pharmacokinetics%2520and%2520in%2520vivo%2520potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4159%26epage%3D4970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Liddle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borthwick, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exall, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamlett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irving, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCafferty, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nerozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peace, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabbir, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westfall, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woollard, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, D. M.</span><span> </span><span class="NLM_article-title">The discovery of GSK221149A: a potent and selective oxytocin antagonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=90-94&author=J.+Liddleauthor=M.+J.+Allenauthor=A.+D.+Borthwickauthor=D.+P.+Brooksauthor=D.+E.+Daviesauthor=R.+M.+Edwardsauthor=A.+M.+Exallauthor=C.+Hamlettauthor=W.+R.+Irvingauthor=A.+M.+Masonauthor=G.+P.+McCaffertyauthor=F.+Nerozziauthor=S.+Peaceauthor=J.+Philpauthor=D.+Pollardauthor=M.+A.+Pullenauthor=S.+S.+Shabbirauthor=S.+L.+Sollisauthor=T.+D.+Westfallauthor=P.+M.+Woollardauthor=C.+Wuauthor=D.+M.+Hickey&title=The+discovery+of+GSK221149A%3A+a+potent+and+selective+oxytocin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiddle%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DBrooks%26aufirst%3DD.%2BP.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DEdwards%26aufirst%3DR.%2BM.%26aulast%3DExall%26aufirst%3DA.%2BM.%26aulast%3DHamlett%26aufirst%3DC.%26aulast%3DIrving%26aufirst%3DW.%2BR.%26aulast%3DMason%26aufirst%3DA.%2BM.%26aulast%3DMcCafferty%26aufirst%3DG.%2BP.%26aulast%3DNerozzi%26aufirst%3DF.%26aulast%3DPeace%26aufirst%3DS.%26aulast%3DPhilp%26aufirst%3DJ.%26aulast%3DPollard%26aufirst%3DD.%26aulast%3DPullen%26aufirst%3DM.%2BA.%26aulast%3DShabbir%26aufirst%3DS.%2BS.%26aulast%3DSollis%26aufirst%3DS.%2BL.%26aulast%3DWestfall%26aufirst%3DT.%2BD.%26aulast%3DWoollard%26aufirst%3DP.%2BM.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DHickey%26aufirst%3DD.%2BM.%26atitle%3DThe%2520discovery%2520of%2520GSK221149A%253A%2520a%2520potent%2520and%2520selective%2520oxytocin%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D90%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">McCafferty, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woollard, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borthwick, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westfall, T. D.</span><span> </span><span class="NLM_article-title">Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">R299</span><span class="NLM_x">–</span> <span class="NLM_lpage">R305</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2007&pages=R299-R305&author=G.+P.+McCaffertyauthor=M.+A.+Pullenauthor=C.+Wuauthor=R.+M.+Edwardsauthor=M.+J.+Allenauthor=P.+M.+Woollardauthor=A.+D.+Borthwickauthor=J.+Liddleauthor=D.+M.+Hickeyauthor=D.+P.+Brooksauthor=T.+D.+Westfall&title=Use+of+a+novel+and+highly+selective+oxytocin+receptor+antagonist+to+characterize+uterine+contractions+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCafferty%26aufirst%3DG.%2BP.%26aulast%3DPullen%26aufirst%3DM.%2BA.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DEdwards%26aufirst%3DR.%2BM.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DWoollard%26aufirst%3DP.%2BM.%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DLiddle%26aufirst%3DJ.%26aulast%3DHickey%26aufirst%3DD.%2BM.%26aulast%3DBrooks%26aufirst%3DD.%2BP.%26aulast%3DWestfall%26aufirst%3DT.%2BD.%26atitle%3DUse%2520of%2520a%2520novel%2520and%2520highly%2520selective%2520oxytocin%2520receptor%2520antagonist%2520to%2520characterize%2520uterine%2520contractions%2520in%2520the%2520rat%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D2007%26volume%3D293%26spage%3DR299%26epage%3DR305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Borthwick, A. D.; Liddle, J.</span><span> </span><span class="NLM_article-title">The design of orally bioavailable 2,5-diketopiperazine oxytocin antagonists: from concept to clinical candidate for premature labour</span>.  <span class="citation_source-journal">Med. Res. Rev.</span>, published online December 21,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span><a href="http://dx.doi.org/10.1002/med.20193" class="extLink">http://dx.doi.org/10.1002/med.20193</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+D.+Borthwick&author=J.+Liddle&title=The+design+of+orally+bioavailable+2%2C5-diketopiperazine+oxytocin+antagonists%3A+from+concept+to+clinical+candidate+for+premature+labour"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26atitle%3DThe%2520design%2520of%2520orally%2520bioavailable%25202%252C5-diketopiperazine%2520oxytocin%2520antagonists%253A%2520from%2520concept%2520to%2520clinical%2520candidate%2520for%2520premature%2520labour%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Borthwick, A. D.; Sollis, S. L.</span> PCT Patent Appl. WO 2006000400 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Borthwick%2C+A.+D.%3B+Sollis%2C+S.+L.+PCT+Patent+Appl.+WO+2006000400+A1%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Borthwick, A. D.; Hickey, D. M. B.; Liddle, J.; Mason, A. M.; Pollard, D. R.; Sollis, S. L.</span> PCT Patent Appl WO 2006000759 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Borthwick%2C+A.+D.%3B+Hickey%2C+D.+M.+B.%3B+Liddle%2C+J.%3B+Mason%2C+A.+M.%3B+Pollard%2C+D.+R.%3B+Sollis%2C+S.+L.+PCT+Patent+Appl+WO+2006000759+A1%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Borthwick, A. D.; Hickey, D. M. B.; Liddle, J.; Mason, A. M.</span> PCT Patent Appl WO 2006000399 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Borthwick%2C+A.+D.%3B+Hickey%2C+D.+M.+B.%3B+Liddle%2C+J.%3B+Mason%2C+A.+M.+PCT+Patent+Appl+WO+2006000399+A1%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span>Reprinted from  <span class="citation_source-journal">Trends in Endocrinology and Metabolism</span><a href="http://www.sciencedirect.com/science/journal/10432760" class="extLink">http://www.sciencedirect.com/science/journal/10432760</a>, Vol.  <span class="NLM_volume">14</span>, <span class="NLM_contrib-group">Zingg, H. H.; Laporte, S. A.</span>, <span> </span><span class="NLM_article-title">The oxytocin receptor</span>, pp  <span class="NLM_fpage">222</span>− <span class="NLM_lpage">227</span>, Copyright <b>2003</b>, with permission from Elsevier.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Reprinted+from+Trends+in+Endocrinology+and+Metabolismhttp%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Fjournal%2F10432760%2C+Vol.+14%2C+Zingg%2C+H.+H.%3B+Laporte%2C+S.+A.%2C+The+oxytocin+receptor%2C+pp+222%E2%88%92227%2C+Copyright+2003%2C+with+permission+from+Elsevier."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Endocrinology%2520and%2520Metabolism%26volume%3D14%26aulast%3DZingg%26aufirst%3DH.%2BH.%26atitle%3DThe%2520oxytocin%2520receptor%26spage%3D222%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span>Reprinted from  <span class="citation_source-journal">Bioorganic & Medicinal Chemistry Letters</span><a href="http://www.sciencedirect.com/science/journal/0960894X" class="extLink">http://www.sciencedirect.com/science/journal/0960894X</a>, Vol.  <span class="NLM_volume">19</span>, <span class="NLM_contrib-group">Barton, N. P.; Bellenie, B. R.; Doran, A. T.; Emmons, A. J.; Heer, J. P.; Salvagno, C. M.</span>, <span> </span><span class="NLM_article-title">Discovery and optimization of a potent and selective tertiary sulfonamide oxytocin antagonist</span>, pp  <span class="NLM_fpage">528</span>− <span class="NLM_lpage">532</span>, Copyright<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span>with permission from Elsevier.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=528-532&author=N.+P.+Barton&author=B.+R.+Bellenie&author=A.+T.+Doran&author=A.+J.+Emmons&author=J.+P.+Heer&author=C.+M.+Salvagno&title=Discovery+and+optimization+of+a+potent+and+selective+tertiary+sulfonamide+oxytocin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26volume%3D19%26aulast%3DBarton%26aufirst%3DN.%2BP.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520potent%2520and%2520selective%2520tertiary%2520sulfonamide%2520oxytocin%2520antagonist%26spage%3D528%26epage%3D532%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':[],'ref54':[],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 25 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xin Li, Zhigao Zhang, Yang Chen, Hong Wan, Jiakang Sun, Bin Wang, Bingqiang Feng, Bing Hu, Xingxing Shi, Jun Feng, Lei Zhang, Feng He, Chang Bai, Lianshan Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Weikang Tao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of SHR1653, a Highly Potent and Selective OTR Antagonist with Improved Blood–Brain Barrier Penetration. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (6)
                                     , 996-1001. <a href="https://doi.org/10.1021/acsmedchemlett.9b00186" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00186%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BSHR1653%25252C%252Ba%252BHighly%252BPotent%252Band%252BSelective%252BOTR%252BAntagonist%252Bwith%252BImproved%252BBlood%2525E2%252580%252593Brain%252BBarrier%252BPenetration%26aulast%3DLi%26aufirst%3DXin%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24042019%26date%3D29052019%26date%3D31052019%26date%3D29052019%26volume%3D10%26issue%3D6%26spage%3D996%26epage%3D1001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yao Ge, Zhaobin Han, Zheng Wang, <span class="NLM_string-name hlFld-ContribAuthor">Kuiling Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Ir-Catalyzed Double Asymmetric Hydrogenation of 3,6-Dialkylidene-2,5-diketopiperazines for Enantioselective Synthesis of Cyclic Dipeptides. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (22)
                                     , 8981-8988. <a href="https://doi.org/10.1021/jacs.9b02920" title="DOI URL">https://doi.org/10.1021/jacs.9b02920</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b02920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b02920%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DIr-Catalyzed%252BDouble%252BAsymmetric%252BHydrogenation%252Bof%252B3%25252C6-Dialkylidene-2%25252C5-diketopiperazines%252Bfor%252BEnantioselective%252BSynthesis%252Bof%252BCyclic%252BDipeptides%26aulast%3DGe%26aufirst%3DYao%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17032019%26date%3D23052019%26date%3D12052019%26volume%3D141%26issue%3D22%26spage%3D8981%26epage%3D8988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marie-Céline Frantz, Lucie P. Pellissier, Elsa Pflimlin, Stéphanie Loison, Jorge Gandía, Claire Marsol, Thierry Durroux, Bernard Mouillac, Jérôme A. J. Becker, Julie Le Merrer, Christel Valencia, Pascal Villa, Dominique Bonnet, <span class="NLM_string-name hlFld-ContribAuthor">Marcel Hibert</span>. </span><span class="cited-content_cbyCitation_article-title">LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (19)
                                     , 8670-8692. <a href="https://doi.org/10.1021/acs.jmedchem.8b00697" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00697%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLIT-001%25252C%252Bthe%252BFirst%252BNonpeptide%252BOxytocin%252BReceptor%252BAgonist%252Bthat%252BImproves%252BSocial%252BInteraction%252Bin%252Ba%252BMouse%252BModel%252Bof%252BAutism%26aulast%3DFrantz%26aufirst%3DMarie-C%25C3%25A9line%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D02052018%26date%3D24092018%26date%3D10092018%26volume%3D61%26issue%3D19%26spage%3D8670%26epage%3D8692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Constantinos G.  Neochoritis</span>, <span class="hlFld-ContribAuthor ">Silvia  Stotani</span>, <span class="hlFld-ContribAuthor ">Bhupendra  Mishra</span>, and <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>  . </span><span class="cited-content_cbyCitation_article-title">Efficient Isocyanide-less Isocyanide-Based Multicomponent Reactions. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (8)
                                     , 2002-2005. <a href="https://doi.org/10.1021/acs.orglett.5b00759" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b00759</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b00759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b00759%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DEfficient%252BIsocyanide-less%252BIsocyanide-Based%252BMulticomponent%252BReactions%26aulast%3DNeochoritis%26aufirst%3DConstantinos%2BG.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D16032015%26date%3D31032015%26date%3D17042015%26volume%3D17%26issue%3D8%26spage%3D2002%26epage%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazimierz  Wiśniewski</span>, <span class="hlFld-ContribAuthor ">Sudarkodi  Alagarsamy</span>, <span class="hlFld-ContribAuthor ">Robert  Galyean</span>, <span class="hlFld-ContribAuthor ">Hiroe  Tariga</span>, <span class="hlFld-ContribAuthor ">Dorain  Thompson</span>, <span class="hlFld-ContribAuthor ">Brian  Ly</span>, <span class="hlFld-ContribAuthor ">Halina  Wiśniewska</span>, <span class="hlFld-ContribAuthor ">Steve  Qi</span>, <span class="hlFld-ContribAuthor ">Glenn  Croston</span>, <span class="hlFld-ContribAuthor ">Regent  Laporte</span>, <span class="hlFld-ContribAuthor ">Pierre J.-M.  Rivière</span>, and <span class="hlFld-ContribAuthor ">Claudio D.  Schteingart</span>  . </span><span class="cited-content_cbyCitation_article-title">New, Potent, and Selective Peptidic Oxytocin Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5306-5317. <a href="https://doi.org/10.1021/jm500365s" title="DOI URL">https://doi.org/10.1021/jm500365s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500365s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500365s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%25252C%252BPotent%25252C%252Band%252BSelective%252BPeptidic%252BOxytocin%252BReceptor%252BAgonists%26aulast%3DWi%25C5%259Bniewski%26aufirst%3DKazimierz%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D07032014%26date%3D12062014%26date%3D26062014%26date%3D29052014%26volume%3D57%26issue%3D12%26spage%3D5306%26epage%3D5317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan D.  Borthwick</span>  . </span><span class="cited-content_cbyCitation_article-title">2,5-Diketopiperazines: Synthesis, Reactions, Medicinal Chemistry, and Bioactive Natural Products. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2012,</strong> <em>112 </em>
                                    (7)
                                     , 3641-3716. <a href="https://doi.org/10.1021/cr200398y" title="DOI URL">https://doi.org/10.1021/cr200398y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr200398y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr200398y%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3D2%25252C5-Diketopiperazines%25253A%252BSynthesis%25252C%252BReactions%25252C%252BMedicinal%252BChemistry%25252C%252Band%252BBioactive%252BNatural%252BProducts%26aulast%3DBorthwick%26aufirst%3DAlan%2BD.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D18102011%26date%3D11052012%26date%3D11072012%26volume%3D112%26issue%3D7%26spage%3D3641%26epage%3D3716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan D.  Borthwick</span>, <span class="hlFld-ContribAuthor ">John  Liddle</span>, <span class="hlFld-ContribAuthor ">Dave E.  Davies</span>, <span class="hlFld-ContribAuthor ">Anne M.  Exall</span>, <span class="hlFld-ContribAuthor ">Christopher  Hamlett</span>, <span class="hlFld-ContribAuthor ">Deirdre M.  Hickey</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Mason</span>, <span class="hlFld-ContribAuthor ">Ian E. D.  Smith</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Nerozzi</span>, <span class="hlFld-ContribAuthor ">Simon  Peace</span>, <span class="hlFld-ContribAuthor ">Derek  Pollard</span>, <span class="hlFld-ContribAuthor ">Steve L.  Sollis</span>, <span class="hlFld-ContribAuthor ">Michael J.  Allen</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Woollard</span>, <span class="hlFld-ContribAuthor ">Mark A.  Pullen</span>, <span class="hlFld-ContribAuthor ">Timothy D.  Westfall</span>, and <span class="hlFld-ContribAuthor ">Dinesh J.  Stanislaus</span>  . </span><span class="cited-content_cbyCitation_article-title">Pyridyl-2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists: Synthesis, Pharmacokinetics, and In Vivo Potency. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (2)
                                     , 783-796. <a href="https://doi.org/10.1021/jm201287w" title="DOI URL">https://doi.org/10.1021/jm201287w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201287w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201287w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyridyl-2%25252C5-Diketopiperazines%252Bas%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BOxytocin%252BAntagonists%25253A%252BSynthesis%25252C%252BPharmacokinetics%25252C%252Band%252BIn%252BVivo%252BPotency%26aulast%3DBorthwick%26aufirst%3DAlan%2BD.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D27092011%26date%3D12012012%26date%3D26012012%26volume%3D55%26issue%3D2%26spage%3D783%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beatrix  Stadler</span>, <span class="hlFld-ContribAuthor ">Michael R.  Whittaker</span>, <span class="hlFld-ContribAuthor ">Betty  Exintaris</span>, <span class="hlFld-ContribAuthor ">Ralf  Middendorff</span>. </span><span class="cited-content_cbyCitation_article-title">Oxytocin in the Male Reproductive Tract; The Therapeutic Potential of Oxytocin-Agonists and-Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Endocrinology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fendo.2020.565731" title="DOI URL">https://doi.org/10.3389/fendo.2020.565731</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fendo.2020.565731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffendo.2020.565731%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Endocrinology%26atitle%3DOxytocin%252Bin%252Bthe%252BMale%252BReproductive%252BTract%25253B%252BThe%252BTherapeutic%252BPotential%252Bof%252BOxytocin-Agonists%252Band-Antagonists%26aulast%3DStadler%26aufirst%3DBeatrix%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wang  Xi</span>, <span class="hlFld-ContribAuthor ">Qiaogen  Zou</span>, <span class="hlFld-ContribAuthor ">Pingkai  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics of cligosiban in dog plasma after oral administration by liquid chromatography electrospray ionization tandem mass spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Biomedical Chromatography</span><span> <strong>2019,</strong> <em>33 </em>
                                    (10)
                                     <a href="https://doi.org/10.1002/bmc.4611" title="DOI URL">https://doi.org/10.1002/bmc.4611</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bmc.4611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbmc.4611%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedical%2520Chromatography%26atitle%3DPharmacokinetics%252Bof%252Bcligosiban%252Bin%252Bdog%252Bplasma%252Bafter%252Boral%252Badministration%252Bby%252Bliquid%252Bchromatography%252Belectrospray%252Bionization%252Btandem%252Bmass%252Bspectrometry%26aulast%3DXi%26aufirst%3DWang%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tianyi  Shang</span>, <span class="hlFld-ContribAuthor ">Yan  Pan</span>, <span class="hlFld-ContribAuthor ">Zhong  Chen</span>, <span class="hlFld-ContribAuthor ">Junjie  Yang</span>, <span class="hlFld-ContribAuthor ">Xinling  Guo</span>, <span class="hlFld-ContribAuthor ">Leilei  Guo</span>, <span class="hlFld-ContribAuthor ">Yan  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Diversity- Oriented Synthesis of 2, 5- diketopiperazines via Ugi/6- Exo- Trig Aza-Michael Reaction Cascades in One Pot. </span><span class="cited-content_cbyCitation_journal-name">IOP Conference Series: Materials Science and Engineering</span><span> <strong>2019,</strong> <em>612 </em>, 022107. <a href="https://doi.org/10.1088/1757-899X/612/2/022107" title="DOI URL">https://doi.org/10.1088/1757-899X/612/2/022107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1088/1757-899X/612/2/022107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1088%2F1757-899X%2F612%2F2%2F022107%26sid%3Dliteratum%253Aachs%26jtitle%3DIOP%2520Conference%2520Series%253A%2520Materials%2520Science%2520and%2520Engineering%26atitle%3DDiversity-%252BOriented%252BSynthesis%252Bof%252B2%25252C%252B5-%252Bdiketopiperazines%252Bvia%252BUgi%25252F6-%252BExo-%252BTrig%252BAza-Michael%252BReaction%252BCascades%252Bin%252BOne%252BPot%26aulast%3DShang%26aufirst%3DTianyi%26date%3D2019%26date%3D2019%26volume%3D612%26spage%3D022107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nelson G. M.  Gomes</span>, <span class="hlFld-ContribAuthor ">Renato B.  Pereira</span>, <span class="hlFld-ContribAuthor ">Paula B.  Andrade</span>, <span class="hlFld-ContribAuthor ">Patrícia  Valentão</span>. </span><span class="cited-content_cbyCitation_article-title">Double the Chemistry, Double the Fun: Structural Diversity and Biological Activity of Marine-Derived Diketopiperazine Dimers. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2019,</strong> <em>17 </em>
                                    (10)
                                     , 551. <a href="https://doi.org/10.3390/md17100551" title="DOI URL">https://doi.org/10.3390/md17100551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md17100551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd17100551%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DDouble%252Bthe%252BChemistry%25252C%252BDouble%252Bthe%252BFun%25253A%252BStructural%252BDiversity%252Band%252BBiological%252BActivity%252Bof%252BMarine-Derived%252BDiketopiperazine%252BDimers%26aulast%3DGomes%26aufirst%3DNelson%2BG.%2BM.%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D10%26spage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueliang  Yue</span>, <span class="hlFld-ContribAuthor ">Lingpan  Lu</span>, <span class="hlFld-ContribAuthor ">Hongshan  Liu</span>, <span class="hlFld-ContribAuthor ">Huanzhou  Xue</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics, bioavailability and metabolism of cligosiban, an antagonist of oxytocin receptor, in rat by liquid chromatography hyphenated with electrospray ionization tandem mass spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2019,</strong> <em>164 </em>, 725-733. <a href="https://doi.org/10.1016/j.jpba.2018.11.045" title="DOI URL">https://doi.org/10.1016/j.jpba.2018.11.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2018.11.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2018.11.045%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DPharmacokinetics%25252C%252Bbioavailability%252Band%252Bmetabolism%252Bof%252Bcligosiban%25252C%252Ban%252Bantagonist%252Bof%252Boxytocin%252Breceptor%25252C%252Bin%252Brat%252Bby%252Bliquid%252Bchromatography%252Bhyphenated%252Bwith%252Belectrospray%252Bionization%252Btandem%252Bmass%252Bspectrometry%26aulast%3DYue%26aufirst%3DXueliang%26date%3D2019%26volume%3D164%26spage%3D725%26epage%3D733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazimierz  Wiśniewski</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Oxytocin Analogs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 235-271. <a href="https://doi.org/10.1007/978-1-4939-9504-2_11" title="DOI URL">https://doi.org/10.1007/978-1-4939-9504-2_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-9504-2_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-9504-2_11%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Bof%252BOxytocin%252BAnalogs%26aulast%3DWi%25C5%259Bniewski%26aufirst%3DKazimierz%26date%3D2019%26date%3D2019%26spage%3D235%26epage%3D271%26pub%3DSpringer%2520New%2520York%26atitle%3DCyclic%252BPeptide%252BDesign%26aulast%3DGoetz%26aufirst%3DGilles%26date%3D2019%26volume%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shivali  Kohli</span>, <span class="hlFld-ContribAuthor ">Madeleine V.  King</span>, <span class="hlFld-ContribAuthor ">Stuart  Williams</span>, <span class="hlFld-ContribAuthor ">Adele  Edwards</span>, <span class="hlFld-ContribAuthor ">Theresa M.  Ballard</span>, <span class="hlFld-ContribAuthor ">Lucinda J.  Steward</span>, <span class="hlFld-ContribAuthor ">Daniella  Alberati</span>, <span class="hlFld-ContribAuthor ">Kevin C. F.  Fone</span>. </span><span class="cited-content_cbyCitation_article-title">Oxytocin attenuates phencyclidine hyperactivity and increases social interaction and nucleus accumben dopamine release in rats. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2019,</strong> <em>44 </em>
                                    (2)
                                     , 295-305. <a href="https://doi.org/10.1038/s41386-018-0171-0" title="DOI URL">https://doi.org/10.1038/s41386-018-0171-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-018-0171-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-018-0171-0%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DOxytocin%252Battenuates%252Bphencyclidine%252Bhyperactivity%252Band%252Bincreases%252Bsocial%252Binteraction%252Band%252Bnucleus%252Baccumben%252Bdopamine%252Brelease%252Bin%252Brats%26aulast%3DKohli%26aufirst%3DShivali%26date%3D2019%26date%3D2018%26volume%3D44%26issue%3D2%26spage%3D295%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiaoyan  Zhao</span>, <span class="hlFld-ContribAuthor ">Xuefeng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">The application of sulfur-containing peptides in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2018,</strong> <em>29 </em>
                                    (7)
                                     , 1079-1087. <a href="https://doi.org/10.1016/j.cclet.2018.05.026" title="DOI URL">https://doi.org/10.1016/j.cclet.2018.05.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2018.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2018.05.026%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DThe%252Bapplication%252Bof%252Bsulfur-containing%252Bpeptides%252Bin%252Bdrug%252Bdiscovery%26aulast%3DZhao%26aufirst%3DJiaoyan%26date%3D2018%26volume%3D29%26issue%3D7%26spage%3D1079%26epage%3D1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D. K.  Nilov</span>, <span class="hlFld-ContribAuthor ">K. I.  Yashina</span>, <span class="hlFld-ContribAuthor ">I. V.  Gushchina</span>, <span class="hlFld-ContribAuthor ">A. L.  Zakharenko</span>, <span class="hlFld-ContribAuthor ">M. V.  Sukhanova</span>, <span class="hlFld-ContribAuthor ">O. I.  Lavrik</span>, <span class="hlFld-ContribAuthor ">V. K.  Švedas</span>. </span><span class="cited-content_cbyCitation_article-title">2,5-Diketopiperazines: A New Class of Poly(ADP-ribose)polymerase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry (Moscow)</span><span> <strong>2018,</strong> <em>83 </em>
                                    (2)
                                     , 152-158. <a href="https://doi.org/10.1134/S0006297918020074" title="DOI URL">https://doi.org/10.1134/S0006297918020074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S0006297918020074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS0006297918020074%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%2520%2528Moscow%2529%26atitle%3D2%25252C5-Diketopiperazines%25253A%252BA%252BNew%252BClass%252Bof%252BPoly%252528ADP-ribose%252529polymerase%252BInhibitors%26aulast%3DNilov%26aufirst%3DD.%2BK.%26date%3D2018%26date%3D2018%26volume%3D83%26issue%3D2%26spage%3D152%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin  Vidal</span>, <span class="hlFld-ContribAuthor ">Iuliia A.  Karpenko</span>, <span class="hlFld-ContribAuthor ">François  Liger</span>, <span class="hlFld-ContribAuthor ">Sylvain  Fieux</span>, <span class="hlFld-ContribAuthor ">Caroline  Bouillot</span>, <span class="hlFld-ContribAuthor ">Thierry  Billard</span>, <span class="hlFld-ContribAuthor ">Marcel  Hibert</span>, <span class="hlFld-ContribAuthor ">Luc  Zimmer</span>. </span><span class="cited-content_cbyCitation_article-title">[ 11 C]PF-3274167 as a PET radiotracer of oxytocin receptors: Radiosynthesis and evaluation in rat brain. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2017,</strong> <em>55 </em>, 1-6. <a href="https://doi.org/10.1016/j.nucmedbio.2017.07.008" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2017.07.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2017.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2017.07.008%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3D%25255B%252B11%252BC%25255DPF-3274167%252Bas%252Ba%252BPET%252Bradiotracer%252Bof%252Boxytocin%252Breceptors%25253A%252BRadiosynthesis%252Band%252Bevaluation%252Bin%252Brat%252Bbrain%26aulast%3DVidal%26aufirst%3DBenjamin%26date%3D2017%26volume%3D55%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Courtney E.  King</span>, <span class="hlFld-ContribAuthor ">William C.  Griffin</span>, <span class="hlFld-ContribAuthor ">Lauryn N.  Luderman</span>, <span class="hlFld-ContribAuthor ">Malcolm M.  Kates</span>, <span class="hlFld-ContribAuthor ">Jacqueline F.  McGinty</span>, <span class="hlFld-ContribAuthor ">Howard C.  Becker</span>. </span><span class="cited-content_cbyCitation_article-title">Oxytocin Reduces Ethanol Self-Administration in Mice. </span><span class="cited-content_cbyCitation_journal-name">Alcoholism: Clinical and Experimental Research</span><span> <strong>2017,</strong> <em>41 </em>
                                    (5)
                                     , 955-964. <a href="https://doi.org/10.1111/acer.13359" title="DOI URL">https://doi.org/10.1111/acer.13359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/acer.13359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Facer.13359%26sid%3Dliteratum%253Aachs%26jtitle%3DAlcoholism%253A%2520Clinical%2520and%2520Experimental%2520Research%26atitle%3DOxytocin%252BReduces%252BEthanol%252BSelf-Administration%252Bin%252BMice%26aulast%3DKing%26aufirst%3DCourtney%2BE.%26date%3D2017%26date%3D2017%26volume%3D41%26issue%3D5%26spage%3D955%26epage%3D964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid I.  Belen’kii</span>, <span class="hlFld-ContribAuthor ">Yu. B.  Evdokimenkova</span>. </span><span class="cited-content_cbyCitation_article-title">The Literature of Heterocyclic Chemistry, Part XII, 2010–2011. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 147-274. <a href="https://doi.org/10.1016/B978-0-12-420160-6.00004-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-420160-6.00004-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-420160-6.00004-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-420160-6.00004-5%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BLiterature%252Bof%252BHeterocyclic%252BChemistry%25252C%252BPart%252BXII%25252C%252B2010%2525E2%252580%2525932011%26aulast%3DBelen%25E2%2580%2599kii%26aufirst%3DLeonid%2BI.%26date%3D2014%26spage%3D147%26epage%3D274%26pub%3DElsevier%26date%3D2014%26volume%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gijs  Koopmanschap</span>, <span class="hlFld-ContribAuthor ">Eelco  Ruijter</span>, <span class="hlFld-ContribAuthor ">Romano VA  Orru</span>. </span><span class="cited-content_cbyCitation_article-title">Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>10 </em>, 544-598. <a href="https://doi.org/10.3762/bjoc.10.50" title="DOI URL">https://doi.org/10.3762/bjoc.10.50</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.10.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.10.50%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIsocyanide-based%252Bmulticomponent%252Breactions%252Btowards%252Bcyclic%252Bconstrained%252Bpeptidomimetics%26aulast%3DKoopmanschap%26aufirst%3DGijs%26date%3D2014%26date%3D2014%26volume%3D10%26spage%3D544%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dean S  Carson</span>, <span class="hlFld-ContribAuthor ">Adam J  Guastella</span>, <span class="hlFld-ContribAuthor ">Emily R  Taylor</span>, <span class="hlFld-ContribAuthor ">Iain S  McGregor</span>. </span><span class="cited-content_cbyCitation_article-title">A brief history of oxytocin and its role in modulating psychostimulant effects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Psychopharmacology</span><span> <strong>2013,</strong> <em>27 </em>
                                    (3)
                                     , 231-247. <a href="https://doi.org/10.1177/0269881112473788" title="DOI URL">https://doi.org/10.1177/0269881112473788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0269881112473788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0269881112473788%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Psychopharmacology%26atitle%3DA%252Bbrief%252Bhistory%252Bof%252Boxytocin%252Band%252Bits%252Brole%252Bin%252Bmodulating%252Bpsychostimulant%252Beffects%26aulast%3DCarson%26aufirst%3DDean%2BS%26date%3D2013%26date%3D2013%26volume%3D27%26issue%3D3%26spage%3D231%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan D.  Borthwick</span>, <span class="hlFld-ContribAuthor ">John  Liddle</span>. </span><span class="cited-content_cbyCitation_article-title">Retosiban and Epelsiban: Potent and Selective Orally Available Oxytocin Antagonists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 225-256. <a href="https://doi.org/10.1002/9783527648207.ch10" title="DOI URL">https://doi.org/10.1002/9783527648207.ch10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527648207.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527648207.ch10%26sid%3Dliteratum%253Aachs%26atitle%3DRetosiban%252Band%252BEpelsiban%25253A%252BPotent%252Band%252BSelective%252BOrally%252BAvailable%252BOxytocin%252BAntagonists%26aulast%3DBorthwick%26aufirst%3DAlan%2BD.%26date%3D2013%26date%3D2013%26spage%3D225%26epage%3D256%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DProtein-Protein%252BInteractions%252Bin%252BDrug%252BDiscovery%26aulast%3DD%25C3%25B6mling%26aufirst%3DAlexander%26date%3D2013%26volume%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John J.  Ferrie</span>, <span class="hlFld-ContribAuthor ">Jessica J.  Gruskos</span>, <span class="hlFld-ContribAuthor ">Ari L.  Goldwaser</span>, <span class="hlFld-ContribAuthor ">Megan E.  Decker</span>, <span class="hlFld-ContribAuthor ">Danielle A.  Guarracino</span>. </span><span class="cited-content_cbyCitation_article-title">A comparative protease stability study of synthetic macrocyclic peptides that mimic two endocrine hormones. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (4)
                                     , 989-995. <a href="https://doi.org/10.1016/j.bmcl.2012.12.041" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.12.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.12.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.12.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bcomparative%252Bprotease%252Bstability%252Bstudy%252Bof%252Bsynthetic%252Bmacrocyclic%252Bpeptides%252Bthat%252Bmimic%252Btwo%252Bendocrine%252Bhormones%26aulast%3DFerrie%26aufirst%3DJohn%2BJ.%26date%3D2013%26volume%3D23%26issue%3D4%26spage%3D989%26epage%3D995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yijun  Huang</span>, <span class="hlFld-ContribAuthor ">Ahmed  Yazbak</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent Reactions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 497-522. <a href="https://doi.org/10.1002/9780470711828.ch18" title="DOI URL">https://doi.org/10.1002/9780470711828.ch18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9780470711828.ch18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9780470711828.ch18%26sid%3Dliteratum%253Aachs%26atitle%3DMulticomponent%252BReactions%26aulast%3DHuang%26aufirst%3DYijun%26date%3D2012%26date%3D2012%26spage%3D497%26epage%3D522%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DGreen%252BTechniques%252Bfor%252BOrganic%252BSynthesis%252Band%252BMedicinal%252BChemistry%26aulast%3DZhang%26aufirst%3DWei%26date%3D2012%26volume%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Manning</span>, <span class="hlFld-ContribAuthor ">A.  Misicka</span>, <span class="hlFld-ContribAuthor ">A.  Olma</span>, <span class="hlFld-ContribAuthor ">K.  Bankowski</span>, <span class="hlFld-ContribAuthor ">S.  Stoev</span>, <span class="hlFld-ContribAuthor ">B.  Chini</span>, <span class="hlFld-ContribAuthor ">T.  Durroux</span>, <span class="hlFld-ContribAuthor ">B.  Mouillac</span>, <span class="hlFld-ContribAuthor ">M.  Corbani</span>, <span class="hlFld-ContribAuthor ">G.  Guillon</span>. </span><span class="cited-content_cbyCitation_article-title">Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroendocrinology</span><span> <strong>2012,</strong> <em>24 </em>
                                    (4)
                                     , 609-628. <a href="https://doi.org/10.1111/j.1365-2826.2012.02303.x" title="DOI URL">https://doi.org/10.1111/j.1365-2826.2012.02303.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1365-2826.2012.02303.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1365-2826.2012.02303.x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroendocrinology%26atitle%3DOxytocin%252Band%252BVasopressin%252BAgonists%252Band%252BAntagonists%252Bas%252BResearch%252BTools%252Band%252BPotential%252BTherapeutics%26aulast%3DManning%26aufirst%3DM.%26date%3D2012%26date%3D2012%26volume%3D24%26issue%3D4%26spage%3D609%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0015.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of agonist oxytocin <b>1</b> and antagonist atosiban <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0016.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Oxytocin and the 7TM G-protein-coupled oxytocin receptor. Reprinted with permission from ref <a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">4</a>. Copyright 2003 Elsevier.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Design of Biaryl Tertiary Sulfonamides Based on Consensus Pharmacophore Derived from Compounds <b>20</b> (grey) and <b>37</b> (gold) (Reprinted with permission from ref <a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">44</a>. Copyright 2003 Elsevier.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Pharmacophore Design of Biaryl Triazole Template</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Triazole SAR<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0010.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Indanyl 2,5-Diketopiperazine Template</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0012.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. 2,5-Diketopiperazine SAR<a onclick="showRef(event, 'ref52 ref55 ref56 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref52 ref55 ref56 ref57 ref58 ref59">(52, 55-59)</a></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/medium/jm-2009-01812z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0013.jpeg" id="rightTab-_i24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray Crystal Structures of 2,5-Diketopiperazine <b>33</b> and Deamino-oxytocin <b>34</b><a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-18/jm901812z/production/images/large/jm-2009-01812z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901812z&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05021" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05021" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 64 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Gimpl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrenholz, F.</span><span> </span><span class="NLM_article-title">The oxytocin receptor system: structure, function, and regulation</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1152%2Fphysrev.2001.81.2.629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=11274341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD3MXislCrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=629-683&author=G.+Gimplauthor=F.+Fahrenholz&title=The+oxytocin+receptor+system%3A+structure%2C+function%2C+and+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The oxytocin receptor system: structure, function, and regulation</span></div><div class="casAuthors">Gimpl, Gerald; Fahrenholz, Falk</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">629-683</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review with 624 refs.  The neurohypophysial peptide oxytocin (OT) and OT-like hormones facilitate reprodn. in all vertebrates at several levels.  The major site of OT gene expression is the magnocellular neurons of the hypothalamic paraventricular and supraoptic nuclei.  In response to a variety of stimuli such as suckling, parturition, or certain kinds of stress, the processed OT peptide is released from the posterior pituitary into the systemic circulation.  Such stimuli also lead to an intranuclear release of OT.  Moreover, oxytocinergic neurons display widespread projections throughout the central nervous system.  However, OT is also synthesized in peripheral tissues, e.g., uterus, placenta, amnion, corpus luteum, testis, and heart.  The OT receptor is a typical class I G protein-coupled receptor that is primarily coupled via Gq proteins to phospholipase C-β.  The high-affinity receptor state requires both Mg2+ and cholesterol, which probably function as allosteric modulators.  The agonist-binding region of the receptor has been characterized by mutagenesis and mol. modeling and is different from the antagonist binding site.  The function and physiol. regulation of the OT system is strongly steroid dependent.  However, this is, unexpectedly, only partially reflected by the promoter sequences in the OT receptor gene.  The classical actions of OT are stimulation of uterine smooth muscle contraction during labor and milk ejection during lactation.  While the essential role of OT for the milk let-down reflex has been confirmed in OT-deficient mice, OT's role in parturition is obviously more complex.  Before the onset of labor, uterine sensitivity to OT markedly increases concomitant with a strong upregulation of OT receptors in the myometrium and, to a lesser extent, in the decidua where OT stimulates the release of PGF2α.  Expts. with transgenic mice suggest that OT acts as a luteotropic hormone opposing the luteolytic action of PGF2α.  Thus, to initiate labor, it might be essential to generate sufficient PGF2α to overcome the luteotropic action of OT in late gestation.  OT also plays an important role in many other reprodn.-related functions, such as control of the estrus cycle length, follicle luteinization in the ovary, and ovarian steroidogenesis.  In the male, OT is a potent stimulator of spontaneous erections in rats and is involved in ejaculation.  OT receptors have also been identified in other tissues, including the kidney, heart, thymus, pancreas, and adipocytes.  For example, in the rat, OT is a cardiovascular hormone acting in concert with atrial natriuretic peptide to induce natriuresis and kaliuresis.  The central actions of OT range from the modulation of the neuroendocrine reflexes to the establishment of complex social and bonding behaviors related to the reprodn. and care of the offspring.  OT exerts potent anti-stress effects that may facilitate pair bonds.  Overall, the regulation by gonadal and adrenal steroids is one of the most remarkable features of the OT system and is, unfortunately, the least understood.  One has to conclude that the physiol. regulation of the OT system will remain puzzling as long as the mol. mechanisms of genomic and nongenomic actions of steroids have not been clarified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp46jO2zW6dQ7Vg90H21EOLACvtfcHk0lgMTw08WtXrJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXislCrsLk%253D&md5=2ee2bbe969b9d4c81729ad2380d3d293</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.2.629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.2.629%26sid%3Dliteratum%253Aachs%26aulast%3DGimpl%26aufirst%3DG.%26aulast%3DFahrenholz%26aufirst%3DF.%26atitle%3DThe%2520oxytocin%2520receptor%2520system%253A%2520structure%252C%2520function%252C%2520and%2520regulation%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D629%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macbeth, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagani, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, W. S.,  III.</span><span> </span><span class="NLM_article-title">Oxytocin: the great facilitator of life</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=19482229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsFyksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2009&pages=127-151&author=H.+J.+Leeauthor=A.+H.+Macbethauthor=J.+H.+Paganiauthor=W.+S.+Young&title=Oxytocin%3A+the+great+facilitator+of+life"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin: The great facilitator of life</span></div><div class="casAuthors">Lee, Heon-Jin; Macbeth, Abbe H.; Pagani, Jerome H.; Young, W. Scott III</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-151</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxytocin (Oxt) is a nonapeptide hormone best known for its role in lactation and parturition.  Since 1906 when its uterine-contracting properties were described until 50 years later when its sequence was elucidated, research has focused on its peripheral roles in reprodn.  Only over the past several decades have researchers focused on what functions Oxt might have in the brain, the subject of this review.  Immunohistochem. studies revealed that magnocellular neurons of the hypothalamic paraventricular and supraoptic nuclei are the neurons of origin for the Oxt released from the posterior pituitary.  Smaller cells in various parts of the brain, as well as release from magnocellular dendrites, provide the Oxt responsible for modulating various behaviors at its only identified receptor.  Although Oxt is implicated in a variety of "non-social" behaviors, such as learning, anxiety, feeding and pain perception, it is Oxt's roles in various social behaviors that have come to the fore recently.  Oxt is important for social memory and attachment, sexual and maternal behavior, and aggression.  Recent work implicates Oxt in human bonding and trust as well.  Human disorders characterized by aberrant social interactions, such as autism and schizophrenia, may also involve Oxt expression.  Many, if not most, of Oxt's functions, from social interactions (affiliation, aggression) and sexual behavior to eventual parturition, lactation and maternal behavior, may be viewed as specifically facilitating species propagation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9FUABILrYYbVg90H21EOLACvtfcHk0lgMTw08WtXrJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsFyksrw%253D&md5=c3550f5708ef2ff6ceccc6a9055e3732</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DMacbeth%26aufirst%3DA.%2BH.%26aulast%3DPagani%26aufirst%3DJ.%2BH.%26aulast%3DYoung%26aufirst%3DW.%2BS.%26atitle%3DOxytocin%253A%2520the%2520great%2520facilitator%2520of%2520life%26jtitle%3DProg.%2520Neurobiol.%26date%3D2009%26volume%3D88%26spage%3D127%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Uvnas-Moberg, K.</span> <span class="citation_source-book">The Oxytocin Factor</span>; <span class="NLM_publisher-name">Da Capo Press</span>: <span class="NLM_publisher-loc">Cambridge, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=K.+Uvnas-Moberg&title=The+Oxytocin+Factor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DUvnas-Moberg%26aufirst%3DK.%26btitle%3DThe%2520Oxytocin%2520Factor%26pub%3DDa%2520Capo%2520Press%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Zingg, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laporte, S. A.</span><span> </span><span class="NLM_article-title">The oxytocin receptor</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1016%2FS1043-2760%2803%2900080-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=12826328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVCmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=222-227&author=H.+H.+Zinggauthor=S.+A.+Laporte&title=The+oxytocin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The oxytocin receptor</span></div><div class="casAuthors">Zingg, Hans H.; Laporte, Stephane A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">222-227</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Novel sites of oxytocin receptor expression have recently been detected, including breast cancer cells, bone cells, myoblasts, cardiomyocytes, and endothelial cells.  These discoveries have greatly expanded the possible spectrum of oxytocin action beyond its classic role as an inducer of uterine contractions and milk ejection.  Addnl. advances in the understanding of oxytocin receptor structure-function relationships, receptor trafficking, and novel receptor-linked signaling cascades have made this receptor an attractive model for the study of G-protein-linked receptor function.  Finally, the tocolytic efficiency of the oxytocin receptor antagonist atosiban, recently approved for clin. use in Europe, has opened new avenues for the prevention and treatment of preterm labor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqax1K5BVg-z7Vg90H21EOLACvtfcHk0ljZMjgbWws2Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVCmu70%253D&md5=5c150703702c627e6823d08839e5c51e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1043-2760%2803%2900080-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-2760%252803%252900080-8%26sid%3Dliteratum%253Aachs%26aulast%3DZingg%26aufirst%3DH.%2BH.%26aulast%3DLaporte%26aufirst%3DS.%2BA.%26atitle%3DThe%2520oxytocin%2520receptor%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2003%26volume%3D14%26spage%3D222%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Schulz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">du Vigneaud, V.</span><span> </span><span class="NLM_article-title">Synthesis of 1-L-penicillamine-oxytocin, 1-<span class="smallcaps smallerCapital">d</span>-penicillamine-oxytocin, and 1-deaminopenicillamine-oxytocin, potent inhibitors of the oxytocic response of oxytocin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00323a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1966&pages=647-650&author=H.+Schulzauthor=V.+du+Vigneaud&title=Synthesis+of+1-L-penicillamine-oxytocin%2C+1-d-penicillamine-oxytocin%2C+and+1-deaminopenicillamine-oxytocin%2C+potent+inhibitors+of+the+oxytocic+response+of+oxytocin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm00323a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00323a001%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DH.%26aulast%3Ddu%2BVigneaud%26aufirst%3DV.%26atitle%3DSynthesis%2520of%25201-L-penicillamine-oxytocin%252C%25201-d-penicillamine-oxytocin%252C%2520and%25201-deaminopenicillamine-oxytocin%252C%2520potent%2520inhibitors%2520of%2520the%2520oxytocic%2520response%2520of%2520oxytocin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1966%26volume%3D9%26spage%3D647%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Nestor, J. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferger, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">du Vigneaud, V.</span><span> </span><span class="NLM_article-title">[1-Beta-mercapto-beta,beta-pentamethylenepropionic acid]oxytocin, a potent inhibitor of oxytocin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00237a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1975&pages=284-287&author=J.+J.+Nestorauthor=M.+F.+Fergerauthor=V.+du+Vigneaud&title=%5B1-Beta-mercapto-beta%2Cbeta-pentamethylenepropionic+acid%5Doxytocin%2C+a+potent+inhibitor+of+oxytocin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm00237a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00237a015%26sid%3Dliteratum%253Aachs%26aulast%3DNestor%26aufirst%3DJ.%2BJ.%26aulast%3DFerger%26aufirst%3DM.%2BF.%26aulast%3Ddu%2BVigneaud%26aufirst%3DV.%26atitle%3D%255B1-Beta-mercapto-beta%252Cbeta-pentamethylenepropionic%2520acid%255Doxytocin%252C%2520a%2520potent%2520inhibitor%2520of%2520oxytocin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1975%26volume%3D18%26spage%3D284%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span> </span><span class="NLM_article-title">Recent advances in the development of oxytocin receptor antagonists</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaK28XjtVKntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=41-58&author=P.+D.+Williamsauthor=D.+J.+Pettibone&title=Recent+advances+in+the+development+of+oxytocin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of oxytocin receptor antagonists</span></div><div class="casAuthors">Williams, P. D.; Pettibone, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-58</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review, with 228 refs.  During the last decade there has been significant progress in the design and discovery of new structural classes of oxytocin antagonists.  Continued study of oxytocin analogs has led to the design of antagonists with novel linear and bicyclic structures, and receptor-based screening has identified smaller cyclic hexapeptide oxytocin antagonists as well as several structural classes of non-peptide oxytocin antagonists.  The similar topog. of important functionalities in peptide and non-peptide oxytocin antagonists suggest the possibility of a common pharmacophore.  New modifications to the classical antagonist analogs of oxytocin have provided analogs with significant improvements in potency, duration of action, oxytocin receptor selectivity, and bioavailability by non-parenteral routes of administration.  In addn., optimization within two structural classes of non-peptides has provided potent and selective analogs which offer the potential for obtaining a clin. useful, orally bioavailable oxytocin antagonist.  Human clin. studies with the peptide oxytocin antagonist, atosiban, have implicated oxytocin as a potential contributor to the pathophysiol. of preterm labor and suggests that oxytocin receptor blockade may offer a useful new method for preventing premature birth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIraVPkCf2ObVg90H21EOLACvtfcHk0li-9BCOhNuPcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVKntLc%253D&md5=5075a28ed13180968cd13ed3b2e82880</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520oxytocin%2520receptor%2520antagonists%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D1996%26volume%3D2%26spage%3D41%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D. G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordaunt, J. E.</span><span> </span><span class="NLM_article-title">Oxytocin antagonists as potential therapeutic agents for the treatment of preterm labour</span> <span class="citation_source-journal">Proc. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1016%2FS0079-6468%2805%2944407-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=16697900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVShtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2006&pages=331-373&author=M.+J.+Allenauthor=D.+G.+H.+Livermoreauthor=J.+E.+Mordaunt&title=Oxytocin+antagonists+as+potential+therapeutic+agents+for+the+treatment+of+preterm+labour"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin antagonists as potential therapeutic agents for the treatment of preterm labour</span></div><div class="casAuthors">Allen, Michael J.; Livermore, David G. H.; Mordaunt, Jacqueline E.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">331-373</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on the developments and discovery of new potent and selective, orally bioavailable non-peptidic antagonists.  Topics discussed include epidemiol. and the impact of preterm labor, the anatomy of the uterus, the treatment of preterm labor, the methods used to measure oxytocin, the antagonist activity, the peptide and non-peptide antagonists, the oxytocin agonists and the structural studies of oxytocin receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUyRFw_Wo9ArVg90H21EOLACvtfcHk0li-9BCOhNuPcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVShtbg%253D&md5=8bcac9661bc4e1ab51055b706b95e481</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2805%2944407-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252805%252944407-0%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%2BH.%26aulast%3DMordaunt%26aufirst%3DJ.%2BE.%26atitle%3DOxytocin%2520antagonists%2520as%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520preterm%2520labour%26jtitle%3DProc.%2520Med.%2520Chem.%26date%3D2006%26volume%3D44%26spage%3D331%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Manning, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillon, G.</span><span> </span><span class="NLM_article-title">Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents</span> <span class="citation_source-journal">Prog. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1016%2FS0079-6123%2808%2900437-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=18655903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2008&pages=473-512&author=M.+Manningauthor=S.+Stoevauthor=B.+Chiniauthor=T.+Durrouxauthor=B.+Mouillacauthor=G.+Guillon&title=Peptide+and+non-peptide+agonists+and+antagonists+for+the+vasopressin+and+oxytocin+V1a%2C+V1b%2C+V2+and+OT+receptors%3A+research+tools+and+potential+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents</span></div><div class="casAuthors">Manning, Maurice; Stoev, Stoytcho; Chini, Bice; Durroux, Thierry; Mouillac, Bernard; Guillon, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">Advances in Vasopressin and Oxytocin</span>),
    <span class="NLM_cas:pages">473-512</span>CODEN:
                <span class="NLM_cas:coden">PBRRA4</span>;
        ISSN:<span class="NLM_cas:issn">0079-6123</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxytocin (OT) and vasopressin (AVP) mediate their biol. actions by acting on four known receptors: The OT (uterine) and the AVP V1a (vasopressor), V1b (pituitary), V2 (renal) receptors and a fifth putative AVP V1c (vasodilating) receptor.  This presentation will summarize some highlights of the recent progress, in the design and synthesis of selective peptide agonists, antagonists, radioiodinated ligands, fluorescent ligands and bivalent ligands for these receptors.  Here we present published and unpublished pharmacol. data on the most widely used agonists, antagonists and labeled ligands.  The pharmacol. properties of promising new selective OT antagonists and V1b agonists are also presented.  This review should serve as a useful guide for the selection of the most appropriate ligand for a given study.  The current status of non-peptide OT and AVP antagonists and agonists is also summarized.  The relative merits of peptide and non-peptide AVP and OT agonists and antagonists as: (1) research tools and (2) therapeutic agents will be evaluated.  Many of the receptor selective peptide agonists and antagonists from this and other labs. are far more widely used as pharmacol. tools for studies on the peripheral and central effects of OT and AVP than their non-peptide counterparts.  In addn. to OT and to a lesser extent AVP (pitressin), a no. of OT and AVP analogs; such as carbetocin (OT agonist) dDAVP (desmopressin, V2 agonist), terlipressin (V1a agonist), felypressin (V1a agonist) and atosiban (Tractocile OT antagonist) are also in clin. use.  Despite much early promise, no non-peptide V1a or OT antagonists are currently in clin. trials.  While a no. of orally active non-peptide V2 antagonists (Vaptans); notably, Tolvaptan, Lixivaptan and Satavaptan, are currently in Phase III clin. trials; to date, only the mixed V2/V1a, antagonist Conivaptan (Vaprisol), has been approved by the US FDA for clin. use (by i.v. administration), for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.  Promising new non-peptide V1b and OT antagonists, as well as non-peptide V2 and OT agonists are now in pre-clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3jiQ5LZT5gLVg90H21EOLACvtfcHk0li-9BCOhNuPcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1CjtrfJ&md5=c21ad467eaee4a2651232a16c7dc61c5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0079-6123%2808%2900437-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6123%252808%252900437-8%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DM.%26aulast%3DStoev%26aufirst%3DS.%26aulast%3DChini%26aufirst%3DB.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DGuillon%26aufirst%3DG.%26atitle%3DPeptide%2520and%2520non-peptide%2520agonists%2520and%2520antagonists%2520for%2520the%2520vasopressin%2520and%2520oxytocin%2520V1a%252C%2520V1b%252C%2520V2%2520and%2520OT%2520receptors%253A%2520research%2520tools%2520and%2520potential%2520therapeutic%2520agents%26jtitle%3DProg.%2520Brain%2520Res.%26date%3D2008%26volume%3D170%26spage%3D473%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Gimpl, G.</span><span> </span><span class="NLM_article-title">Oxytocin receptor ligands: a survey of the patent literature</span> <span class="citation_source-journal">Expert Opin.Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1239</span><span class="NLM_x">–</span> <span class="NLM_lpage">1251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1517%2F13543776.18.11.1239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlShu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1239-1251&author=G.+Gimpl&title=Oxytocin+receptor+ligands%3A+a+survey+of+the+patent+literature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin receptor ligands: a survey of the patent literature</span></div><div class="casAuthors">Gimpl, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1239-1251</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Background: Oxytocin is produced primarily in hypothalamic neurons and is secreted from the posterior pituitary gland into the circulation in response to stimuli such as suckling, parturition, or stress.  Oxytocin functions as an essential component in milk ejection and is among the most potent uterotonic substances known.  The oxytocin receptor system supports physiol. processes assocd. with reprodn. at several levels.  Objective: To characterize and evaluate oxytocin receptor ligands for therapeutic applications.  Methods: Anal. of oxytocin analogs and nonpeptide oxytocin receptor ligands, and major applications of these substances.  Results/conclusion: Oxytocin receptor ligands, peptides, and nonpeptide mols., with high specificity over the related vasopressin receptors, are currently available.  These ligands are expected to show therapeutic utility for a vast range of applications, e.g., increasing lactation, improving in vitro inseminations, and inducing cardiomyogenesis; and also acting against preterm labor, breast cancer, an over-reactive immune system, osteoporosis, and autism-related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXEAZdk8Cy8bVg90H21EOLACvtfcHk0lhFbebzr5XO3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlShu7jK&md5=02503dd059ccf4cdee3e6ca8f2b37bf5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.11.1239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.11.1239%26sid%3Dliteratum%253Aachs%26aulast%3DGimpl%26aufirst%3DG.%26atitle%3DOxytocin%2520receptor%2520ligands%253A%2520a%2520survey%2520of%2520the%2520patent%2520literature%26jtitle%3DExpert%2520Opin.Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D1239%26epage%3D1251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Tsatsaris, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbonne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabrol, D.</span><span> </span><span class="NLM_article-title">Atosiban for Preterm Labour</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=375-382&author=V.+Tsatsarisauthor=B.+Carbonneauthor=D.+Cabrol&title=Atosiban+for+Preterm+Labour"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsatsaris%26aufirst%3DV.%26aulast%3DCarbonne%26aufirst%3DB.%26aulast%3DCabrol%26aufirst%3DD.%26atitle%3DAtosiban%2520for%2520Preterm%2520Labour%26jtitle%3DDrugs%26date%3D2004%26volume%3D64%26spage%3D375%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lamont, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kam, K. Y. R.</span><span> </span><span class="NLM_article-title">Atosiban as a tocolytic for the treatment of spontaneous preterm labor</span> <span class="citation_source-journal">Expert Rev. Obstet. Gynecol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1586%2F17474108.3.2.163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislKnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=163-174&author=R.+F.+Lamontauthor=K.+Y.+R.+Kam&title=Atosiban+as+a+tocolytic+for+the+treatment+of+spontaneous+preterm+labor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Atosiban as a tocolytic for the treatment of spontaneous preterm labor</span></div><div class="casAuthors">Lamont, Ronald F.; Kam, Ky ronald</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Obstetrics & Gynecology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-174</span>CODEN:
                <span class="NLM_cas:coden">EROGBG</span>;
        ISSN:<span class="NLM_cas:issn">1747-4108</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Preterm birth is the major cause of perinatal mortality and morbidity in the developed world, imposing a huge burden on healthcare costs.  Tocolytic drugs inhibit contractions and delay delivery in the hope of improving survival and preventing handicap.  Historically, most tocolytics were not initially developed to treat preterm labor, and so are not uterospecific and have multiorgan side effects.  Atosiban (Tractocile) is a vasopressin-oxytocin receptor antagonist, which is much more uterospecific than previous tocolytics, and, consequently has placebo-level side effects.  Atosiban has a strong evidence base and is a significant addn. to the treatment options for preterm labor and should be used for first-line therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqieFYnJ9OnKrVg90H21EOLACvtfcHk0lhFbebzr5XO3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislKnsLo%253D&md5=153cc3f20e24b73761d24adaecedafbe</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1586%2F17474108.3.2.163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F17474108.3.2.163%26sid%3Dliteratum%253Aachs%26aulast%3DLamont%26aufirst%3DR.%2BF.%26aulast%3DKam%26aufirst%3DK.%2BY.%2BR.%26atitle%3DAtosiban%2520as%2520a%2520tocolytic%2520for%2520the%2520treatment%2520of%2520spontaneous%2520preterm%2520labor%26jtitle%3DExpert%2520Rev.%2520Obstet.%2520Gynecol.%26date%3D2008%26volume%3D3%26spage%3D163%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Coomarasamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, K. S.</span><span> </span><span class="NLM_article-title">Oxytocin antagonists for tocolysis in preterm labour−a systematic review</span> <span class="citation_source-journal">Med. Sci. Monit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">RA268</span><span class="NLM_x">–</span> <span class="NLM_lpage">RA273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=RA268-RA273&author=A.+Coomarasamyauthor=E.+M.+Knoxauthor=H.+Geeauthor=K.+S.+Khan&title=Oxytocin+antagonists+for+tocolysis+in+preterm+labour%E2%88%92a+systematic+review"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoomarasamy%26aufirst%3DA.%26aulast%3DKnox%26aufirst%3DE.%2BM.%26aulast%3DGee%26aufirst%3DH.%26aulast%3DKhan%26aufirst%3DK.%2BS.%26atitle%3DOxytocin%2520antagonists%2520for%2520tocolysis%2520in%2520preterm%2520labour%25E2%2588%2592a%2520systematic%2520review%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2002%26volume%3D8%26spage%3DRA268%26epage%3DRA273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Bossmar, T.</span><span> </span><span class="NLM_article-title">Treatment of preterm labor with the oxytocin and vasopressin antagonist atosiban</span> <span class="citation_source-journal">J. Perinat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1515%2Fjpme.1998.26.6.458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=10224602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaK1MXhtV2ltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1998&pages=458-465&author=T.+Bossmar&title=Treatment+of+preterm+labor+with+the+oxytocin+and+vasopressin+antagonist+atosiban"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of preterm labor with the oxytocin and vasopressin antagonist atosiban</span></div><div class="casAuthors">Bossmar, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Perinatal Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">458-465</span>CODEN:
                <span class="NLM_cas:coden">JPEMAO</span>;
        ISSN:<span class="NLM_cas:issn">0300-5577</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter & Co.</span>)
        </div><div class="casAbstract">A review with 67 refs., describing the role of oxytocin and vasopressin in the initiation of labor preterm and at term, etiol. and current available treatment of preterm labor, and clin. development and potential risks of atosiban.  Atosiban is a specific inhibitor of oxytocin induced uterine contractions, it offers a much more specific treatment in comparison to current therapies, and has fewer side-effects compared to β-mimetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC8SaCBPPgfbVg90H21EOLACvtfcHk0ljBSPFQc23T7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtV2ltr8%253D&md5=4e81624f95710b905c6b86bea72ca032</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1515%2Fjpme.1998.26.6.458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fjpme.1998.26.6.458%26sid%3Dliteratum%253Aachs%26aulast%3DBossmar%26aufirst%3DT.%26atitle%3DTreatment%2520of%2520preterm%2520labor%2520with%2520the%2520oxytocin%2520and%2520vasopressin%2520antagonist%2520atosiban%26jtitle%3DJ.%2520Perinat.%2520Med.%26date%3D1998%26volume%3D26%26spage%3D458%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Brown, A. D.; Ellis, D.; Smith, C. R.</span><span> </span><span class="NLM_article-title">Substituted triazole derivatives as oxytocin antagonist</span>. Patent WO2005028452,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">, </span>and references therein .</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=A.+D.+Brown&author=D.+Ellis&author=C.+R.+Smith&title=Substituted+triazole+derivatives+as+oxytocin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%2BD.%26atitle%3DSubstituted%2520triazole%2520derivatives%2520as%2520oxytocin%2520antagonist%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Tiwari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chugh, A.</span><span> </span><span class="NLM_article-title">Benign prostatic hyperplasia: an insight into current investigational medical therapies</span> <span class="citation_source-journal">Expert. Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1372</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=1359-1372&author=A.+Tiwariauthor=N.+S.+Krishnaauthor=K.+Nandaauthor=A.+Chugh&title=Benign+prostatic+hyperplasia%3A+an+insight+into+current+investigational+medical+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTiwari%26aufirst%3DA.%26aulast%3DKrishna%26aufirst%3DN.%2BS.%26aulast%3DNanda%26aufirst%3DK.%26aulast%3DChugh%26aufirst%3DA.%26atitle%3DBenign%2520prostatic%2520hyperplasia%253A%2520an%2520insight%2520into%2520current%2520investigational%2520medical%2520therapies%26jtitle%3DExpert.%2520Opin.%2520Investig.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D1359%26epage%3D1372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span> </span><span class="NLM_article-title">Small molecule ligands for oxytocin and vasopressin receptors</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C1%3A%3AAID-MED1%3E3.0.CO%3B2-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=8979247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaK2sXkslSnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=1-16&author=R.+M.+Freidingerauthor=D.+J.+Pettibone&title=Small+molecule+ligands+for+oxytocin+and+vasopressin+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule ligands for oxytocin and vasopressin receptors</span></div><div class="casAuthors">Freidinger, Roger M.; Pettibone, Douglas J.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">A review, with 68 refs.  Topics discussed include: endogenous hormones and receptors, peptide structure-activity studies, and small mol. vasopressin and oxytocin receptor-selective antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF6NnlfieO3bVg90H21EOLACvtfcHk0lili83kmkCqMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkslSnug%253D%253D&md5=8f085a42967e880d4d78716972a1a4a1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199701%2917%3A1%3C1%3A%3AAID-MED1%3E3.0.CO%3B2-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199701%252917%253A1%253C1%253A%253AAID-MED1%253E3.0.CO%253B2-5%26sid%3Dliteratum%253Aachs%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26atitle%3DSmall%2520molecule%2520ligands%2520for%2520oxytocin%2520and%2520vasopressin%2520receptors%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1997%26volume%3D17%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Borthwick, A. D.</span><span> </span><span class="NLM_article-title">Oxytocin antagonists and agonists</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=413-422&author=A.+D.+Borthwick&title=Oxytocin+antagonists+and+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26atitle%3DOxytocin%2520antagonists%2520and%2520agonists%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2006%26volume%3D41%26spage%3D413%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, P.</span><span> </span><span class="NLM_article-title">Preterm labour: an overview of current and emerging therapeutics</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1441</span><span class="NLM_x">–</span> <span class="NLM_lpage">1468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.2174%2F0929867033457331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=12871140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1Wrur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=1441-1468&author=M.+K.+Schwarzauthor=P.+Page&title=Preterm+labour%3A+an+overview+of+current+and+emerging+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Preterm labor: An overview of current and emerging therapeutics</span></div><div class="casAuthors">Schwarz, Matthias K.; Page, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1441-1468</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Preterm labour is a major cause of perinatal mortality and morbidity.  However, during the past 40 yr of clin. studies and despite the use of multiple therapeutic agents, the rate of preterm birth has not drastically declined.  In 1991, it was estd. that in the US approx. 116,000 women admitted with acute episodes of preterm labour were treated each year with ritodrine, which is the first drug approved by the US FDA and still remains the std. therapy for treating preterm labour.  Ritodrine (Yutopar) stimulates the β2-adrenergic receptor throughout the body, causing an inhibitory action in different tissues that, among other side effects, also leads to an attenuation of uterine contractility.  More recently, a new therapeutic agent, atosiban (Tractocile), a peptidic oxytocin receptor antagonist, has been introduced to the market.  However, the use of the various pharmacol. agents to treat preterm labour remains restricted, due to lack of uterine selectivity, low efficacy and potentially serious side effects for the mother or the fetus.  Therefore, there is an urgent need to develop drugs with myometrial selectivity that would allow long-lasting inhibition of labour and prolong pregnancy up to a stage when good fetal maturation raises the chances of survival.  One of the major obstacles hampering the development of new therapeutic agents is the marked inter-species difference in terms of preterm labour physiol., which complicates the preclin. evaluation of new candidate mols. in animal models of disease.  In this review, the authors will provide a comprehensive update of past, current and new approaches for the management of preterm labour, including β2-adrenergic agonists, calcium channel blockers, oxytocin antagonists, prostaglandin antagonists and other potential therapeutics.  For each of the therapies used today, the review will cover the mechanism of action, benefit and adverse effects, and discuss the promise and potential benefits of new emerging therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVKIjKbPIIQbVg90H21EOLACvtfcHk0lili83kmkCqMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1Wrur4%253D&md5=b4f99b81170d59cf3dda33a0843d73fc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2174%2F0929867033457331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033457331%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DPage%26aufirst%3DP.%26atitle%3DPreterm%2520labour%253A%2520an%2520overview%2520of%2520current%2520and%2520emerging%2520therapeutics%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D1441%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Havass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulop, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zupko, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falkay, G.</span><span> </span><span class="NLM_article-title">Noncompetitive nature of oxytocin antagonists with general structure Mpa1Xxx2Sar7Arg8</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1419</span><span class="NLM_x">–</span> <span class="NLM_lpage">1425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=1419-1425&author=J.+Havassauthor=K.+Bakosauthor=A.+Markiauthor=R.+Gasparauthor=L.+Geraauthor=J.+M.+Stewartauthor=F.+Fulopauthor=G.+K.+Tothauthor=I.+Zupkoauthor=G.+Falkay&title=Noncompetitive+nature+of+oxytocin+antagonists+with+general+structure+Mpa1Xxx2Sar7Arg8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHavass%26aufirst%3DJ.%26aulast%3DBakos%26aufirst%3DK.%26aulast%3DMarki%26aufirst%3DA.%26aulast%3DGaspar%26aufirst%3DR.%26aulast%3DGera%26aufirst%3DL.%26aulast%3DStewart%26aufirst%3DJ.%2BM.%26aulast%3DFulop%26aufirst%3DF.%26aulast%3DToth%26aufirst%3DG.%2BK.%26aulast%3DZupko%26aufirst%3DI.%26aulast%3DFalkay%26aufirst%3DG.%26atitle%3DNoncompetitive%2520nature%2520of%2520oxytocin%2520antagonists%2520with%2520general%2520structure%2520Mpa1Xxx2Sar7Arg8%26jtitle%3DPeptides%26date%3D2002%26volume%3D23%26spage%3D1419%26epage%3D1425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Melin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojnar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilhardt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerlund, M.</span><span> </span><span class="NLM_article-title">Synthetic antagonists of the myometrial response to vasopressin and oxytocin</span> <span class="citation_source-journal">J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1677%2Fjoe.0.1110125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=3783079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaL28XmtF2js7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=1986&pages=125-131&author=P.+Melinauthor=J.+Trojnarauthor=B.+Johanssonauthor=H.+Vilhardtauthor=M.+Akerlund&title=Synthetic+antagonists+of+the+myometrial+response+to+vasopressin+and+oxytocin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic antagonists of the myometrial response to vasopressin and oxytocin</span></div><div class="casAuthors">Melin, P.; Trojnar, J.; Johansson, B.; Vilhardt, H.; Aakerlund, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-31</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    </div><div class="casAbstract">In an attempt to develop inhibitors of vasopressin- and oxytocin-induced uterine activity, 17 analogs of 1-deamino-oxytocin were synthesized by the solid-phase method.  Modifications were made at position 2, O-methyltyrosine (Tyr(OMe)), O-ethyltyrosine (Tyr(OEt)),D-Tyr, D-Tyr(OEt), or D-Trptophan (D-Trp), at position 4, Valine (Val) or Threonine (Thr), and(or) at position 8, Ornithine (Orn), Citrulline (Cit), Arginine (Arg), or D-Arg.  The analogs were tested for antiuterotonic activity in vitro and in vivo in the rat and in vitro on myometrial strips from nonpregnant women and pregnant women at term.  Their selectivity was also investigated in the blood pressure and antidiuretic bioassay in rats.  Results were compared with those of the antiuterotonic analog 1-deamino-Tyr(OEt)2-oxytocin (d(OEt)-oxytocin)  [77648-79-4].  All analogs possessed higher antiuterotonic activity than d(OEt)-oxytocin in the rat in vitro and in vivo.  The neg. logarithm of the molar concn. of the antagonist which reduced the effect of a dose of agonist to that of half the dose (pA2) was 7.6-8.9 for all the new inhibitors, compared with 7.2 for d(OEt)-oxytocin.  The highest pA2 value was found for [1-deamino-Tyr(OMe)2,Orn8]-oxytocin  [105317-61-1] (8.9) and [1-deamino-Tyr(OEt)2-Thr4,Orn8]-oxytocin  [90779-66-1] (8.9).  In myometrium from nonpregnant women, the most potent peptide was [1-deamino-D-Tyr(OEt)2,Thr4,Orn8]-oxytocin  [90779-69-4] (17.2-fold more potent that d(OEt)-oxytocin).  In myometrium from pregnant women, the inhibitory effects of the majority of the analogs were less pronounced.  In the rat in vivo, the most potent analog, [1-deamino-D-Trp2,Val4,Orn8]-oxytocin  [92407-79-9], was 19.9-fold more active than d(OEt)-oxytocin.  Exchanging L-Tyr for the D-form generally increased inhibitory activity as well as the specificity of the analogs.  Alkylation of the D-Tyr residue did not appear to be necessary for inhibition.  Substitution with D-tryptophan at position 2 gave analogs with high inhibitory potency in the rat in vitro and in vivo, but which exhibited weak effects in women in vitro.  There was no correlation between the inhibitory effects on myometrium from nonpregnant and pregnant women or between rat and human data.  The high antiuterotonic activity of [1-deamino-D-Tyr(OEt)2-Val4-Orn8]-oxytocin  [90779-68-3] and [1-deamino-D-Tyr(OEt)2-Thr4-Orn8]-oxytocin combined with low blood pressure and antidiuretic effects make these 2 analogs interesting for clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpclwW2oDDmYLVg90H21EOLACvtfcHk0lhcNP_LVpPdrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XmtF2js7k%253D&md5=02585b2a019acd05fc685d7b80b4c516</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1677%2Fjoe.0.1110125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Fjoe.0.1110125%26sid%3Dliteratum%253Aachs%26aulast%3DMelin%26aufirst%3DP.%26aulast%3DTrojnar%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DB.%26aulast%3DVilhardt%26aufirst%3DH.%26aulast%3DAkerlund%26aufirst%3DM.%26atitle%3DSynthetic%2520antagonists%2520of%2520the%2520myometrial%2520response%2520to%2520vasopressin%2520and%2520oxytocin%26jtitle%3DJ.%2520Endocrinol.%26date%3D1986%26volume%3D111%26spage%3D125%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Melin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilhardt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerlund, M.</span><span> </span><span class="NLM_article-title">Inhibitory effect of O-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity</span> <span class="citation_source-journal">J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1677%2Fjoe.0.0880173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=7193709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaL3MXitVaqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1981&pages=173-180&author=P.+Melinauthor=H.+Vilhardtauthor=G.+Lindebergauthor=L.+E.+Larssonauthor=M.+Akerlund&title=Inhibitory+effect+of+O-alkylated+analogues+of+oxytocin+and+vasopressin+on+human+and+rat+myometrial+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory effect of O-alkylated analogs of oxytocin and vasopressin on human and rat myometrial activity</span></div><div class="casAuthors">Melin, P.; Vilhardt, H.; Lindeberg, G.; Larsson, L. E.; Aakerlund, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-80</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    </div><div class="casAbstract">Analogs of oxytocin and vasopressin modified by O-alkylation (Me, Et, and Bu) at position 2 of the peptide chain showed no appreciable oxytocic activity on rat uterus in vivo and isolated rat and human myometrial prepns.  When tested together with oxytocin or vasopressin the analogs inhibited the uterine response to the hormones in a dose-dependent and reversible manner.  Et analogs were more powerful antagonists than Me analogs, but further prolongation of the alkyl chain (Bu) diminished the antagonistic properties of the compds.  The effect on antagonistic potency of deamination at position 1 of the analogs varied among the analogs and depended on the test system used.  The possible clin. value of the antagonists is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe7bRRgMErLrVg90H21EOLACvtfcHk0lhcNP_LVpPdrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXitVaqurs%253D&md5=d0cdccc51721f9b82b9c6f3c230b92d9</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1677%2Fjoe.0.0880173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Fjoe.0.0880173%26sid%3Dliteratum%253Aachs%26aulast%3DMelin%26aufirst%3DP.%26aulast%3DVilhardt%26aufirst%3DH.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DLarsson%26aufirst%3DL.%2BE.%26aulast%3DAkerlund%26aufirst%3DM.%26atitle%3DInhibitory%2520effect%2520of%2520O-alkylated%2520analogues%2520of%2520oxytocin%2520and%2520vasopressin%2520on%2520human%2520and%2520rat%2520myometrial%2520activity%26jtitle%3DJ.%2520Endocrinol.%26date%3D1981%26volume%3D88%26spage%3D173%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanizawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownstein, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okayama, H.</span><span> </span><span class="NLM_article-title">Structure and expression of a human oxytocin receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=1992&pages=526-529&author=T.+Kimuraauthor=O.+Tanizawaauthor=K.+Moriauthor=M.+J.+Brownsteinauthor=H.+Okayama&title=Structure+and+expression+of+a+human+oxytocin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DTanizawa%26aufirst%3DO.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DBrownstein%26aufirst%3DM.%2BJ.%26aulast%3DOkayama%26aufirst%3DH.%26atitle%3DStructure%2520and%2520expression%2520of%2520a%2520human%2520oxytocin%2520receptor%26jtitle%3DNature%26date%3D1992%26volume%3D356%26spage%3D526%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clineschmidt, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishel, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lis, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woyden, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haluska, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novy, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowensohn, R. I.</span><span> </span><span class="NLM_article-title">Identification of an orally active, nonpeptidyl oxytocin antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=8423533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaK3sXhtFKksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1993&pages=308-314&author=D.+J.+Pettiboneauthor=B.+V.+Clineschmidtauthor=M.+T.+Kishelauthor=E.+V.+Lisauthor=D.+R.+Reissauthor=C.+J.+Woydenauthor=B.+E.+Evansauthor=R.+M.+Freidingerauthor=D.+F.+Veberauthor=M.+J.+Cookauthor=G.+J.+Haluskaauthor=M.+J.+Novyauthor=R.+I.+Lowensohn&title=Identification+of+an+orally+active%2C+nonpeptidyl+oxytocin+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an orally active, nonpeptidyl oxytocin antagonist</span></div><div class="casAuthors">Pettibone, D. J.; Clineschmidt, B. V.; Kishel, M. T.; Lis, E. V.; Reiss, D. R.; Woyden, C. J.; Evans, B. E.; Freidinger, R. M.; Veber, D. F.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">264</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">308-14</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">L-366,509 (I), a member of a novel class of nonpeptidyl compds., has been characterized as an orally active oxytocin (OT) antagonist.  L-366,509 exhibits a moderate binding affinity (Ki values, 370-780 nM) for the rat, rhesus and human uterine OT receptor.  L-366,509 also binds to vasopressin receptor subtypes (arginine vasopressin-V1 and V2) with measurable affinity in rat (Ki values, 25-30 μM) and primate (Ki values, 2-6 μM) tissues.  In rat uterine slices, L-366,509 inhibits (IC50 = 1.6 μM) the stimulation of phosphatidylinositol turnover induced by OT but not bradykinin.  In the rat isolated uterus, L-366,509 is a competitive and reversible OT antagonist (pA2 = 7.32).  In vitro, L-366,509 given i.v. (10 mg/kg) or intraduodenally (10-50 mg/kg) to rats causes a marked and long-lasting inhibition of OT-stimulated uterine activity.  OT antagonist activity in a pregnant rhesus macaque (∼day 135 gestation) is also obsd. with L-366,509 after i.v. or p.o. dosing.  L-366,509 represents a prototype for a new chem. class of OT antagonists with significant p.o. bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8VfFkVEYgCLVg90H21EOLACvtfcHk0lh0hWKFgLlIUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtFKksr4%253D&md5=c1b187aaed0a7cf3818b5d8bd55cba75</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DKishel%26aufirst%3DM.%2BT.%26aulast%3DLis%26aufirst%3DE.%2BV.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DWoyden%26aufirst%3DC.%2BJ.%26aulast%3DEvans%26aufirst%3DB.%2BE.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DCook%26aufirst%3DM.%2BJ.%26aulast%3DHaluska%26aufirst%3DG.%2BJ.%26aulast%3DNovy%26aufirst%3DM.%2BJ.%26aulast%3DLowensohn%26aufirst%3DR.%2BI.%26atitle%3DIdentification%2520of%2520an%2520orally%2520active%252C%2520nonpeptidyl%2520oxytocin%2520antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1993%26volume%3D264%26spage%3D308%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Evans, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leighton, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPardo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber., D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clineschmidt, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span> </span><span class="NLM_article-title">Orally active, nonpeptide oxytocin antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">3919</span><span class="NLM_x">–</span> <span class="NLM_lpage">3927</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00099a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaK38XlvFWltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=3919-3927&author=B.+E.+Evansauthor=J.+L.+Leightonauthor=K.+E.+Rittleauthor=K.+F.+Gilbertauthor=G.+F.+Lundellauthor=N.+P.+Gouldauthor=D.+W.+Hobbsauthor=R.+M.+DiPardoauthor=D.+F.+Veber.author=D.+J.+Pettiboneauthor=B.+V.+Clineschmidtauthor=P.+S.+Andersonauthor=R.+M.+Freidinger&title=Orally+active%2C+nonpeptide+oxytocin+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Orally active, nonpeptide oxytocin antagonists</span></div><div class="casAuthors">Evans, Ben E.; Leighton, James L.; Rittle, Kenneth E.; Gilbert, Kevin F.; Lundell, George F.; Gould, Norman P.; Hobbs, Doug W.; DiPardo, Robert M.; Veber, Daniel F.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3919-27</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Spiroindenepiperidines, including I, were prepd. as orally bioavailable oxytocin antagonists; I showed good in vivo duration.  The potential use of these agents for treatment of preterm labor and their significance as new nonpeptide ligands for peptide receptors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFxnwaKxipsrVg90H21EOLACvtfcHk0lh0hWKFgLlIUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvFWltrY%253D&md5=b6b67125432c382fe7d8861f04666a38</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00099a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00099a020%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DB.%2BE.%26aulast%3DLeighton%26aufirst%3DJ.%2BL.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DLundell%26aufirst%3DG.%2BF.%26aulast%3DGould%26aufirst%3DN.%2BP.%26aulast%3DHobbs%26aufirst%3DD.%2BW.%26aulast%3DDiPardo%26aufirst%3DR.%2BM.%26aulast%3DVeber.%26aufirst%3DD.%2BF.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26atitle%3DOrally%2520active%252C%2520nonpeptide%2520oxytocin%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D3919%26epage%3D3927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, S.-H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clineschmidt, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundell, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawluczyk, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlow, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitzenberger, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span> </span><span class="NLM_article-title">1-((7,7-Dimethyl-2(<i>S</i>)-(2(<i>S</i>)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(<i>S</i>)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00031a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=565-571&author=P.+D.+Williamsauthor=P.+S.+Andersonauthor=R.+G.+Ballauthor=M.+G.+Bockauthor=L.+A.+Carrollauthor=S.-H.+L.+Chiuauthor=B.+V.+Clineschmidtauthor=J.+C.+Culbersonauthor=J.+M.+Erbauthor=B.+E.+Evansauthor=S.+L.+Fitzpatrickauthor=R.+M.+Freidingerauthor=M.+J.+Kaufmanauthor=G.+F.+Lundellauthor=J.+S.+Murphyauthor=J.+M.+Pawluczykauthor=D.+S.+Perlowauthor=D.+J.+Pettiboneauthor=S.+M.+Pitzenbergerauthor=K.+L.+Thompsonauthor=D.+F.+Veber&title=1-%28%287%2C7-Dimethyl-2%28S%29-%282%28S%29-amino-4-%28methylsulfonyl%29butyramido%29bicyclo+%5B2.2.1%5D-heptan-1%28S%29-yl%29methyl%29sulfonyl%29-4-%282-methylphenyl%29piperazine+%28L-368%2C899%29%3A+an+orally+bioavailable%2C+non-peptide+oxytocin+antagonist+with+potential+utility+for+managing+preterm+labor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm00031a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00031a004%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DAnderson%26aufirst%3DP.%2BS.%26aulast%3DBall%26aufirst%3DR.%2BG.%26aulast%3DBock%26aufirst%3DM.%2BG.%26aulast%3DCarroll%26aufirst%3DL.%2BA.%26aulast%3DChiu%26aufirst%3DS.-H.%2BL.%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DCulberson%26aufirst%3DJ.%2BC.%26aulast%3DErb%26aufirst%3DJ.%2BM.%26aulast%3DEvans%26aufirst%3DB.%2BE.%26aulast%3DFitzpatrick%26aufirst%3DS.%2BL.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DKaufman%26aufirst%3DM.%2BJ.%26aulast%3DLundell%26aufirst%3DG.%2BF.%26aulast%3DMurphy%26aufirst%3DJ.%2BS.%26aulast%3DPawluczyk%26aufirst%3DJ.%2BM.%26aulast%3DPerlow%26aufirst%3DD.%2BS.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DPitzenberger%26aufirst%3DS.%2BM.%26aulast%3DThompson%26aufirst%3DK.%2BL.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26atitle%3D1-%2528%25287%252C7-Dimethyl-2%2528S%2529-%25282%2528S%2529-amino-4-%2528methylsulfonyl%2529butyramido%2529bicyclo%2520%255B2.2.1%255D-heptan-1%2528S%2529-yl%2529methyl%2529sulfonyl%2529-4-%25282-methylphenyl%2529piperazine%2520%2528L-368%252C899%2529%253A%2520an%2520orally%2520bioavailable%252C%2520non-peptide%2520oxytocin%2520antagonist%2520with%2520potential%2520utility%2520for%2520managing%2520preterm%2520labor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D565%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clineschmidt, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidotti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lis, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woyden, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, S.-H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schorn, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegl, P. K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cukierski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haluska, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novy, M. J.</span><span> </span><span class="NLM_article-title">L-368,899, a potent orally active oxytocin antagonist for potential use in preterm labor</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1993&pages=129-142&author=D.+J.+Pettiboneauthor=B.+V.+Clineschmidtauthor=M.+T.+Guidottiauthor=E.+V.+Lisauthor=D.+R.+Reissauthor=C.+J.+Woydenauthor=M.+G.+Bockauthor=B.+E.+Evansauthor=R.+M.+Freidingerauthor=D.+W.+Hobbsauthor=D.+F.+Veberauthor=P.+D.+Williamsauthor=S.-H.+L.+Chiuauthor=K.+L.+Thompsonauthor=T.+W.+Schornauthor=P.+K.+S.+Sieglauthor=M.+J.+Kaufmanauthor=M.+A.+Cukierskiauthor=S.+J.+Haluskaauthor=M.+J.+Cookauthor=M.+J.+Novy&title=L-368%2C899%2C+a+potent+orally+active+oxytocin+antagonist+for+potential+use+in+preterm+labor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DGuidotti%26aufirst%3DM.%2BT.%26aulast%3DLis%26aufirst%3DE.%2BV.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DWoyden%26aufirst%3DC.%2BJ.%26aulast%3DBock%26aufirst%3DM.%2BG.%26aulast%3DEvans%26aufirst%3DB.%2BE.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DHobbs%26aufirst%3DD.%2BW.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DChiu%26aufirst%3DS.-H.%2BL.%26aulast%3DThompson%26aufirst%3DK.%2BL.%26aulast%3DSchorn%26aufirst%3DT.%2BW.%26aulast%3DSiegl%26aufirst%3DP.%2BK.%2BS.%26aulast%3DKaufman%26aufirst%3DM.%2BJ.%26aulast%3DCukierski%26aufirst%3DM.%2BA.%26aulast%3DHaluska%26aufirst%3DS.%2BJ.%26aulast%3DCook%26aufirst%3DM.%2BJ.%26aulast%3DNovy%26aufirst%3DM.%2BJ.%26atitle%3DL-368%252C899%252C%2520a%2520potent%2520orally%2520active%2520oxytocin%2520antagonist%2520for%2520potential%2520use%2520in%2520preterm%2520labor%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1993%26volume%3D30%26spage%3D129%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Egerman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougherty, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capra, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staub, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winchell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constanzer, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catroneo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caritis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibai, B.</span><span> </span><span class="NLM_article-title">The oxytocin receptor antagonist L-368,899 inhibits stimulated uterine contractions in women during the post partum period (Abstract)</span> <span class="citation_source-journal">Am. J. Obstet. Gynecol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=1995&pages=414&author=R.+Egermanauthor=M.+G.+Murphyauthor=E.+Doughertyauthor=N.+Capraauthor=T.+Staubauthor=G.+Winchellauthor=M.+L.+Constanzerauthor=C.+Chavezauthor=N.+Meyerauthor=M.+Catroneoauthor=S.+Caritisauthor=B.+Sibai&title=The+oxytocin+receptor+antagonist+L-368%2C899+inhibits+stimulated+uterine+contractions+in+women+during+the+post+partum+period+%28Abstract%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEgerman%26aufirst%3DR.%26aulast%3DMurphy%26aufirst%3DM.%2BG.%26aulast%3DDougherty%26aufirst%3DE.%26aulast%3DCapra%26aufirst%3DN.%26aulast%3DStaub%26aufirst%3DT.%26aulast%3DWinchell%26aufirst%3DG.%26aulast%3DConstanzer%26aufirst%3DM.%2BL.%26aulast%3DChavez%26aufirst%3DC.%26aulast%3DMeyer%26aufirst%3DN.%26aulast%3DCatroneo%26aufirst%3DM.%26aulast%3DCaritis%26aufirst%3DS.%26aulast%3DSibai%26aufirst%3DB.%26atitle%3DThe%2520oxytocin%2520receptor%2520antagonist%2520L-368%252C899%2520inhibits%2520stimulated%2520uterine%2520contractions%2520in%2520women%2520during%2520the%2520post%2520partum%2520period%2520%2528Abstract%2529%26jtitle%3DAm.%2520J.%2520Obstet.%2520Gynecol.%26date%3D1995%26volume%3D172%26spage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Chiu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvaro, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huskey, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span> </span><span class="NLM_article-title">The role of drug metabolism in drug discovery: a case study in the selection of an oxytocin receptor antagonist for development</span> <span class="citation_source-journal">Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1177%2F019262339502300204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=7569665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADyaK2MXlslCqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1995&pages=124-130&author=S.+H.+Chiuauthor=K.+A.+Thompsonauthor=S.+H.+Vincentauthor=R.+F.+Alvaroauthor=S.+W.+Huskeyauthor=R.+A.+Stearnsauthor=D.+J.+Pettibone&title=The+role+of+drug+metabolism+in+drug+discovery%3A+a+case+study+in+the+selection+of+an+oxytocin+receptor+antagonist+for+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The role of drug metabolism in drug discovery: a case study in the selection of an oxytocin receptor antagonist for development</span></div><div class="casAuthors">Chiu, Shuet-Hing L.; Thompson, Katherine A.; Vincent, Stella H.; Alvaro, Raul F.; Huskey, Su-Er W.; Stearns, Ralph A.; Pettibone, Douglas J.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-30</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    </div><div class="casAbstract">Drug discovery is a process involving multiple disciplines and interests.  During the research phase of drug discovery, usually a large no. of compds. are evaluated for biol. activity and toxicol. potential in animal species.  Various types of problems with respect to pharmacodynamics, pharmacokinetics, and toxicity are commonly encountered at this stage.  Drug metab., as a discipline participating in a drug discovery team, can play an important role in identifying factors underlying the problems, facilitate the optimal selection of compds. for further development, provide information on metabolites for possible improvement in drug design, and contribute to the identification of the appropriate animal species for subsequent toxicity testing.  During the process of evaluating oxytocin receptor antagonists for further development for treatment of preterm labor, in vivo and in vitro drug metab. studies conducted in rats, dogs, and monkeys contributed to the selection of L-368,899 as the development candidate on the basis of pharmacokinetic and metab. observations.  The presence of active N-demethylated metabolites of two other equipotent compds. in rats and dogs was found to be the major factor responsible for the discrepancy between oral bioavailability and efficacies obsd. for these 2 compds.  For L-368,899, a compd. that demonstrated 20-40% oral bioavailability in rats, dogs, and chimpanzees, extensive first-pass metab. rather than absorption was detd. as the major factor responsible for the poor bioavailability (<1%) in rhesus monkeys.  In vitro metab. studies with hepatic microsomes from rats, dogs, monkeys, and humans substantiated the conclusion that the rate of hepatic metab. of L-368,899 in monkeys is faster than in the other species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9bHtGrwarc7Vg90H21EOLACvtfcHk0li7ouMWzy6gTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlslCqtb4%253D&md5=5f1931284e8c5bb88b4838a79bfe113b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1177%2F019262339502300204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F019262339502300204%26sid%3Dliteratum%253Aachs%26aulast%3DChiu%26aufirst%3DS.%2BH.%26aulast%3DThompson%26aufirst%3DK.%2BA.%26aulast%3DVincent%26aufirst%3DS.%2BH.%26aulast%3DAlvaro%26aufirst%3DR.%2BF.%26aulast%3DHuskey%26aufirst%3DS.%2BW.%26aulast%3DStearns%26aufirst%3DR.%2BA.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520role%2520of%2520drug%2520metabolism%2520in%2520drug%2520discovery%253A%2520a%2520case%2520study%2520in%2520the%2520selection%2520of%2520an%2520oxytocin%2520receptor%2520antagonist%2520for%2520development%26jtitle%3DToxicol.%2520Pathol.%26date%3D1995%26volume%3D23%26spage%3D124%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Boccia, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goursaud, A. P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachevalier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, C. A.</span><span> </span><span class="NLM_article-title">Peripherally administered non-peptide oxytocin antagonist, L368,899, accumulates in limbic brain areas: a new pharmacological tool for the study of social motivation in non-human primates</span> <span class="citation_source-journal">Horm. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1016%2Fj.yhbeh.2007.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=17583705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFKis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2007&pages=344-351&author=M.+L.+Bocciaauthor=A.+P.+S.+Goursaudauthor=J.+Bachevalierauthor=K.+D.+Andersonauthor=C.+A.+Pedersen&title=Peripherally+administered+non-peptide+oxytocin+antagonist%2C+L368%2C899%2C+accumulates+in+limbic+brain+areas%3A+a+new+pharmacological+tool+for+the+study+of+social+motivation+in+non-human+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Peripherally administered non-peptide oxytocin antagonist, L368,899, accumulates in limbic brain areas: A new pharmacological tool for the study of social motivation in non-human primates</span></div><div class="casAuthors">Boccia, Maria L.; Goursaud, Anne-Pierre S.; Bachevalier, Jocelyne; Anderson, Kenneth D.; Pedersen, Cort A.</div><div class="citationInfo"><span class="NLM_cas:title">Hormones and Behavior</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-351</span>CODEN:
                <span class="NLM_cas:coden">HOBEAO</span>;
        ISSN:<span class="NLM_cas:issn">0018-506X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Central administration of oxytocin (OT) antagonists inhibits maternal and sexual behavior in non-primates, providing the strongest exptl. evidence that endogenous OT facilitates these behaviors.  While there have been a few reports that ICV administration of OT increases social behaviors in monkeys, no studies to date have assessed the effects of OT antagonists.  Therefore, we studied in rhesus monkeys whether L368,899 a non-peptide antagonist produced by Merck that selectively blocks the human uterine OT receptor, penetrates the CNS after peripheral administration and alters female maternal and sexual behavior.  In two studies in four male monkeys, L368,899 was injected iv (1 mg/kg) after which (1) CSF samples were collected at intervals over 4 h and (2) brains were collected at 60 min.  Assay of samples confirmed that iv-administered L368,899 entered CSF and accumulated in the hypothalamus, septum, orbitofrontal cortex, amygdala and hippocampus, but not other areas.  An adult female monkey was tested for interest in either an infant or sexual behavior, receiving a different iv treatment prior to each test (1 or 3 mg/kg of L368,899 or saline).  OT antagonist treatment reduced or eliminated interest in the infant and sexual behavior.  These results, although preliminary, are the first to directly implicate endogenous OT in activation of primate maternal interest and sexual behavior.  While it remains to be empirically demonstrated that peripherally administered L368,899 blocks central OT receptors, our behavioral findings suggest that this non-peptide antagonist may facilitate testing OT involvement in a variety of social and other behaviors in primates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXBQycmcApGrVg90H21EOLACvtfcHk0lhaVlLktXWUug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFKis7Y%253D&md5=90dcde56dec03719e61ca64b21774b00</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.yhbeh.2007.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yhbeh.2007.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DBoccia%26aufirst%3DM.%2BL.%26aulast%3DGoursaud%26aufirst%3DA.%2BP.%2BS.%26aulast%3DBachevalier%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DK.%2BD.%26aulast%3DPedersen%26aufirst%3DC.%2BA.%26atitle%3DPeripherally%2520administered%2520non-peptide%2520oxytocin%2520antagonist%252C%2520L368%252C899%252C%2520accumulates%2520in%2520limbic%2520brain%2520areas%253A%2520a%2520new%2520pharmacological%2520tool%2520for%2520the%2520study%2520of%2520social%2520motivation%2520in%2520non-human%2520primates%26jtitle%3DHorm.%2520Behav.%26date%3D2007%26volume%3D52%26spage%3D344%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clineschmidt, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidotti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lis, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawluczyk, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woyden, C. J.</span><span> </span><span class="NLM_article-title">1-(1-[4-[(<i>N</i>-Acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4-yl)-4<i>H</i>-3,1-benzoxazin-2(1<i>H</i>)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">4634</span><span class="NLM_x">–</span> <span class="NLM_lpage">4636</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00023a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=4634-4636&author=P.+D.+Williamsauthor=B.+V.+Clineschmidtauthor=J.+M.+Erbauthor=R.+M.+Freidingerauthor=M.+T.+Guidottiauthor=E.+V.+Lisauthor=J.+M.+Pawluczykauthor=D.+J.+Pettiboneauthor=D.+R.+Reissauthor=D.+F.+Veberauthor=C.+J.+Woyden&title=1-%281-%5B4-%5B%28N-Acetyl-4-piperidinyl%29oxy%5D-2-methoxybenzoyl%5Dpiperidin-4-yl%29-4H-3%2C1-benzoxazin-2%281H%29-one+%28L-371%2C257%29%3A+a+new%2C+orally+bioavailable%2C+non-peptide+oxytocin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00023a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00023a002%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DClineschmidt%26aufirst%3DB.%2BV.%26aulast%3DErb%26aufirst%3DJ.%2BM.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DGuidotti%26aufirst%3DM.%2BT.%26aulast%3DLis%26aufirst%3DE.%2BV.%26aulast%3DPawluczyk%26aufirst%3DJ.%2BM.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DWoyden%26aufirst%3DC.%2BJ.%26atitle%3D1-%25281-%255B4-%255B%2528N-Acetyl-4-piperidinyl%2529oxy%255D-2-methoxybenzoyl%255Dpiperidin-4-yl%2529-4H-3%252C1-benzoxazin-2%25281H%2529-one%2520%2528L-371%252C257%2529%253A%2520a%2520new%252C%2520orally%2520bioavailable%252C%2520non-peptide%2520oxytocin%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D4634%26epage%3D4636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guare, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidotti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halpin, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homnick, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lis, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathre, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawluczyk, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woyden, C. J.</span><span> </span><span class="NLM_article-title">Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2146</span><span class="NLM_x">–</span> <span class="NLM_lpage">2163</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9800797" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2146-2163&author=I.+M.+Bellauthor=J.+M.+Erbauthor=R.+M.+Freidingerauthor=S.+N.+Gallicchioauthor=J.+P.+Guareauthor=M.+T.+Guidottiauthor=R.+A.+Halpinauthor=D.+W.+Hobbsauthor=C.+F.+Homnickauthor=M.+S.+Kuoauthor=E.+V.+Lisauthor=D.+J.+Mathreauthor=S.+R.+Michelsonauthor=J.+M.+Pawluczykauthor=D.+J.+Pettiboneauthor=D.+R.+Reissauthor=S.+Vickersauthor=P.+D.+Williamsauthor=C.+J.+Woyden&title=Development+of+orally+active+oxytocin+antagonists%3A+studies+on+1-%281-%5B4-%5B1-%282-methyl-1-oxidopyridin-3-ylmethyl%29piperidin-4-yloxy%5D-2-+methoxybenzoyl%5Dpiperidin-4-yl%29-1%2C4-dihydrobenz%5Bd%5D%5B1%2C3%5Doxazin-2-one+%28L-372%2C662%29+and+related+pyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm9800797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9800797%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DErb%26aufirst%3DJ.%2BM.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DGallicchio%26aufirst%3DS.%2BN.%26aulast%3DGuare%26aufirst%3DJ.%2BP.%26aulast%3DGuidotti%26aufirst%3DM.%2BT.%26aulast%3DHalpin%26aufirst%3DR.%2BA.%26aulast%3DHobbs%26aufirst%3DD.%2BW.%26aulast%3DHomnick%26aufirst%3DC.%2BF.%26aulast%3DKuo%26aufirst%3DM.%2BS.%26aulast%3DLis%26aufirst%3DE.%2BV.%26aulast%3DMathre%26aufirst%3DD.%2BJ.%26aulast%3DMichelson%26aufirst%3DS.%2BR.%26aulast%3DPawluczyk%26aufirst%3DJ.%2BM.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DReiss%26aufirst%3DD.%2BR.%26aulast%3DVickers%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DWoyden%26aufirst%3DC.%2BJ.%26atitle%3DDevelopment%2520of%2520orally%2520active%2520oxytocin%2520antagonists%253A%2520studies%2520on%25201-%25281-%255B4-%255B1-%25282-methyl-1-oxidopyridin-3-ylmethyl%2529piperidin-4-yloxy%255D-2-%2520methoxybenzoyl%255Dpiperidin-4-yl%2529-1%252C4-dihydrobenz%255Bd%255D%255B1%252C3%255Doxazin-2-one%2520%2528L-372%252C662%2529%2520and%2520related%2520pyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2146%26epage%3D2163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Williams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bock, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freidinger, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span> </span><span class="NLM_article-title">Progress in the development of oxytocin antagonists for use in preterm labor</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">449</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=449&publication_year=1998&pages=473-479&author=P.+D.+Williamsauthor=M.+G.+Bockauthor=B.+E.+Evansauthor=R.+M.+Freidingerauthor=D.+J.+Pettibone&title=Progress+in+the+development+of+oxytocin+antagonists+for+use+in+preterm+labor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DP.%2BD.%26aulast%3DBock%26aufirst%3DM.%2BG.%26aulast%3DEvans%26aufirst%3DB.%2BE.%26aulast%3DFreidinger%26aufirst%3DR.%2BM.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520oxytocin%2520antagonists%2520for%2520use%2520in%2520preterm%2520labor%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1998%26volume%3D449%26spage%3D473%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Hawtin, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettibone, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheatley, M.</span><span> </span><span class="NLM_article-title">A Gly/Ala switch contributes to high affinity binding of benzoxazinone-based non-peptide oxytocin receptor antagonists</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">579</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2005&pages=349-356&author=S.+R.+Hawtinauthor=S.+N.+Haauthor=D.+J.+Pettiboneauthor=M.+Wheatley&title=A+Gly%2FAla+switch+contributes+to+high+affinity+binding+of+benzoxazinone-based+non-peptide+oxytocin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHawtin%26aufirst%3DS.%2BR.%26aulast%3DHa%26aufirst%3DS.%2BN.%26aulast%3DPettibone%26aufirst%3DD.%2BJ.%26aulast%3DWheatley%26aufirst%3DM.%26atitle%3DA%2520Gly%252FAla%2520switch%2520contributes%2520to%2520high%2520affinity%2520binding%2520of%2520benzoxazinone-based%2520non-peptide%2520oxytocin%2520receptor%2520antagonists%26jtitle%3DFEBS%2520Lett.%26date%3D2005%26volume%3D579%26spage%3D349%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilcott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordaunt, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woollard, P. M.</span><span> </span><span class="NLM_article-title">Identification of potent and selective oxytocin antagonists. Part 1: indole and benzofuran derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1399-1404&author=P.+G.+Wyattauthor=M.+J.+Allenauthor=J.+Chilcottauthor=A.+Fosterauthor=D.+G.+Livermoreauthor=J.+E.+Mordauntauthor=J.+Scicinskiauthor=P.+M.+Woollard&title=Identification+of+potent+and+selective+oxytocin+antagonists.+Part+1%3A+indole+and+benzofuran+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DChilcott%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DA.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DMordaunt%26aufirst%3DJ.%2BE.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DWoollard%26aufirst%3DP.%2BM.%26atitle%3DIdentification%2520of%2520potent%2520and%2520selective%2520oxytocin%2520antagonists.%2520Part%25201%253A%2520indole%2520and%2520benzofuran%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1399%26epage%3D1404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chilcott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordaunt, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nerozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perren, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weingarten, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woollard, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span> </span><span class="NLM_article-title">Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1405</span><span class="NLM_x">–</span> <span class="NLM_lpage">1411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1405-1411&author=P.+G.+Wyattauthor=M.+J.+Allenauthor=J.+Chilcottauthor=C.+Gardnerauthor=A.+Fosterauthor=D.+G.+Livermoreauthor=J.+E.+Mordauntauthor=F.+Nerozziauthor=M.+Patelauthor=M.+J.+Perrenauthor=G.+G.+Weingartenauthor=S.+Shabirauthor=P.+M.+Woollardauthor=P.+Zhou&title=Identification+of+potent+and+selective+oxytocin+antagonists.+Part+2%3A+further+investigation+of+benzofuran+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DChilcott%26aufirst%3DJ.%26aulast%3DGardner%26aufirst%3DC.%26aulast%3DFoster%26aufirst%3DA.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DMordaunt%26aufirst%3DJ.%2BE.%26aulast%3DNerozzi%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DPerren%26aufirst%3DM.%2BJ.%26aulast%3DWeingarten%26aufirst%3DG.%2BG.%26aulast%3DShabir%26aufirst%3DS.%26aulast%3DWoollard%26aufirst%3DP.%2BM.%26aulast%3DZhou%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520potent%2520and%2520selective%2520oxytocin%2520antagonists.%2520Part%25202%253A%2520further%2520investigation%2520of%2520benzofuran%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1405%26epage%3D1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ashton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittaker, M.</span><span> </span><span class="NLM_article-title">The selection and design of GPCR ligands: from concept to the clinic</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.2174%2F1386207043328607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=15320711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFegsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=441-452&author=M.+Ashtonauthor=M.+H.+Charltonauthor=M.+K.+Schwarzauthor=R.+J.+Thomasauthor=M.+Whittaker&title=The+selection+and+design+of+GPCR+ligands%3A+from+concept+to+the+clinic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The selection and design of GPCR ligands: From concept to the clinic</span></div><div class="casAuthors">Ashton, Mark; Charlton, Michael H.; Schwarz, Matthias K.; Thomas, Russell J.; Whittaker, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry and High Throughput Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">441-452</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Virtual screening methods using structure-based, pharmacophore-based and descriptor based protocols may be used to identify ligands for the G-protein coupled receptor target family.  A complementary approach is the synthesis and screening of compd. libraries designed using privileged motifs and/or based on validated hit mols.  A virtual screening approach based on mol. docking performed with GOLD using a templated homol. model and a consensus scoring procedure can identify vasopressin 1a receptor antagonists.  In a sep. project a library design and synthesis approach based around validated hit GPCR ligands led to the identification of potent oxytocin antagonists.  Subsequent optimization of the initial library compds. has provided compds. that are now being evaluated in the clinic for the treatment of preterm labor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZgujPxZO_XLVg90H21EOLACvtfcHk0ljS_CjNyI06UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFegsrg%253D&md5=603d8db3e597f1fafc727f52448add13</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F1386207043328607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1386207043328607%26sid%3Dliteratum%253Aachs%26aulast%3DAshton%26aufirst%3DM.%26aulast%3DCharlton%26aufirst%3DM.%2BH.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DThomas%26aufirst%3DR.%2BJ.%26aulast%3DWhittaker%26aufirst%3DM.%26atitle%3DThe%2520selection%2520and%2520design%2520of%2520GPCR%2520ligands%253A%2520from%2520concept%2520to%2520the%2520clinic%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2004%26volume%3D7%26spage%3D441%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Schwarz, M.; Page, P.; Pomel, V.; Quattropani, A.; Thomas, R. J.</span><span> </span><span class="NLM_article-title">Pyrrolidine oxidazaole and thiadiazole derivatives</span>. Patent WO 02102799,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=M.+Schwarz&author=P.+Page&author=V.+Pomel&author=A.+Quattropani&author=R.+J.+Thomas&title=Pyrrolidine+oxidazaole+and+thiadiazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarz%26aufirst%3DM.%26atitle%3DPyrrolidine%2520oxidazaole%2520and%2520thiadiazole%2520derivatives%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Cirillo., R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillio.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quattropani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missotten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorbais, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giachetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golzio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevillard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurent, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portet, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, A.</span><span> </span><span class="NLM_article-title">Pharmacology of (2<i>S</i>,4<i>Z</i>)-<i>N</i>-[(2<i>S</i>)-2-hydroxy-2-phenylethyl]-4-(methoxyimino)-1-[(2′-methyl[1,1′-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1124%2Fjpet.103.049395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=12660315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvF2lu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=253-61&author=R.+Cirillo.author=+Gillio.author=E.+Tosauthor=M.+K.+Schwarzauthor=A.+Quattropaniauthor=A.+Scheerauthor=M.+Missottenauthor=J.+Dorbaisauthor=A.+Nicholsauthor=F.+Borrelliauthor=C.+Giachettiauthor=L.+Golzioauthor=P.+Marinelliauthor=R.+J.+Thomasauthor=C.+Chevillardauthor=F.+Laurentauthor=K.+Portetauthor=C.+Barberisauthor=A.+Chollet&title=Pharmacology+of+%282S%2C4Z%29-N-%5B%282S%29-2-hydroxy-2-phenylethyl%5D-4-%28methoxyimino%29-1-%5B%282%E2%80%B2-methyl%5B1%2C1%E2%80%B2-biphenyl%5D-4-yl%29carbonyl%5D-2-pyrrolidinecarboxamide%2C+a+new+potent+and+selective+nonpeptide+antagonist+of+the+oxytocin+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino)-1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor</span></div><div class="casAuthors">Cirillo, Rocco; Tos, Enrico Gillio; Schwarz, Matthias K.; Quattropani, Anna; Scheer, Alexander; Missotten, Marc; Dorbais, Jerome; Nichols, Anthony; Borrelli, Francesco; Giachetti, Claudio; Golzio, Lucia; Marinelli, Paolo; Thomas, Russell J.; Chevillard, Claude; Laurent, Florence; Portet, Karine; Barberis, Claude; Chollet, Andre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">253-261</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We have discovered a new, potent, selective, and orally active oxytocin receptor antagonist, (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino)-1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide (I).  We report the biochem., pharmacol., and pharmacokinetic characterization in vitro and in vivo of this compd.  I competitively inhibits binding of [3H]oxytocin and the peptide antagonist 125I-ornithine vasotocin analog to human and rat oxytocin receptor expressed in human embryonic kidney 293-EBNA or Chinese hamster ovary cells with nanomolar potency.  Selectivity against vasopressin receptor subtypes is >6-fold for V1a and >350-fold for V2 and V1b.  I inhibits oxytocin-evoked intracellular Ca2+ mobilization (IC50 = 8 nM).  I has no intrinsic agonist activity at the oxytocin receptor.  Oxytocin-induced contraction of isolated rat uterine strips is blocked by I (pA2 = 7.82).  In anesthetized nonpregnant rats, single administration of I by i.v. or oral routes causes dose-dependent inhibition of contractions elicited by repeated injections of oxytocin with ED50 = 3.5 mg/kg i.v. and 89 mg/kg p.o., resp.  I significantly inhibits spontaneous uterine contractions in pregnant rats near term when administered i.v. or orally.  We conclude that I is a potent, selective, and orally active nonpeptide oxytocin receptor antagonist, which is a suitable candidate for evaluation as a potential tocolytic agent for the management of preterm labor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruo04G8lDiGrVg90H21EOLACvtfcHk0lgAOMZ5MZa1RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvF2lu7k%253D&md5=d00ce1eedf70a781fa47116af4749c87</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.049395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.049395%26sid%3Dliteratum%253Aachs%26aulast%3DCirillo.%26aufirst%3DR.%26aulast%3DGillio.%26aulast%3DTos%26aufirst%3DE.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26aulast%3DQuattropani%26aufirst%3DA.%26aulast%3DScheer%26aufirst%3DA.%26aulast%3DMissotten%26aufirst%3DM.%26aulast%3DDorbais%26aufirst%3DJ.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DBorrelli%26aufirst%3DF.%26aulast%3DGiachetti%26aufirst%3DC.%26aulast%3DGolzio%26aufirst%3DL.%26aulast%3DMarinelli%26aufirst%3DP.%26aulast%3DThomas%26aufirst%3DR.%2BJ.%26aulast%3DChevillard%26aufirst%3DC.%26aulast%3DLaurent%26aufirst%3DF.%26aulast%3DPortet%26aufirst%3DK.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DChollet%26aufirst%3DA.%26atitle%3DPharmacology%2520of%2520%25282S%252C4Z%2529-N-%255B%25282S%2529-2-hydroxy-2-phenylethyl%255D-4-%2528methoxyimino%2529-1-%255B%25282%25E2%2580%25B2-methyl%255B1%252C1%25E2%2580%25B2-biphenyl%255D-4-yl%2529carbonyl%255D-2-pyrrolidinecarboxamide%252C%2520a%2520new%2520potent%2520and%2520selective%2520nonpeptide%2520antagonist%2520of%2520the%2520oxytocin%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D253%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Jorand-Lebrun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valognes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorbais, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quattropani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, A.</span><span> </span><span class="NLM_article-title">Pyrrolidine ether derivatives of new oxytocin receptors antagonists</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. A</span><span class="NLM_x">) </span> <span class="NLM_fpage">P222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=P222&issue=Suppl.+A&author=C.+Jorand-Lebrunauthor=D.+Valognesauthor=M.+Schwarzauthor=J.+Dorbaisauthor=A.+Quattropaniauthor=A.+Chollet&title=Pyrrolidine+ether+derivatives+of+new+oxytocin+receptors+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJorand-Lebrun%26aufirst%3DC.%26aulast%3DValognes%26aufirst%3DD.%26aulast%3DSchwarz%26aufirst%3DM.%26aulast%3DDorbais%26aufirst%3DJ.%26aulast%3DQuattropani%26aufirst%3DA.%26aulast%3DChollet%26aufirst%3DA.%26atitle%3DPyrrolidine%2520ether%2520derivatives%2520of%2520new%2520oxytocin%2520receptors%2520antagonists%26jtitle%3DDrugs%2520Future%26date%3D2004%26volume%3D29%26issue%3DSuppl.%2520A%26spage%3DP222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Foulon, L.; Garcia, G.; Serradeil-Le Gal, C.; Valette, G.</span><span> </span><span class="NLM_article-title">Indolin-2-one derivatives, preparation and their use as oxytocin receptor ligands</span> Patent WO2001074775(A1),<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=L.+Foulon&author=G.+Garcia&author=C.+Serradeil-Le+Gal&author=G.+Valette&title=Indolin-2-one+derivatives%2C+preparation+and+their+use+as+oxytocin+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFoulon%26aufirst%3DL.%26atitle%3DIndolin-2-one%2520derivatives%252C%2520preparation%2520and%2520their%2520use%2520as%2520oxytocin%2520receptor%2520ligands%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Serradeil-Le Gal, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valette, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foulon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Advenier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naline, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinolle, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouzet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raufaste, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double-Cazanave, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scatton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffrand, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Fur, G.</span><span> </span><span class="NLM_article-title">SSR126768A (4-chloro-3-[3<i>R</i>)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1<i>H</i>-indol-3-yl]-<i>N</i>-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1124%2Fjpet.103.061200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=14722330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A280%3ADC%252BD2c7lsVyitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=414-424&author=C.+Serradeil-Le+Galauthor=G.+Valetteauthor=L.+Foulonauthor=G.+Germainauthor=C.+Advenierauthor=E.+Nalineauthor=M.+Bardouauthor=J.+P.+Martinolleauthor=B.+Pouzetauthor=D.+Raufasteauthor=C.+Garciaauthor=E.+Double-Cazanaveauthor=M.+Paulyauthor=M.+Pascalauthor=A.+Barbierauthor=B.+Scattonauthor=J.+P.+Maffrandauthor=G.+Le+Fur&title=SSR126768A+%284-chloro-3-%5B3R%29-%28%2B%29-5-chloro-1-%282%2C4-dimethoxybenzyl%29-3-methyl-2-oxo-2%2C3-dihydro-1H-indol-3-yl%5D-N-%283-pyridylmethyl%29-benzamide%2C+hydrochloride%29%3A+a+new+selective+and+orally+active+oxytocin+receptor+antagonist+for+the+prevention+of+preterm+labor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor</span></div><div class="casAuthors">Serradeil-Le Gal Claudine; Valette Gerard; Foulon Loic; Germain Guy; Advenier Charles; Naline Emmanuel; Bardou Marc; Martinolle Jean-Pierre; Pouzet Brigitte; Raufaste Danielle; Garcia Corinne; Double-Cazanave Eleonore; Pauly Maxime; Pascal Marc; Barbier Alain; Scatton Bernard; Maffrand Jean-Pierre; Le Fur Gerard</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">414-24</span>
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)benzamide, hydrochloride (SSR126768A), a new potent and selective, orally active oxytocin (OT) receptor antagonist was characterized in several biochemical and pharmacological models.  In binding studies, SSR126768A showed nanomolar affinity for rat and human recombinant and native OT receptors (K(i) = 0.44 nM) and exhibited much lower affinity for V(1a), V(1b), and V(2) receptors.  In addition, it did not interact with a large number of other receptors, enzymes, and ion channels (1 microM).  In autoradiographic experiments performed on at-term human pregnant uterus sections, SSR126768A dose dependently displaced [I(125)]d(CH(2))(5)[Tyr(Me)(2), Thr(4), Orn(8) (125)I-Tyr-NH(2)(9)]VT in situ labeling to OT receptors highly expressed in these tissues.  In functional studies, SSR126768A behaved as a full antagonist and potently antagonized OT-induced intracellular Ca(2+) increase (K(i) = 0.50 nM) and prostaglandin release (K(i) = 0.45 nM) in human uterine smooth muscle cells.  In rat isolated myometrium, OT-induced uterine contractions were competitively antagonized by SSR126768A (pA(2) = 8.47).  Similarly, in human pregnant myometrial strips, SSR126768A inhibited the contractile uterine response to OT.  In conscious telemetrated rats, oral administration of SSR126768A (1-10 mg/kg) produced a competitive inhibition of the dose response to OT on uterine contractions up to 24 h at 3 mg/kg p.o.; no tachyphylaxis was observed after 4-day repeated treatment.  Finally, SSR126768A (30 mg/kg p.o.) significantly delayed parturition in pregnant rats in labor similar to ritodrine (10 mg/kg p.o.).  Thus, SSR126768A is a potent, highly selective, orally active OT receptor antagonist with a long duration of action.  This molecule could find therapeutic application as a tocolytic agent for acute and chronic oral management of preterm labor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6iUVbkwozC5dYoSR9eyvsfW6udTcc2ebflWtL6b10H7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7lsVyitQ%253D%253D&md5=136e693c816a368597799687f167dc0a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.061200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.061200%26sid%3Dliteratum%253Aachs%26aulast%3DSerradeil-Le%2BGal%26aufirst%3DC.%26aulast%3DValette%26aufirst%3DG.%26aulast%3DFoulon%26aufirst%3DL.%26aulast%3DGermain%26aufirst%3DG.%26aulast%3DAdvenier%26aufirst%3DC.%26aulast%3DNaline%26aufirst%3DE.%26aulast%3DBardou%26aufirst%3DM.%26aulast%3DMartinolle%26aufirst%3DJ.%2BP.%26aulast%3DPouzet%26aufirst%3DB.%26aulast%3DRaufaste%26aufirst%3DD.%26aulast%3DGarcia%26aufirst%3DC.%26aulast%3DDouble-Cazanave%26aufirst%3DE.%26aulast%3DPauly%26aufirst%3DM.%26aulast%3DPascal%26aufirst%3DM.%26aulast%3DBarbier%26aufirst%3DA.%26aulast%3DScatton%26aufirst%3DB.%26aulast%3DMaffrand%26aufirst%3DJ.%2BP.%26aulast%3DLe%2BFur%26aufirst%3DG.%26atitle%3DSSR126768A%2520%25284-chloro-3-%255B3R%2529-%2528%252B%2529-5-chloro-1-%25282%252C4-dimethoxybenzyl%2529-3-methyl-2-oxo-2%252C3-dihydro-1H-indol-3-yl%255D-N-%25283-pyridylmethyl%2529-benzamide%252C%2520hydrochloride%2529%253A%2520a%2520new%2520selective%2520and%2520orally%2520active%2520oxytocin%2520receptor%2520antagonist%2520for%2520the%2520prevention%2520of%2520preterm%2520labor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D414%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Quattropani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorbais, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pittet, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colovray, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxhead, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halazy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missotten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayala, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradshaw, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Raemy-Schenk, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tos, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giachetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golzio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Church, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, M. K.</span><span> </span><span class="NLM_article-title">Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7882</span><span class="NLM_x">–</span> <span class="NLM_lpage">7905</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050645f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7882-7905&author=A.+Quattropaniauthor=J.+Dorbaisauthor=D.+Coviniauthor=P.-A.+Pittetauthor=V.+Colovrayauthor=R.+J.+Thomasauthor=R.+Coxheadauthor=S.+Halazyauthor=A.+Scheerauthor=M.+Missottenauthor=G.+Ayalaauthor=C.+Bradshawauthor=A.-M.+De+Raemy-Schenkauthor=A.+Nicholsauthor=R.+Cirilloauthor=E.+G.+Tosauthor=C.+Giachettiauthor=L.+Golzioauthor=P.+Marinelliauthor=D.+J.+Churchauthor=C.+Barberisauthor=A.+Cholletauthor=M.+K.+Schwarz&title=Discovery+and+development+of+a+new+class+of+potent%2C+selective%2C+orally+active+oxytocin+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm050645f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050645f%26sid%3Dliteratum%253Aachs%26aulast%3DQuattropani%26aufirst%3DA.%26aulast%3DDorbais%26aufirst%3DJ.%26aulast%3DCovini%26aufirst%3DD.%26aulast%3DPittet%26aufirst%3DP.-A.%26aulast%3DColovray%26aufirst%3DV.%26aulast%3DThomas%26aufirst%3DR.%2BJ.%26aulast%3DCoxhead%26aufirst%3DR.%26aulast%3DHalazy%26aufirst%3DS.%26aulast%3DScheer%26aufirst%3DA.%26aulast%3DMissotten%26aufirst%3DM.%26aulast%3DAyala%26aufirst%3DG.%26aulast%3DBradshaw%26aufirst%3DC.%26aulast%3DDe%2BRaemy-Schenk%26aufirst%3DA.-M.%26aulast%3DNichols%26aufirst%3DA.%26aulast%3DCirillo%26aufirst%3DR.%26aulast%3DTos%26aufirst%3DE.%2BG.%26aulast%3DGiachetti%26aufirst%3DC.%26aulast%3DGolzio%26aufirst%3DL.%26aulast%3DMarinelli%26aufirst%3DP.%26aulast%3DChurch%26aufirst%3DD.%2BJ.%26aulast%3DBarberis%26aufirst%3DC.%26aulast%3DChollet%26aufirst%3DA.%26aulast%3DSchwarz%26aufirst%3DM.%2BK.%26atitle%3DDiscovery%2520and%2520development%2520of%2520a%2520new%2520class%2520of%2520potent%252C%2520selective%252C%2520orally%2520active%2520oxytocin%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7882%26epage%3D7905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Barton, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellenie, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvagno, C. M.</span><span> </span><span class="NLM_article-title">Discovery and optimization of a potent and selective tertiary sulfonamide oxytocin antagonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=528-532&author=N.+P.+Bartonauthor=B.+R.+Bellenieauthor=A.+T.+Doranauthor=A.+J.+Emmonsauthor=J.+P.+Heerauthor=C.+M.+Salvagno&title=Discovery+and+optimization+of+a+potent+and+selective+tertiary+sulfonamide+oxytocin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarton%26aufirst%3DN.%2BP.%26aulast%3DBellenie%26aufirst%3DB.%2BR.%26aulast%3DDoran%26aufirst%3DA.%2BT.%26aulast%3DEmmons%26aufirst%3DA.%2BJ.%26aulast%3DHeer%26aufirst%3DJ.%2BP.%26aulast%3DSalvagno%26aufirst%3DC.%2BM.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520potent%2520and%2520selective%2520tertiary%2520sulfonamide%2520oxytocin%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D528%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Kakefuda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.</span><span> </span><span class="NLM_article-title">Discovery of 4,5-diphenyl-1,2,4-triazole derivatives as a novel class of selective antagonists for the human V(1A) receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1905</span><span class="NLM_x">–</span> <span class="NLM_lpage">1912</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=1905-1912&author=A.+Kakefudaauthor=T.+Suzukiauthor=T.+Tobeauthor=A.+Taharaauthor=S.+Sakamotoauthor=S.+Tsukamoto&title=Discovery+of+4%2C5-diphenyl-1%2C2%2C4-triazole+derivatives+as+a+novel+class+of+selective+antagonists+for+the+human+V%281A%29+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKakefuda%26aufirst%3DA.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DTobe%26aufirst%3DT.%26aulast%3DTahara%26aufirst%3DA.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DTsukamoto%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25204%252C5-diphenyl-1%252C2%252C4-triazole%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520selective%2520antagonists%2520for%2520the%2520human%2520V%25281A%2529%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D1905%26epage%3D1912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Brown, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puhalo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, L.</span><span> </span><span class="NLM_article-title">Design and optimization of potent, selective antagonists of oxytocin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4278</span><span class="NLM_x">–</span> <span class="NLM_lpage">4281</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4278-4281&author=A.+Brownauthor=L.+Brownauthor=D.+Ellisauthor=N.+Puhaloauthor=C.+R.+Smithauthor=O.+Wallaceauthor=L.+Watson&title=Design+and+optimization+of+potent%2C+selective+antagonists+of+oxytocin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DPuhalo%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DC.%2BR.%26aulast%3DWallace%26aufirst%3DO.%26aulast%3DWatson%26aufirst%3DL.%26atitle%3DDesign%2520and%2520optimization%2520of%2520potent%252C%2520selective%2520antagonists%2520of%2520oxytocin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4278%26epage%3D4281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZTh5Hnv1Itorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: a lipophilic efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB%282%29+agonists+using+parallel+synthesis+protocols%3A+a+lipophilic+efficiency+%28LipE%29+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0lgzEd4dIIbnvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB%25282%2529%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520a%2520lipophilic%2520efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Brown, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puhalo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, L.5.</span><span> </span><span class="NLM_article-title">Triazole oxytocin antagonists: identification of aryl ether replacements for a biaryl substituent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5242</span><span class="NLM_x">–</span> <span class="NLM_lpage">5244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm901812z&amp;key=10.1016%2Fj.bmcl.2008.08.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm901812z&amp;key=18778939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm901812z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFert7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5242-5244&author=A.+Brownauthor=L.+Brownauthor=T.+B.+Brownauthor=A.+Calabreseauthor=D.+Ellisauthor=N.+Puhaloauthor=C.+R.+Smithauthor=O.+Wallaceauthor=L.5.+Watson&title=Triazole+oxytocin+antagonists%3A+identification+of+aryl+ether+replacements+for+a+biaryl+substituent"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Triazole oxytocin antagonists: Identification of aryl ether replacements for a biaryl substituent</span></div><div class="casAuthors">Brown, Alan; Brown, Lindsay; Brown, T. Bruce; Calabrese, Andrew; Ellis, Dave; Puhalo, Nicholas; Smith, Chris R.; Wallace, Olga; Watson, Lesa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5242-5244</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Several potent aryl ether/triazole oxytocin antagonists are described.  The lead compd. in this series had significantly improved aq. soly. over related systems contg. a biaryl substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8262GdEWJdbVg90H21EOLACvtfcHk0lhWG5Hb_PRptw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFert7%252FE&md5=c7c71c5defecf0626e40639296846116</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.08.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.08.066%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DBrown%26aufirst%3DT.%2BB.%26aulast%3DCalabrese%26aufirst%3DA.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DPuhalo%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DC.%2BR.%26aulast%3DWallace%26aufirst%3DO.%26aulast%3DWatson%26aufirst%3DL.5.%26atitle%3DTriazole%2520oxytocin%2520antagonists%253A%2520identification%2520of%2520aryl%2520ether%2520replacements%2520for%2520a%2520biaryl%2520substituent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5242%26epage%3D5244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Brown, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puhalo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, L.</span><span> </span><span class="NLM_article-title">Triazole oxytocin antagonists: identification of an aryloxyazetidine replacement for a biaryl substituent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=516-520&author=A.+Brownauthor=T.+B.+Brownauthor=A.+Calabreseauthor=D.+Ellisauthor=N.+Puhaloauthor=M.+Ralphauthor=L.+Watson&title=Triazole+oxytocin+antagonists%3A+identification+of+an+aryloxyazetidine+replacement+for+a+biaryl+substituent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DT.%2BB.%26aulast%3DCalabrese%26aufirst%3DA.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DPuhalo%26aufirst%3DN.%26aulast%3DRalph%26aufirst%3DM.%26aulast%3DWatson%26aufirst%3DL.%26atitle%3DTriazole%2520oxytocin%2520antagonists%253A%2520identification%2520of%2520an%2520aryloxyazetidine%2520replacement%2520for%2520a%2520biaryl%2520substituent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D516%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Brown, A.</span><span> </span><span class="NLM_article-title">Identification and optimization of triazole oxytocin antagonists, leading to a clinical candidate</span>. Presented at the <span class="NLM_conf-name">15th RSC-SCI Medicinal Chemistry Symposium</span>, <span class="NLM_conf-loc">Cambridge, UK</span>, <span class="NLM_conf-date">6−9 September, 2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Brown%2C+A.+Identification+and+optimization+of+triazole+oxytocin+antagonists%2C+leading+to+a+clinical+candidate.+Presented+at+the+15th+RSC-SCI+Medicinal+Chemistry+Symposium%2C+Cambridge%2C+UK%2C+6%E2%88%929+September%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DA.%26atitle%3DIdentification%2520and%2520optimization%2520of%2520triazole%2520oxytocin%2520antagonists%252C%2520leading%2520to%2520a%2520clinical%2520candidate" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borthwick, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exall, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatley, R. J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irving, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nerozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span> </span><span class="NLM_article-title">2,5-Diketopiperazines as potent and selective oxytocin antagonists. 1: Identification, stereochemistry and initial SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2579</span><span class="NLM_x">–</span> <span class="NLM_lpage">2582</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2579-2582&author=P.+G.+Wyattauthor=M.+J.+Allenauthor=A.+D.+Borthwickauthor=D.+E.+Daviesauthor=A.+M.+Exallauthor=R.+J.+D.+Hatleyauthor=W.+R.+Irvingauthor=D.+G.+Livermoreauthor=N.+D.+Millerauthor=F.+Nerozziauthor=S.+L.+Sollisauthor=A.+K.+Szardenings&title=2%2C5-Diketopiperazines+as+potent+and+selective+oxytocin+antagonists.+1%3A+Identification%2C+stereochemistry+and+initial+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DExall%26aufirst%3DA.%2BM.%26aulast%3DHatley%26aufirst%3DR.%2BJ.%2BD.%26aulast%3DIrving%26aufirst%3DW.%2BR.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DMiller%26aufirst%3DN.%2BD.%26aulast%3DNerozzi%26aufirst%3DF.%26aulast%3DSollis%26aufirst%3DS.%2BL.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26atitle%3D2%252C5-Diketopiperazines%2520as%2520potent%2520and%2520selective%2520oxytocin%2520antagonists.%25201%253A%2520Identification%252C%2520stereochemistry%2520and%2520initial%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2579%26epage%3D2582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="note"><p class="first last">The in silico predictions (with high levels of confidence) for CNS-penetration of this class of compounds (and in particular Retosiban) have always been low and therefore it was not been considered a significant risk.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="note"><p class="first last">High B/A efflux ratios of 16:1 and 19:1 were obtained for the initial leads 4-F-phenyl derivative <b>31</b> and the 4-NMe<sub>2</sub>-phenyl derivative <b>32</b> in the in vitro MDR1-MDCK cell line model for CNS-penetration, unpublished observations.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Borthwick, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exall, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nerozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabbir, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woollard, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span> </span><span class="NLM_article-title">2,5-Diketopiperazines as potent, selective and orally bioavailable oxytocin antagonists. 2: Synthesis, chirality and pharmacokinetics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6956</span><span class="NLM_x">–</span> <span class="NLM_lpage">6969</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050557v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6956-6969&author=A.+D.+Borthwickauthor=D.+E.+Daviesauthor=A.+M.+Exallauthor=D.+G.+Livermoreauthor=S.+L.+Sollisauthor=F.+Nerozziauthor=M.+J.+Allenauthor=M.+Perrenauthor=S.+S.+Shabbirauthor=P.+M.+Woollardauthor=P.+G.+Wyatt&title=2%2C5-Diketopiperazines+as+potent%2C+selective+and+orally+bioavailable+oxytocin+antagonists.+2%3A+Synthesis%2C+chirality+and+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm050557v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050557v%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DExall%26aufirst%3DA.%2BM.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DSollis%26aufirst%3DS.%2BL.%26aulast%3DNerozzi%26aufirst%3DF.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DPerren%26aufirst%3DM.%26aulast%3DShabbir%26aufirst%3DS.%2BS.%26aulast%3DWoollard%26aufirst%3DP.%2BM.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26atitle%3D2%252C5-Diketopiperazines%2520as%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520oxytocin%2520antagonists.%25202%253A%2520Synthesis%252C%2520chirality%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6956%26epage%3D6969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Borthwick, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exall, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatley, R. J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irving, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nerozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valko, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabbir, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woollard, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, M. A.</span><span> </span><span class="NLM_article-title">2,5-Diketopiperazines as Potent, Selective and Orally Bioavailable Oxytocin Antagonists 3: Synthesis, Pharmacokinetics and in vivo potency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4159</span><span class="NLM_x">–</span> <span class="NLM_lpage">4970</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060073e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4159-4970&author=A.+D.+Borthwickauthor=D.+E.+Daviesauthor=A.+M.+Exallauthor=R.+J.+D.+Hatleyauthor=J.+A.+Hughesauthor=W.+R.+Irvingauthor=D.+G.+Livermoreauthor=S.+L.+Sollisauthor=F.+Nerozziauthor=K.+L.+Valkoauthor=M.+J.+Allenauthor=M.+Perrenauthor=S.+S.+Shabbirauthor=P.+M.+Woollardauthor=M.+A.+Price&title=2%2C5-Diketopiperazines+as+Potent%2C+Selective+and+Orally+Bioavailable+Oxytocin+Antagonists+3%3A+Synthesis%2C+Pharmacokinetics+and+in+vivo+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm060073e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060073e%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DExall%26aufirst%3DA.%2BM.%26aulast%3DHatley%26aufirst%3DR.%2BJ.%2BD.%26aulast%3DHughes%26aufirst%3DJ.%2BA.%26aulast%3DIrving%26aufirst%3DW.%2BR.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DSollis%26aufirst%3DS.%2BL.%26aulast%3DNerozzi%26aufirst%3DF.%26aulast%3DValko%26aufirst%3DK.%2BL.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DPerren%26aufirst%3DM.%26aulast%3DShabbir%26aufirst%3DS.%2BS.%26aulast%3DWoollard%26aufirst%3DP.%2BM.%26aulast%3DPrice%26aufirst%3DM.%2BA.%26atitle%3D2%252C5-Diketopiperazines%2520as%2520Potent%252C%2520Selective%2520and%2520Orally%2520Bioavailable%2520Oxytocin%2520Antagonists%25203%253A%2520Synthesis%252C%2520Pharmacokinetics%2520and%2520in%2520vivo%2520potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4159%26epage%3D4970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Liddle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borthwick, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exall, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamlett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irving, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCafferty, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nerozzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peace, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabbir, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sollis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westfall, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woollard, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, D. M.</span><span> </span><span class="NLM_article-title">The discovery of GSK221149A: a potent and selective oxytocin antagonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=90-94&author=J.+Liddleauthor=M.+J.+Allenauthor=A.+D.+Borthwickauthor=D.+P.+Brooksauthor=D.+E.+Daviesauthor=R.+M.+Edwardsauthor=A.+M.+Exallauthor=C.+Hamlettauthor=W.+R.+Irvingauthor=A.+M.+Masonauthor=G.+P.+McCaffertyauthor=F.+Nerozziauthor=S.+Peaceauthor=J.+Philpauthor=D.+Pollardauthor=M.+A.+Pullenauthor=S.+S.+Shabbirauthor=S.+L.+Sollisauthor=T.+D.+Westfallauthor=P.+M.+Woollardauthor=C.+Wuauthor=D.+M.+Hickey&title=The+discovery+of+GSK221149A%3A+a+potent+and+selective+oxytocin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiddle%26aufirst%3DJ.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DBrooks%26aufirst%3DD.%2BP.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26aulast%3DEdwards%26aufirst%3DR.%2BM.%26aulast%3DExall%26aufirst%3DA.%2BM.%26aulast%3DHamlett%26aufirst%3DC.%26aulast%3DIrving%26aufirst%3DW.%2BR.%26aulast%3DMason%26aufirst%3DA.%2BM.%26aulast%3DMcCafferty%26aufirst%3DG.%2BP.%26aulast%3DNerozzi%26aufirst%3DF.%26aulast%3DPeace%26aufirst%3DS.%26aulast%3DPhilp%26aufirst%3DJ.%26aulast%3DPollard%26aufirst%3DD.%26aulast%3DPullen%26aufirst%3DM.%2BA.%26aulast%3DShabbir%26aufirst%3DS.%2BS.%26aulast%3DSollis%26aufirst%3DS.%2BL.%26aulast%3DWestfall%26aufirst%3DT.%2BD.%26aulast%3DWoollard%26aufirst%3DP.%2BM.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DHickey%26aufirst%3DD.%2BM.%26atitle%3DThe%2520discovery%2520of%2520GSK221149A%253A%2520a%2520potent%2520and%2520selective%2520oxytocin%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D90%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">McCafferty, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woollard, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borthwick, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westfall, T. D.</span><span> </span><span class="NLM_article-title">Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">R299</span><span class="NLM_x">–</span> <span class="NLM_lpage">R305</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2007&pages=R299-R305&author=G.+P.+McCaffertyauthor=M.+A.+Pullenauthor=C.+Wuauthor=R.+M.+Edwardsauthor=M.+J.+Allenauthor=P.+M.+Woollardauthor=A.+D.+Borthwickauthor=J.+Liddleauthor=D.+M.+Hickeyauthor=D.+P.+Brooksauthor=T.+D.+Westfall&title=Use+of+a+novel+and+highly+selective+oxytocin+receptor+antagonist+to+characterize+uterine+contractions+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCafferty%26aufirst%3DG.%2BP.%26aulast%3DPullen%26aufirst%3DM.%2BA.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DEdwards%26aufirst%3DR.%2BM.%26aulast%3DAllen%26aufirst%3DM.%2BJ.%26aulast%3DWoollard%26aufirst%3DP.%2BM.%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26aulast%3DLiddle%26aufirst%3DJ.%26aulast%3DHickey%26aufirst%3DD.%2BM.%26aulast%3DBrooks%26aufirst%3DD.%2BP.%26aulast%3DWestfall%26aufirst%3DT.%2BD.%26atitle%3DUse%2520of%2520a%2520novel%2520and%2520highly%2520selective%2520oxytocin%2520receptor%2520antagonist%2520to%2520characterize%2520uterine%2520contractions%2520in%2520the%2520rat%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D2007%26volume%3D293%26spage%3DR299%26epage%3DR305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Borthwick, A. D.; Liddle, J.</span><span> </span><span class="NLM_article-title">The design of orally bioavailable 2,5-diketopiperazine oxytocin antagonists: from concept to clinical candidate for premature labour</span>.  <span class="citation_source-journal">Med. Res. Rev.</span>, published online December 21,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span><a href="http://dx.doi.org/10.1002/med.20193" class="extLink">http://dx.doi.org/10.1002/med.20193</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+D.+Borthwick&author=J.+Liddle&title=The+design+of+orally+bioavailable+2%2C5-diketopiperazine+oxytocin+antagonists%3A+from+concept+to+clinical+candidate+for+premature+labour"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26atitle%3DThe%2520design%2520of%2520orally%2520bioavailable%25202%252C5-diketopiperazine%2520oxytocin%2520antagonists%253A%2520from%2520concept%2520to%2520clinical%2520candidate%2520for%2520premature%2520labour%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Borthwick, A. D.; Sollis, S. L.</span> PCT Patent Appl. WO 2006000400 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Borthwick%2C+A.+D.%3B+Sollis%2C+S.+L.+PCT+Patent+Appl.+WO+2006000400+A1%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Borthwick, A. D.; Hickey, D. M. B.; Liddle, J.; Mason, A. M.; Pollard, D. R.; Sollis, S. L.</span> PCT Patent Appl WO 2006000759 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Borthwick%2C+A.+D.%3B+Hickey%2C+D.+M.+B.%3B+Liddle%2C+J.%3B+Mason%2C+A.+M.%3B+Pollard%2C+D.+R.%3B+Sollis%2C+S.+L.+PCT+Patent+Appl+WO+2006000759+A1%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Borthwick, A. D.; Hickey, D. M. B.; Liddle, J.; Mason, A. M.</span> PCT Patent Appl WO 2006000399 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Borthwick%2C+A.+D.%3B+Hickey%2C+D.+M.+B.%3B+Liddle%2C+J.%3B+Mason%2C+A.+M.+PCT+Patent+Appl+WO+2006000399+A1%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBorthwick%26aufirst%3DA.%2BD.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span>Reprinted from  <span class="citation_source-journal">Trends in Endocrinology and Metabolism</span><a href="http://www.sciencedirect.com/science/journal/10432760" class="extLink">http://www.sciencedirect.com/science/journal/10432760</a>, Vol.  <span class="NLM_volume">14</span>, <span class="NLM_contrib-group">Zingg, H. H.; Laporte, S. A.</span>, <span> </span><span class="NLM_article-title">The oxytocin receptor</span>, pp  <span class="NLM_fpage">222</span>− <span class="NLM_lpage">227</span>, Copyright <b>2003</b>, with permission from Elsevier.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Reprinted+from+Trends+in+Endocrinology+and+Metabolismhttp%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Fjournal%2F10432760%2C+Vol.+14%2C+Zingg%2C+H.+H.%3B+Laporte%2C+S.+A.%2C+The+oxytocin+receptor%2C+pp+222%E2%88%92227%2C+Copyright+2003%2C+with+permission+from+Elsevier."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Endocrinology%2520and%2520Metabolism%26volume%3D14%26aulast%3DZingg%26aufirst%3DH.%2BH.%26atitle%3DThe%2520oxytocin%2520receptor%26spage%3D222%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span>Reprinted from  <span class="citation_source-journal">Bioorganic & Medicinal Chemistry Letters</span><a href="http://www.sciencedirect.com/science/journal/0960894X" class="extLink">http://www.sciencedirect.com/science/journal/0960894X</a>, Vol.  <span class="NLM_volume">19</span>, <span class="NLM_contrib-group">Barton, N. P.; Bellenie, B. R.; Doran, A. T.; Emmons, A. J.; Heer, J. P.; Salvagno, C. M.</span>, <span> </span><span class="NLM_article-title">Discovery and optimization of a potent and selective tertiary sulfonamide oxytocin antagonist</span>, pp  <span class="NLM_fpage">528</span>− <span class="NLM_lpage">532</span>, Copyright<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span>with permission from Elsevier.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=528-532&author=N.+P.+Barton&author=B.+R.+Bellenie&author=A.+T.+Doran&author=A.+J.+Emmons&author=J.+P.+Heer&author=C.+M.+Salvagno&title=Discovery+and+optimization+of+a+potent+and+selective+tertiary+sulfonamide+oxytocin+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26volume%3D19%26aulast%3DBarton%26aufirst%3DN.%2BP.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520potent%2520and%2520selective%2520tertiary%2520sulfonamide%2520oxytocin%2520antagonist%26spage%3D528%26epage%3D532%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901812z&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm901812z%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901812z" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679971000fdb3d9a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
